Characterization of She2p-dependent mRNP assembly in Saccharomyces cerevisiae by Müller, Marisa
Dissertation zur Erlangung des Doktorgrades 
der Fakultät für Chemie und Pharmazie 
der Ludwig-Maximilians-Universität München 
 
 
 
Characterization of She2p-dependent mRNP assembly 
in Saccharomyces cerevisiae 
 
 
 
 
 
 
 
Marisa Müller 
aus 
Pforzheim 
2009
  
Erklärung 
Diese Dissertation wurde im Sinne von § 13 Abs. 3 der Promotionsordnung vom 29. Januar 
1998 von Herrn Prof. Dr. Patrick Cramer betreut. 
 
 
Ehrenwörtliche Versicherung 
Diese Dissertation wurde selbständig, ohne unerlaubte Hilfe erarbeitet. 
 
München, am 26. Mai 2009  
 
 
........................................................ 
Marisa Müller 
 
 
 
 
 
Dissertation eingereicht am 26. Mai 2009 
1. Gutachter: Prof. Dr. Patrick Cramer 
2. Gutachter: Prof. Dr. Klaus Förstemann 
Mündliche Prüfung am 8. Juli 2009 
TABLE OF CONTENTS 
 
Table of Contents 
 
         SUMMARY ................................................................................................................................ 1 
1 INTRODUCTION ....................................................................................................................... 2 
1.1 mRNA localization – a common mechanism for targeting proteins ........................................... 3 
1.2 Assembly and translocation of an mRNA-transport particle ...................................................... 4 
1.2.1 Assembly of the mRNP (Step1 in Figure 2) ...................................................................... 5 
1.2.2 Motor-driven translocation of a translationally silenced mRNP along cytoskeletal tracks 
 (Step 2 in Figure 2) ........................................................................................................... 7 
1.2.3 Anchoring of the mRNP and translation of localized mRNAs 
 (Steps 3 and 4 in Figure 2) ............................................................................................... 9 
1.3 mRNA localization in somatic cells ............................................................................................ 9 
1.3.1 mRNA localization in fibroblasts ....................................................................................... 9 
1.3.2 mRNA localization in the neuronal system ..................................................................... 10 
1.4 mRNA localization in oocytes and developing embryos .......................................................... 11 
1.4.1 mRNA localization in Xenopus laevis oocytes ................................................................ 11 
1.4.2 Localization of gurken, bicoid and oskar mRNA during Drosophila oogenesis .............. 12 
1.5 mRNA localization in Saccharomyces cerevisiae ................................................................... 13 
1.5.1 “Mating type switching” – the biological function of ASH1-mRNA localization ............... 14 
1.5.2 ASH1 and at least 23 additional bud-localized mRNAs .................................................. 15 
1.5.3 She2p – the cargo-binding protein .................................................................................. 17 
1.5.4 She3p links the She2p:mRNA complex to the myosin-motor protein Myo4p ................. 19 
1.5.5 Additional trans-acting factors involved in ASH1-mRNA localization ............................. 20 
1.5.6 Current model of ASH1-mRNA localization .................................................................... 22 
1.6 Objectives ................................................................................................................................ 23 
2 RESULTS ................................................................................................................................ 24 
2.1 Structural studies on the She2p:RNA interaction .................................................................... 24 
2.1.1 Purification of She2p variants ......................................................................................... 24 
2.1.2 Designing She2p variants for crystallization ................................................................... 25 
2.1.3 Identification of suitable ASH1-RNA fragments for co-crystallization ............................. 26 
2.1.3.1 She2p-(6-246)-ΔCys is suitable for crystallization with ASH1-E3 RNA and 
 minimized ASH1 zipcodes...................................................................................... 27 
2.1.3.2 Binding studies with She2p-Δloop and She2p-ΔhelixE .......................................... 28 
2.1.4 Co-crystallization experiments with ASH1-E3, E1min, and E2Bmin RNA ...................... 28 
2.1.5 Crystallization of She2p in complex with ASH1 E2Bmin-21 variants ............................. 29 
2.1.6 Can She2p crystals be soaked with RNA? ..................................................................... 30 
2.1.7 Exploratory NMR experiments with She2p ..................................................................... 31 
TABLE OF CONTENTS 
 
2.2 Functional analysis of mRNP assembly .................................................................................. 32 
2.2.1 She2p binds to zipcode elements with nanomolar affinity .............................................. 32 
2.2.2 She2p has considerable affinity to stem-loop containing RNAs ..................................... 34 
2.2.4 She2p has low affinity to a short zipcode-consensus sequence .................................... 35 
2.2.5 Identification of conserved regions in She2p for mutational analysis ............................. 37 
2.2.6 The basic helical hairpin motif provides a general binding platform for stem-loop 
 containing RNA ............................................................................................................... 39 
2.2.7 The upper uncharged surface region is also required for recognition of stem-loop 
 containing RNAs ............................................................................................................. 39 
2.2.8 Helix E is required for recognition of ASH1 zipcodes ..................................................... 41 
2.2.9 The She2p C-terminus also contributes to ASH1-mRNA binding .................................. 42 
2.2.10 Reduction of basic RNA binding abolishes bud-tip localization of She2p in vivo ....... 43 
2.2.11 Selectively impaired ASH1-mRNA binding results in mislocalization of She2p 
 in vivo .......................................................................................................................... 44 
2.2.12 Impaired ASH1-mRNA binding by She2p results in mislocalization of ASH1 mRNA  
 in vivo .......................................................................................................................... 46 
2.2.13 Impaired RNA binding by She2p affects translocation-complex assembly ................ 46 
2.2.14 She2p forms homo-oligomers through the upper surface region ............................... 48 
2.2.14.1 Dynamic Light Scattering indicates large She2p particles ..................................... 49 
2.2.14.2 Analytical ultracentrifugation identifies She2p decamers that assemble through  
 the upper surface region ........................................................................................ 50 
2.2.14.3 Electron microscopy suggests She2p oligomers smaller than a decamer ............ 53 
2.2.15 She2p is tetrameric at physiological protein concentrations ...................................... 53 
2.2.16 Small Angle X-ray Scattering (SAXS) studies identify She2p tetramers .................... 56 
2.2.16.1 Identification of suitable buffer conditions for SAXS measurements ..................... 56 
2.2.16.2 SAXS confirms tetramer formation in solution ....................................................... 58 
2.2.17 SAXS indicates that She2p forms an elongated tetramer .......................................... 61 
2.2.18 Low resolution models of wild-type She2p ................................................................. 66 
2.2.19 Attempt to obtain an atomic model of tetrameric She2p ............................................ 68 
3 DISCUSSION .......................................................................................................................... 69 
3.1 She2p binds RNA through a composite binding site ............................................................... 69 
3.2 She2p tetramers are the functional units ................................................................................. 76 
3.3 She2p-tetramer formation allows simultaneous binding of different RNAs ............................. 80 
3.4 How are She2p-dependent priming complexes stabilized? - Implications for She2p- 
 dependent mRNP assembly in S. cerevisiae .......................................................................... 82 
3.5 She2p binds RNA in multiple modes ....................................................................................... 85 
4 MATERIALS AND METHODS ................................................................................................. 87 
4.1 Consumables and chemicals ................................................................................................... 87 
4.2 Oligonucleotides ...................................................................................................................... 87 
4.2.1 DNA oligonucleotides ...................................................................................................... 87 
4.2.2 RNA oligonucleotides ...................................................................................................... 88 
4.2.3 DNA oligonucleotides to generate templates for in vitro transcription ............................ 89 
TABLE OF CONTENTS 
 
4.3 Plasmids .................................................................................................................................. 90 
4.3.1 Plasmids for protein expression in E. coli ....................................................................... 90 
4.3.2 Yeast plasmids ................................................................................................................ 91 
4.4 Bacterial strains ....................................................................................................................... 91 
4.5 Yeast strains ............................................................................................................................ 91 
4.6 Media and supplements........................................................................................................... 92 
4.7 Antibodies ................................................................................................................................ 93 
4.8 Bioinformatic tools and software .............................................................................................. 93 
4.9 Cloning, expression and purification methods ......................................................................... 94 
4.9.1 Cloning ............................................................................................................................ 94 
4.9.2 Recombinant protein expression in E. coli ...................................................................... 94 
4.9.3 Isotopic 15N-labeling for NMR spectroscopy ................................................................... 95 
4.9.4 Purification of recombinant She2p variants .................................................................... 95 
4.10 Methods for protein analysis ............................................................................................... 96 
4.10.1 Western blotting .......................................................................................................... 96 
4.10.2 Dynamic Light Scattering ............................................................................................ 97 
4.10.3 Analytical ultracentrifugation ....................................................................................... 97 
4.10.4 Analytical size-exclusion chromatography ................................................................. 98 
4.10.5 Monoclonal antibodies ................................................................................................ 98 
4.11 Biochemical analysis of She2p:RNA interactions ............................................................... 99 
4.11.1 In vitro transcription and RNA purification .................................................................. 99 
4.11.2 Isotopic labeling of RNA oligonucleotides ................................................................ 100 
4.11.2.1 5’-end labeling ...................................................................................................... 100 
4.11.2.2 3’-end labeling ...................................................................................................... 100 
4.11.3 Electrophoretic mobility shift assay (EMSA) ............................................................. 101 
4.11.4 RNA filter-binding assay ........................................................................................... 101 
4.11.5 Surface Plasmon Resonance ................................................................................... 101 
4.12 In vivo analysis of protein function .................................................................................... 102 
4.12.1 Transformation and cultivation of yeast cells ........................................................... 102 
4.12.2 Preparation of yeast analytical whole-cell extracts ................................................... 102 
4.12.3 Co-immunoprecipitation ............................................................................................ 102 
4.12.4 Fluorescence microscopy ......................................................................................... 104 
4.12.4.1 Preparation of yeast spheroplasts ........................................................................ 104 
4.12.4.2 Indirect immunofluorescence ............................................................................... 104 
4.13 Methods for structural analysis.......................................................................................... 104 
4.13.1 NMR data acquisition................................................................................................ 104 
4.13.2 Crystallization of She2p:RNA complexes ................................................................. 105 
4.13.3 Small Angle X-ray Scattering (SAXS) experiments and data processing ................ 105 
5 REFERENCES ...................................................................................................................... 107 
TABLE OF CONTENTS 
 
6 APPENDIX ............................................................................................................................. 120 
6.1 Secondary-structure predictions of zipcode elements and of unrelated stem-loop      
 containing RNAs .................................................................................................................... 120 
6.2 RNA oligonucleotides used for co-crystallization experiments with She2p-(6-246)-ΔCys .... 121 
6.3 2D 1H-15N-HSQC spectrum of wild-type She2p ..................................................................... 121 
6.4 She2p-sequence alignment ................................................................................................... 122 
6.5 Assessment of ASH1-mRNA localization by in situ hybridization ......................................... 123 
6.6 Sedimentation profile of wild-type She2p as obtained in sedimentation-velocity      
 experiments ........................................................................................................................... 123 
CURRICULUM VITAE .................................................................................................................... 124 
PUBLICATIONS ............................................................................................................................. 125 
ACKNOWLEDGEMENTS .............................................................................................................. 126 
 
 
SUMMARY 
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Summary 
 
Selective translocation of ASH1 mRNA during the budding of Saccharomyces cerevisiae 
represents the most comprehensively understood example of mRNA localization. The three 
core components of the ASH1-translocation complex - the RNA-binding protein She2p, the 
adapter protein She3p, and the myosin-motor protein Myo4p - assemble together into an 
mRNP and transport the RNA cargo to the daughter cell. Besides ASH1 mRNA, more than 
30 mRNAs are known to localize in a She2p-dependent manner. Each mRNA contains 
distinct zipcode elements that need to be specifically recognized by She2p. The present study 
dealt with the question, how the RNA-binding protein She2p selectively recognizes its target 
mRNAs and how RNA binding influences the assembly of functional mRNPs.  
Biochemical studies revealed that She2p binds with nanomolar affinity to different zipcode 
elements from localizing mRNAs. Surprisingly, She2p showed significant binding to a subset 
of unrelated stem-loop containing RNAs, raising the question how She2p discriminates 
between target and non-target RNAs. Mutational analyses identified the protruding α-helix E 
and the very C-terminus of She2p to be required for specific ASH1-mRNA binding, but not 
for binding to unrelated stem-loop containing RNAs. In contrast, the basic unspecifc 
recognition of RNA stem-loop structures was assigned to the basic helical hairpin RNA-
binding motif. Selective impairment of specific RNA binding by mutation of the α-helix E or 
the very C-terminus results in loss of ASH1-mRNA and She2p localization in vivo. In addition, 
the formation of stable transport complexes is disrupted, demonstrating the requirement of 
correct target-mRNA recognition by She2p for the assembly of translocation-competent 
mRNPs. In the previously determined crystal structure of She2p, a dimer was suggested to be 
the functional oligomeric state in solution. The present study, however, revealed that She2p 
forms larger oligomers through its upper uncharged surface area. Two She2p dimers associate 
in a head-to-head orientation to form an elongated tetrameric complex. Along the opposing 
flat sides of this tetramer, two extended continuous RNA-binding surfaces are generated by 
the basic helical hairpin motif, the protruding helix E, and the very C-terminus of She2p. Such 
a composite RNA-binding motif on She2p tetramers is indispensable for RNA binding and 
specific mRNP assembly in vivo. With its combination of static and flexible structural elements 
She2p appears to be well designed to specifically recognize a number of different localizing 
mRNAs by applying multiple binding modes. 
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1  Introduction 
 
 
 
 
 
 
 
 
 
A milestone publication by the laboratory of Henry M. Krause showed that the majority of 
transcripts expressed during early embryogenesis of Drosophila display specific subcellular 
localizations (Lecuyer et al., 2007). Besides the most prevalent sub-embryonic localization 
patterns, they identified a large number of mRNAs exhibiting novel distribution patterns. For 
example, they observed varieties in apico-basal, membrane-associated or nuclei-associated 
patterns. In Figure 1, a selection of observed localization patterns is shown. Together with 
genetic approaches (Tenenbaum et al., 2000; Ule et al., 2003), these systematic genome-wide 
analyses have enabled global surveys of the mRNA localization dynamics. Importantly, these 
studies also revealed tight correlations between mRNA localization and the distribution and 
function of the encoded proteins, suggesting an important role of transcript localization in 
organizing cellular architecture.  
The following introduction begins with a summary of the mechanisms by which RNAs can 
become localized. Next, the assembly and translocation of an RNA transport particle will be 
explained, followed by a presentation of selected examples for localized mRNAs in somatic 
cells, in oocytes, and in embryos of higher eukaryotes. Finally, Saccharomyces cerevisiae, the best-
characterized model organism for studying mRNA translocation, will be introduced and the 
principles of mRNA localization in yeast will be explained in detail. 
Figure 1: mRNA localization is a universal mechanism to control cellular architecture and 
function. Analysis of about 25 % of the mRNAs encoded by the Drosophila genome by high-resolution 
fluorescent in situ hybridization revealed that among those RNAs 71 % of expressed transcripts are 
subcellularly localized (Lecuyer et al., 2007). The illustration shows a selection of the observed localization 
patterns in early developmental stages of Drosophila embryogenesis. The anterior pole is to the left, the 
posterior pole to the right. mRNA is stained in green, nuclei are stained in red. Image was taken from 
Martin and Ephrussi, 2009. 
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1.1  mRNA localization – a common mechanism for targeting   
  proteins 
The discovery of the signal peptide by Günter Blobel and colleagues suggested that proteins 
are targeted to specific regions in a cell exclusively following translation (Blobel and 
Dobberstein, 1975). However, over the last 20 years it became clear that subcellular 
localization of messenger RNA also serves as a way of post-transcriptional gene regulation. 
Precise spatial and temporal control of the mRNA-localization process permits localized 
translation at discrete sites within cells. This specific positioning of cytoplasmic determinants 
results in cellular polarization and functional compartmentalization. It thereby contributes to 
many key-biological processes as body-axis specification, cell-fate determination, motility, and 
synaptic plasticity (Kloc et al., 2002; St Johnston, 2005). Why should cells regulate protein 
distribution by localizing its mRNA? An important reason is the possibility to spatially restrict 
protein synthesis within the cytoplasm. This allows cells to respond rapidly to local stimuli 
and, by this means, to regulate gene expression independently in different parts of the cell. 
Furthermore, mRNA localization not only targets the protein to the site of destination but 
also prevents its synthesis elsewhere. This is important if the protein might have toxic or 
deleterious effects on other cellular compartments. Additionally, a localized mRNA can be 
translated “in place” multiple times resulting in high local protein concentration. This process 
is more economic than transporting every single copy of the protein to a distinct site. 
Asymmetric sorting of mRNAs can be achieved by several processes. The simplest, but very 
rare mechanism to localize an mRNA is by its local synthesis. This has been described for the 
mRNAs encoding the δ- and ε-subunits of the acetylcholine receptor that are exclusively 
transcribed in nuclei close to the neuromuscular junctions in mammalian myofibers (Brenner 
et al., 1990; Simon et al., 1992). The local transcription thus targets the mRNAs to the 
synapses, their later site of function. Secondly, mRNAs can be asymmetrically sorted by 
localized protection of degradation. This mechanism has been shown best for the heat-shock 
protein-83 (hsp83) mRNA, which restricts hsp83 mRNA to the posterior pole plasm in the egg 
of Drosophila melanogaster (Ding et al., 1993). Interestingly, this process requires two 
independent regions within the 3’ untranslated region of the mRNA. One element targets the 
mRNA for destruction within all regions of the egg and a second element protects and 
stabilizes correctly localized mRNAs at the posterior pole (Bashirullah et al., 1999). Thirdly, 
mRNAs can become localized to specific subcellular regions by passively diffusing through 
the cytoplasm and subsequent entrapment by a localized anchor. This mechanism is known to 
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translocate Drosophila nanos mRNA late in oogenesis from the nurse cell to the posterior pole 
of the oocyte. At the posterior pole nanos localizes by association with the assembled pole 
plasm and by actin-dependent anchoring (Forrest and Gavis, 2003). This mechanism has also 
been proposed for Xcat2 mRNA from Xenopus laevis. In germ cell development, Xcat2 mRNA 
localizes to the developing germ plasm by random diffusion through the cytoplasm and 
successive immobilization through association with the endoplasmic reticulum in the 
mitochondrial cloud (Chang et al., 2004). Lastly, the most-prominent and probably best-
characterized mechanism for asymmetric distribution of mRNA is the active and directed 
transport (St Johnston, 2005). This multistep process starts with the recognition of cis-acting 
elements within the mRNA, termed “localization elements” or “zipcodes”, by trans-acting 
factors. These are usually dedicated RNA-binding proteins, which then recruit specific motor-
protein complexes. Dependent on the type of the motor protein, the mRNA-transport particle 
(mRNP) is transported along microtubules (dynein, kinesin) or actin filaments (myosin). At 
the site of destination, the mRNA is anchored and the encoded protein is translated. The 
process of directed mRNA transport will be explained in detail in the following chapter (1.2). 
 
1.2  Assembly and translocation of an mRNA-transport particle 
From the first discoveries of localized transcripts about 30 years ago until now, we know more 
and more details of the mechanisms underlying localization processes. However, despite the 
dramatically increased understanding, the initially proposed general principles how mRNAs 
are actively localized, have virtually not changed. In the early 1990s, an ordered pathway for 
unidirectional movement of “particles” has been proposed and is sketched in Figure 2 
(Wilhelm and Vale, 1993). With respect to additional information we now have on each of the 
described steps, this scheme is still valid.  
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1.2.1 Assembly of the mRNP (Step1 in Figure 2) 
The first step in mRNP assembly already occurs in the nucleus when a dedicated trans-acting 
factor specifically binds most likely co-transcriptionally to cis-acting elements within the 
mRNA target. It is suggested that the cytoplasmic fate of localizing mRNAs is predestined by 
factors acquired in the nucleus (Giorgi and Moore, 2007).  
Cis-acting elements 
In order to become specifically localized to subcellular regions, mRNAs contain so called cis-
acting localization elements or “zipcodes”. These elements comprise the cellular “address” of 
the transcript and are recognized by specific trans-acting factors. Zipcodes are most frequently 
found in the 3’ untranslated region (UTR) of the transcript, although in some cases they also 
reside in the 5’ UTR or within the coding region (Jambhekar and DeRisi, 2007). In general, 
zipcodes function independently of nearby RNA sequences. Zipcodes fused to reporter RNAs 
direct a subcellular distribution of the reporter RNA similar to that observed for the native 
mRNA (Jambhekar and DeRisi, 2007). In some instances, zipcodes have been shown to 
function in different cell types, suggesting a certain redundancy when recognized by shared, 
Figure 2: Pathway for mRNP translocation. In the nucleus, dedicated RNA-binding proteins 
recognize specific cis-acting elements in their target mRNA, which reside usually in the 3’ UTR and often 
fold into stem-loop structures. During splicing, additional factors assemble on the nuclear mRNP 
(step 1), which is then exported to the cytoplasm. In the cytoplasm, the mRNP is remodeled. Additional 
proteins like translational repressors and proteins linking the mRNP to motor proteins join the complex 
(step 1). Dyneins and kinesins transport the mature mRNP along microtubules, whereas myosins 
translocate their cargo along actin microfilaments to the final site of destination (step 2). After anchoring 
the mRNP at cytoskeletal elements (step 3), the translational repression is released and the localized 
mRNA is spatially translated (step 4). The figure was taken from Wilhelm and Vale, 1993. 
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homologous RNA-binding proteins (Bullock and Ish-Horowicz, 2001). Zipcodes are very 
heterogeneous in their nature and complexity and thus, are very difficult to predict (Hamilton 
and Davis, 2007). The length of zipcodes can range from only five to six nucleotides (e.g. the 
VM1 and E2 elements in the 3’ UTR of the Xenopus Vg1 mRNA) up to 1 kb (e.g. the 3’ UTR 
of MBP mRNA) (Ainger et al., 1997; Deshler et al., 1997). In case of MBP mRNA (see also 
below, chapter 1.3.2), it is only the primary sequence of the 11-nucleotides zipcode A2RE, 
which directs the localization of MBP mRNA to oligodendrocyte processes (Hoek et al., 
1998). However, localization elements usually form distinct secondary structures, most 
commonly stem-loop structures that are critical for localization. In some mRNAs, like in 
Xenopus Vg1 mRNA, multiples copies of the zipcode are clustered and act synergistically to 
localize the mRNA (Lewis et al., 2004). Drosophila nanos mRNA contains four zipcode 
elements in its 3’ UTR, each of which localizes nanos to the posterior pole of the ooycte. 
However, all four elements together localize nanos with high efficiency to its final site (Gavis et 
al., 1996). Similarly, ASH1 mRNA from Saccharomyces cerevisiae contains four distinct zipcodes, 
each of which are sufficient for localization but are altogether required for full levels of ASH1 
localization (for further details on mRNA localization in S. cerevisiae, see chapter 1.5) 
(Chartrand et al., 1999; Gonzalez et al., 1999). Such synergistic effects are believed to facilitate 
the association of trans-acting factors and the formation of a translocation-competent mRNP. 
Trans-acting factors  
Trans-acting factors play an important role in directing and regulating mRNA localization, 
since they recognize the zipcodes within the mRNA, recruit motor proteins, and link the 
mRNA target to cytoskeletal tracks. However, the molecular mechanisms underlying the 
coupling of mRNA to motor complexes are only poorly understood. Trans-acting factors have 
been identified by genetic screens for genes involved in mRNA localization and by affinity 
purification of proteins associated with known localization elements (Martin and Ephrussi, 
2009). One of the most-prominent trans-acting factors involved in mRNA localization is 
Staufen. Staufen was first identified in Drosophila melanogaster because of its role in body-axis 
formation, which reflects its function in oskar and bicoid mRNA localization (St Johnston et al., 
1991) (see also chapter 1.4.2). When injected into early embryos, Staufen binds to stem-loop 
structures in the bicoid 3’ UTR to form mRNPs that move in a microtubule-dependent manner 
(Ferrandon et al., 1994). Drosophila Staufen contains five conserved double-stranded RNA-
binding domains (dsRBD), each of which can bind to dsRNA (Ferrandon et al., 1994; St 
Johnston et al., 1992). Interestingly, the Staufen dsRBDs are individually necessary for 
INTRODUCTION 
7 
different transport pathways. For instance, dsRBD5 mediates the actin-dependent localization 
of prospero mRNA, whereas dsRBD2 is necessary for microtubule-dependent oskar localization 
(St Johnston, 2005). Thus, different domains in Staufen connect the Staufen:mRNA 
complexes to both actin- and microtubule-dependent transport pathways (Micklem et al., 
2000). However it is unclear, how the assembly of such diverse mRNPs is regulated. Another 
well known conserved trans-acting factor is the zipcode binding protein 1 (ZBP1). ZBP1 has 
been identified by affinity-purification experiments of proteins interacting with the β-actin-
mRNA zipcode in chick fibroblasts (Ross et al., 1997). ZBP1 contains two RNA recognition 
motifs (RRM) and four hnRNP K homology (KH) domains, for which distinct functions have 
been identified (Farina et al., 2003). The RRMs are required for the localization of the β-actin 
mRNP itself, whereas two out of four KH domains specifically bind to the β-actin zipcode and 
connect the assembled mRNP to the actin cytoskeleton (Farina et al., 2003). In addition, 
ZBP1 is implicated in the microtubule-dependent transport of β-actin mRNA in neurons 
(Tiruchinapalli et al., 2003; Zhang et al., 2001). In analogy to Staufen, ZBP1 is able to couple 
its target mRNA to different types of cytoskeletal elements, but additional regulatory factors 
for β-actin mRNP assembly are largely unknown. ZBP1 homologues in Xenopus laevis 
(Vg1RBP/Vera, see chapter 1.4.1) and in mammalian cells (IMP1) have both been shown to 
function in mRNA localization. This example nicely demonstrates the conservation of trans-
acting factors among cell types and species (Atlas et al., 2004; Havin et al., 1998). However, 
another well-characterized trans-acting factor, the RNA-binding protein She2p from 
S. cerevisiae, lacks any homologous counterparts in higher eukaryotes (Niessing et al., 2004). 
She2p is responsible for the transport of at least 24 mRNAs (Oeffinger et al., 2007; Shepard 
et al., 2003; Takizawa and Vale, 2000) suggesting that not only highly conserved trans-acting 
factors with defined RNA-binding motifs are able to selectively recognize their targets. 
Further details on She2p-dependent mRNA localization are described in chapter 1.5. 
 
1.2.2 Motor-driven translocation of a translationally silenced mRNP along   
  cytoskeletal tracks (Step 2 in Figure 2) 
Following export to the cytoplasm, the mRNP usually undergoes remodeling. Cytoplasmic 
factors join the RNA:protein complex, whereas nuclear factors might dissociate (Martin and 
Ephrussi, 2009). Assembled mRNPs associate with motor proteins and travel along 
microtubules or actin microfilaments, the railways for translocating mRNAs in the cytoplasm. 
Three main families of motor proteins exist: the dynein, kinesin, and the myosin families 
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(Vale, 2003). Most mRNA translocation processes involve dynein and kinesin motors, which 
move along polarized microtubules. For instance, Drosophila bicoid mRNA is transported in a 
dynein-dependent manner to the anterior pole of the oocyte, whereas oskar mRNA localizes to 
the posterior pole requiring the kinesin-1 motor protein (Duncan and Warrior, 2002; 
Januschke et al., 2002; Zimyanin et al., 2008). Similarly, mRNAs translocate along 
microtubules in Xenopus oocytes coordinated by multiple kinesin motors (Messitt et al., 2008). 
In comparison, less mRNA-localization processes are known that require myosin-motor 
proteins and polarized actin cables. Examples for actin-dependent transport processes are the 
localization of β-actin mRNA in migrating fibroblasts as well as mRNA localization by the She 
machinery in S. cerevisiae (see also chapters 1.3.1 and 1.5). In yeast, the core components of the 
translocation complex are known and the interactions between the RNA-binding protein 
She2p, the linker protein She3p, and the motor protein Myo4p are well defined (see chapter 
1.5) (Böhl et al., 2000; Jansen et al., 1996; Long et al., 2000; Takizawa and Vale, 2000). 
However, in other systems only the involvement of different motor proteins has been clearly 
established, while the connections between the zipcode-interacting proteins and motors are 
poorly understood (Bullock, 2007).  
Especially in neuronal cells it was shown that mRNPs assemble into heterogeneous granules. 
Besides several mRNAs, these granules also contain factors of the translation machinery 
including ribosomal subunits and factors involved in translational regulation (see also chapter 
1.2.3) (Kiebler and Bassell, 2006). It is generally assumed that localizing mRNAs are 
translationally silenced during the transport through the cytoplasm (Besse and Ephrussi, 
2008). This is supported by the fact that proteins encoded by the localizing mRNAs 
accumulate exclusively at the sites of destination. Translational repressors were found to 
associate with localizing mRNAs (Besse and Ephrussi, 2008). Most frequently, translation 
initiation, the rate-limiting step in translation, is regulated by targeting the eukaryotic 
translation initiation complex eIF4F. For instance, this has been shown for the Drosophila Cup 
protein, which simultaneously binds to eIF4E and oskar-associated Bruno protein thus 
preventing premature translation of oskar mRNA (Nakamura et al., 2004). Similarly, in 
S. cerevisiae ASH1-mRNA translation is repressed by association of the RNA-binding proteins 
Khd1p and Puf6p (see chapters 1.2.3 and 1.5) (Deng et al., 2008; Paquin et al., 2007).  
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1.2.3 Anchoring of the mRNP and translation of localized mRNAs (Steps 3 and
  4 in Figure 2) 
At the place of destination, the mRNP needs to be anchored and translation must be 
activated. The actin cytoskeleton was shown to be important for anchoring of a number of 
localizing mRNAs, including ASH1 mRNA in yeast, β-actin mRNA in fibroblasts, arc mRNA 
in neurons, bicoid mRNA in Drosophila oocytes and embryos, and Vg1 mRNA in Xenopus 
(Beach et al., 1999; Farina et al., 2003; Huang et al., 2007; Takizawa et al., 1997; Weil et al., 
2008; Yisraeli et al., 1990). After anchoring, the translational repression must be abrogated. 
This is commonly achieved by reducing the affinity of repressor complexes to their target 
mRNAs, for instance by spatially restricted phosphorylation of RNA-associated proteins 
(Besse and Ephrussi, 2008). Kinase-based regulation of RNA-binding proteins most likely 
represents a common mechanism for translational regulation, although it was observed for 
only a few proteins. In chick fibroblasts, phosphorylation of ZBP1 by Src kinase decreases 
ZBP1’s affinity to the bound β-actin zipcode and results in spatially restricted synthesis of β-
actin protein (Hüttelmaier et al., 2005). In yeast, the two translational repressors of ASH1 
mRNA, Puf6p and Khd1p, are phosphorylated by casein kinase II (CK2) and the type I casein 
kinase Yck1p, respectively. This leads to dissociation of Puf6p and Khd1p from ASH1 
mRNA and activation of localized translation (Deng et al., 2008; Paquin et al., 2007) (see also 
chapter 1.5). 
 
1.3  mRNA localization in somatic cells 
As mentioned above, localization of mRNA is a global mechanism to restrict protein synthesis 
to specific subcellular regions. This and the following chapter 1.4 aim to present selected, well-
understood examples of localized mRNAs in higher eukaryotes. In polarized somatic cells 
such as fibroblasts or nerve cells, localization of mRNA often contributes to cell motility and 
the development of cellular morphology.  
 
1.3.1 mRNA localization in fibroblasts 
In migrating chick and mammalian fibroblasts, β-actin mRNA localizes to the leading edge of 
lamellipodia where increased levels of the β-actin protein are required for cytoskeleton-
mediated movement (Figure 3 a) (Condeelis and Singer, 2005; Lawrence and Singer, 1986). β-
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actin mRNA localization in chick fibroblasts is initiated by co-transcriptional association of the 
zipcode binding protein 2 (ZBP2), a homologue of the human splicing factor KSRP, with the 
nascent transcript (Gu et al., 2002; Pan et al., 2007). This interaction then facilitates 
subsequent binding of the shuttling protein ZBP1 to the 54-nucleotide zipcode in the 3’ UTR 
of β-actin mRNA (Kislauskis et al., 1994; Pan et al., 2007; Ross et al., 1997). ZBP1 stays 
associated with the mRNA during the localization process and prevents premature translation 
by blocking translation initiation. At the final destination translational repression is released by 
phosphorylation of ZBP1 (see also chapter 1.2.3) (Hüttelmaier et al., 2005). The cooperative 
action of ZBP1 and ZBP2 nicely shows that the cytoplasmic localization of an mRNA is 
already triggered by the association of nuclear factors, thereby regulating the formation of a 
functional mRNP (Martin and Ephrussi, 2009). Additionally, these sequential events reflect 
the temporal and spatial control of β-actin mRNA localization that results in exclusive 
accumulation of the β-actin protein at lamellipodia. 
 
1.3.2 mRNA localization in the neuronal system 
Neurons are highly polarized and compartmentalized cells. Formation and maintenance of a 
functioning nervous system relies in part on the localization of mRNAs to defined regions in 
the neuron, including axons and dendrites. This eventually allows local translation in the 
extremities of the neuronal cells (Job and Eberwine, 2001). Purification of RNA granules from 
mouse brain that associate with the kinesin-motor protein KIF5 resulted in the identification 
of CamKIIα and arc mRNAs and about 40 proteins (Kanai et al., 2004). Among them were 
proteins previously known to function in mRNA localization in neurons, as Staufen1, the 
Fragile X Mental Retardation Protein (FMRP), and Pur-α as well as components of the 
translation machinery. However, also new proteins were found to be involved in dendritic 
RNA transport, including hnRNP U and polypyrimidine tract binding protein-associated 
splicing factor (PSF). This study suggests that many components of RNA granules may not be 
essential for the localization process itself, but may rather be structural components involved 
in mRNP assembly and stabilization. The CamKII gene encodes the calcium-dependent 
calmodulin protein kinase II, a serine-threonine kinase highly expressed in adult neurons 
composed of α- and β-subunits. CamKIIα mRNA encodes the α-subunit of CamKII and 
localizes to dendrites dependent on at least three localization elements residing in the 3’ UTR 
of the transcript (Dahm et al., 2007). However, the trans-acting factors binding to the CamKIIα 
mRNA are still largely unknown. In mammalian oligodendrocytes, myelin basic protein (MBP) 
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mRNA localizes to myelinating compartments that enclose neuronal axons (Figure 3 b). 
Interestingly, directed transport of MBP mRNA depends on two distinct localization elements 
(Ainger et al., 1997; Munro et al., 1999). One of these is called RNA trafficking signal (RTE) 
or A2RE, is only 11 nucleotides long and is bound by the heterogeneous ribonucleoprotein 
A2 (hnRNP A2). The second localization element, the RNA localization region (RLR), spans 
much of the 3’ UTR and is predicted to form extensive secondary structures with multiple 
stem loops. The first zipcode directs the transport of the MBP mRNA out of the soma 
whereas the latter targets the mRNA into the myelinating compartment. 
 
1.4  mRNA localization in oocytes and developing embryos 
Body patterning during the development of multicellular organisms essentially relies on the 
localization of mRNA to subcellular regions. This chapter aims to show some of the best-
understood examples of localized mRNAs in Xenopus and Drosophila oocytes and embryos.  
 
1.4.1 mRNA localization in Xenopus laevis oocytes 
In Xenopus oocytes, mRNAs are asymmetrically sorted to the animal or vegetal pole and 
thereby contribute to the definition of the germ cell lineage and the development of the 
animal/vegetal axis. Two indispensable pathways exist, through which mRNA localization is 
temporally restricted to early (stages I and II) and late (stages III-V) developmental stages 
(Kloc and Etkin, 1995). In the early pathway or METRO (messenger transport organizer), 
germ granules, mRNAs involved in germ cell specification, and germ-line specific 
mitochondria are transported to a specialized structure, which is known as the Balbiani body 
or the mitochondrial cloud. It serves as a vehicle to localize RNAs at the vegetal pole (Kloc 
and Etkin, 1995). Mitochondrial-cloud localization elements (MCLEs) that direct the RNA 
into the mitochondrial cloud have been discovered in the 3’ UTR of Xcat2 mRNA and within 
the non-coding Xlsirts RNA (Allen et al., 2003; Kloc et al., 1993; Zhou and King, 1996). 
Additionally, Xcat2 mRNA contains the germinal granule localization element, which 
determines Xcat2 mRNA localization to the germ-plasm region within the mitochondrial 
cloud (Figure 3 c) (Kloc et al., 2000). The localization of RNAs to the mitochondrial cloud is 
believed to be independent from cytoskeletal elements and occurs most likely through a 
diffusion/entrapment mechanism (see chapter 1.1) (Chang et al., 2004; Kloc et al., 1996). 
However, there is recent evidence that the ATP availability in the oocyte regulates Xcat2-
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mRNA localization and that the motor protein kinesin II is involved in this process (Heinrich 
and Deshler, 2009). The late pathway during mid and late oogenesis localizes mRNAs such as 
Vg1 and FatVg to the vegetal cortex (Kloc and Etkin, 2005). This process depends on 
microtubules and is believed to involve kinesin-motor proteins. Additionally, a unique 
endoplasmic-reticulum (ER) subdomain forms between the oocyte nucleus and the vegetal 
pole in which localizing mRNAs accumulate. It is still not clear if the ER serves as a matrix for 
the formation of microtubule tracks or if localizing RNAs bind to ER vesicles and are co-
transported along microtubules to the vegetal pole (Deshler et al., 1997; Kloc and Etkin, 
1998). Multiple redundant localization elements within the 3’ UTRs of Vg1 mRNA (see also 
chapter 1.2.1) and several trans-acing factors associated with them have been identified (Kloc 
and Etkin, 2005). Among these factors is the protein Vg1RBP/Vera that binds to zipcodes in 
the Vg1 3’ UTR through its KH domains and mediates association with microtubules (Deshler 
et al., 1998; Havin et al., 1998). Vg1RBP/Vera is the homologue of mammalian ZBP1, 
whereas another Vg1 mRNA-binding protein, Vg1RBP71, was shown to be the homologue of 
ZBP2. This demonstrates a functional relevance of conserved trans-acting factors (Martin and 
Ephrussi, 2009).  
 
1.4.2 Localization of gurken, bicoid and oskar mRNA during Drosophila   
  oogenesis 
Drosophila oogenesis represents a great system to investigate differential sorting of mRNAs 
within the same cell. It results in the selectively localized translation of proteins establishing 
the prospective body axis. At early stages in oogenesis, maternal mRNAs are transported from 
the nurse cells into the oocyte. For this transport process, a complex consisting of the 
microtubule-dependent motor dynein, and the proteins Egalitarian and Bicaudal-D is required 
(Bullock and Ish-Horowicz, 2001). Later, three of these early localized mRNAs, gurken, bicoid, 
and oskar, relocalize within the oocyte in a dynein- (gurken and bicoid mRNA) and kinesin- 
(oskar mRNA) dependent fashion. Gurken encodes for the Drosophila homologue of 
transforming growth factor α (TGFα), which is required for sequential establishment of both 
the antero-posterior and the dorso-ventral axes (Gonzalez-Reyes et al., 1995; Neuman-
Silberberg and Schupbach, 1993). bicoid and oskar mRNA localize to the anterior and posterior 
of the oocyte, respectively, thus patterning the antero-posterior axis (Berleth et al., 1988; 
Ephrussi et al., 1991; Kim-Ha et al., 1991). In addition to the oskar 3’ UTR, several factors are 
required for oskar localization to the posterior pole. The splicing process of oskar mRNA 
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triggers the complex formation with components of the exon-junction complex, which 
accompany the mRNA to its final site (Hachet and Ephrussi, 2004). The cytoplasmic proteins 
Barentz, Hrp48 and Staufen also co-localize with oskar mRNA at the posterior pole and are 
supposed to be part of the localization complex (St Johnston, 2005). Localization of bicoid 
mRNA to the anterior pole of the oocyte occurs during different stages in oogenesis and 
involves several cis- and trans-acting factors (Figure 3 d). At late stages, bicoid localization to the 
anterior pole relies on the interaction of Staufen with stem-loop structures in the bicoid 3’ UTR 
(Ferrandon et al., 1994; St Johnston et al., 1991). The encoded protein Bicoid is a transcription 
factor that forms a morphogenic gradient by diffusing from the anterior pole throughout the 
embryo (Ephrussi and St Johnston, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
1.5  mRNA localization in Saccharomyces cerevisiae 
As shown in previous chapters, in higher eukaryotes a significant number of mRNP 
components has been identified, but a precise function was assigned to only a few of them, 
reflecting the high complexity of these transport complexes (Martin and Ephrussi, 2009). In 
contrast, in the budding yeast Saccharomyces cerevisiae, the essential components of the ASH1 
Figure 3: RNA localization is observed in various cell types and organisms. a) β-actin mRNA 
(red) localizes to the leading edge of a migrating fibroblast cell. β-actin protein is stained in green 
and the nucleus is stained in blue. b) MBP mRNA-transport particles (red) associate with 
microtubules (green) and localize to myelinating processes in oligodendrocytes. c) Localization of 
Xenopus laevis Xcat2 mRNA to the vegetal cortex in a stage IV oocyte. d) In the Drosophila egg, bicoid 
mRNA is tightly localized to the anterior pole. e) In Saccharomyces cerevisiae, ASH1 mRNA localizes 
to the bud tip in late anaphase of a dividing cell. Pictures were taken from Dahm and Kiebler, 2005; 
Ephrussi and St Johnston, 2004; St Johnston, 1995, 2005. 
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mRNA-translocation complex are known and have been genetically and biochemically 
characterized (Jansen et al., 1996; Martin and Ephrussi, 2009; Paquin and Chartrand, 2008). 
The initial genetic screen identified 5 genes (SHE1-5), whose gene products are involved in 
ASH1-mRNA translocation (Jansen et al., 1996). Three of them, the proteins She1p, She2p 
and She3p, were shown to represent the core components of the ASH1 translocation 
complex, also referred to as the locasome (Böhl et al., 2000; Gonsalvez et al., 2004; Long et al., 
2000; Takizawa and Vale, 2000). She1p/Myo4p is a type V myosin-motor protein, which 
transports the mRNP along the polarized actin network. The motor protein is connected via 
the adapter protein She3p to the RNA-binding protein She2p. She2p itself binds to the 
mRNA target and thereby links the cargo to the motor of the transport complex. She4p, a 
member of the UCS class of proteins, associates with Myo4p and is supposed to function in 
proper folding of the Myo4p-motor domain (Wesche et al., 2003). Lastly, Bni1p/She5p is a 
formin that is involved in actin filament organization, thus ensuring continuous transport of 
the ASH1 mRNP (Beach et al., 1999; Evangelista et al., 2003). To date, the ASH1 mRNP 
represents the best-characterized example for directed transport of a cell fate determinant to 
subcellular regions (Figure 3 e). 
 
1.5.1 “Mating type switching” – the biological function of ASH1-mRNA   
  localization 
The life cycle of S. cerevisiae is characterized by diploid and haploid growth states. Under 
conditions of nutrient deprivation, S. cerevisiae undergoes meiotic cell division, which results in 
two haploid cells - one larger mother cell and a smaller daughter cell - of the opposite mating 
type “a” or “α”. To re-establish the diploid growth state, two cells of the opposite mating type 
mate to form an a/α diploid cell. Interconversion between “a” and “α” mating types in the 
haploid cell is achieved by the mother cell-specific asymmetric expression of the HO 
endonuclease. HO endonuclease initiates genomic rearrangements of the MAT-gene locus 
only in the haploid mother cell (Cosma, 2004). This phenomenon has been termed “mating 
type switching”. In the daughter cell, expression of HO endonuclease is repressed by the 
transcription factor Ash1p, which specifically binds to the HO endonuclease promoter and, 
thus, inhibits the transcription of the inducer of mating type switching (Bobola et al., 1996; 
Jansen et al., 1996; Sil and Herskowitz, 1996). Restriction of Ash1p to the daughter cell is 
achieved by specific translocation of the ASH1 mRNA to the bud tip and its exclusive 
translation in the daughter cell. 
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1.5.2 ASH1 and at least 23 additional bud-localized mRNAs 
DNA-microarray analyses identified a total of 24 mRNAs, including ASH1 mRNA, to 
specifically associate with tagged She2p-She3p-Myo4p complexes (Table 1) (Shepard et al., 
2003; Takizawa and Vale, 2000). However, a recent study found that 41 mRNAs co-purify 
with Protein A-tagged She2p from native mRNPs suggesting that the number of She2p-
dependent localized mRNAs in S. cerevisiae might be even larger (Oeffinger et al., 2007). It is 
interesting to note, that the majority of localized transcripts in budding yeast encodes for 
membrane or membrane-associated proteins. 
Gene 
Cell cycle 
regulation 
Localization of encoded protein Predicted protein function 
ASH1 M Bud nucleus Transcription 
BRO1 None Punctae on vacuole Stress transduction 
CLB2 M Nuclei, spindle poles Cyclin B
CPS1 None Cytoplasmic punctae Carboxypeptidase 
DNM1 S Mitochondrial periphery Mitochondrial fission 
EGT2 M Membranes, large-bud enriched Cellulase
ERG2 M Endoplasmic reticulum Sterol isomerase 
IST2 None Bud plasma membrane Transporter 
MID2 None Cell periphery, mother-bud junction Membrane receptor 
MMR1 M 
Bud sites and tips, mother-bud 
junction 
Unknown 
SRL1 G1 Periphery of small buds Unknown
TPO1 M Bud plasma membrane Polyamine transport 
WSC2 S Membranes, bud-enriched Membrane receptor 
TAM41 None Mitochondria Unknown
IRC8 M Membranes, bud-enriched Unknown
YLR434C None Mitochondria Unknown
TCB3 G2 Membranes, bud-enriched Lipid binding 
EAR1 None Endoplasmic reticulum Unknown
TCB2 None Membranes, bud-enriched Unknown
KSS1 None not defined Mitogen-activated protein kinase
LCB1 None Endoplasmic reticulum Lipid synthesis 
MET4 None Nuclei Transcription 
MTL1 None not defined MID2-like
YPL066W None not defined Unknown
 
 
Table 1: Overview of localized mRNAs in S. cerevisiae. The table shows yeast genes whose mRNAs are 
localized in a She protein-dependent manner and lists localization and function of the respective encoded 
proteins. Information given in this table was obtained from Shepard et al., 2003 and from the Saccharomyces 
Genome Database (http://www.yeastgenome.org). 
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The best-characterized example of mRNA sorting in yeast is the localization of ASH1 
(asymmetric synthesis of HO) mRNA to the bud tip during late anaphase (Figure 3 e) (Paquin 
and Chartrand, 2008). In order to get recognized by the trans-acting factor She2p, ASH1 
contains four cis-acting elements, termed E1, E2A, E2B, and E3. Three of them (E1, E2A, 
E2B) are located in the coding sequence of ASH1, whereas the E3 zipcode comprises the 
termination codon and is mainly part of the 3’ UTR (Chartrand et al., 2002; Chartrand et al., 
1999; Gonzalez et al., 1999; Long et al., 1997; Takizawa et al., 1997). Interestingly, the ASH1 
zipcodes function redundantly, since each of them can individually localize a heterologous 
reporter RNA to the bud tip (Chartrand et al., 2002). However, the presence of all four 
zipcodes enhances the efficiency of the translocation process. Thus it provides another 
example for synergistic clustering of multiple elements (see chapter 1.2.1). As observed also in 
other systems, ASH1 zipcodes show no obvious sequence similarity to each other, but are 
rather predicted to fold into distinct stem-loop structures that are recognized by She2p (Böhl 
et al., 2000; Long et al., 2000; Olivier et al., 2005). Huge effort was made to determine features 
in ASH1 that are required for proper sorting. In two recent studies, nucleotides essential for 
She2p recognition have been identified by in vivo selection from libraries of partially 
randomized ASH1 zipcodes and by non-homologous random recombination of zipcode-
containing fragments of pools from known localized mRNAs, respectively (Jambhekar et al., 
2005; Olivier et al., 2005). The resulting recognition motif consists of a loop-stem-loop RNA 
structure containing a highly conserved CGA triplet with a downstream stretch of adenosines 
in one loop and an oppositely located single conserved cytosine. Mutation of this motif 
resulted in ASH1 mislocalization in vivo. Additionally, the distance between these nucleotides 
as well as their spatial orientation seems to be crucial for in vivo ASH1-mRNA localization. 
These studies suggested that She2p recognizes ASH1 zipcodes on the basis of both primary 
sequence and secondary structure. Using their techniques, both laboratories identified so far 
unknown localization elements containing the She2p-recognition motif in other bud-localized 
mRNAs (Jambhekar et al., 2005; Olivier et al., 2005). Among them, they found single zipcodes 
in IST2 and EAR1, and two zipcodes in WSC2, which were all shown to function in mRNA 
localization in vivo. Unfortunately, the major fraction of zipcodes within bud-localized mRNAs 
remains unknown. 
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1.5.3 She2p – the cargo-binding protein 
Structural characterization of a significant number of RNA-binding proteins led to the 
identification of a variety of RNA-binding domains. Examples are the hnRNP K homology 
(KH) domain, the RNA-recognition motif (RRM), the double-stranded RNA-binding domain 
(dsRBD), or the glycine-rich domain (Dreyfuss et al., 2002). Surprisingly, the motif by which 
She2p binds its mRNA cargo could not be attributed to any of these RNA-binding motifs, 
suggesting that She2p represents a unique class of RNA-binding proteins with an unknown 
mechanism of RNA binding. The crystal structure of She2p revealed an almost exclusively α-
helical protein, which has no similarity to previously described nucleic acid-binding proteins 
(Figure 4) (Niessing et al., 2004). This finding is not surprising, since She2p homologues are 
found only in related yeast species, thus emphasizing the novel protein fold. She2p folds into a 
single domain consisting of a bundle of five anti-parallel α-helices and an additional helix 
protruding at right angles from the middle of the bundle. In the crystal lattice, She2p forms a 
stable homodimer of 56 kDa in size. Mutation of residues Cys68 and Ser120 in the dimer 
interface disrupts dimer formation and results in inefficient binding to the ASH1-E3 zipcode 
in vitro and mislocalization of ASH1 mRNA in vivo. Thus, She2p dimers were suggested to be 
the functional unit in vivo (Niessing et al., 2004). 
In order to map the RNA-binding region in She2p, the electrostatic potential of the She2p 
surface was analyzed (Figure 4 d-f). The surface mainly consists of negatively charged 
(especially in the bottom region) and hydrophobic residues (in the upper surface region) with 
exception of a distinct positively charged region at the side of the protein. From previous 
studies it was known that several basic residues within the first 70 amino acids of She2p are 
important for ASH1 mRNA binding (Gonsalvez et al., 2003; Kruse et al., 2002). Consistently, 
these residues match very well with the positively charged patch of She2p and lie in the 
putative RNA-binding region. Further in vitro RNA-binding studies and in vivo ASH1 mRNA-
localization experiments with She2p selectively mutated in this positively charged region 
confirmed the previous findings and resulted in the determination of a new RNA-binding 
motif. This motif, termed “basic helical hairpin”, consists of two antiparallel α-helices that are 
separated by a loop, and is located on each monomer of the She2p homodimer (Figure 4 a-c, 
labeled in yellow). It is thought that this local tertiary structure feature provides the primary 
anchor for ASH1 mRNA binding (Niessing et al., 2004). Thus far, She2p’s affinity to zipcode-
containing mRNA has been poorly analyzed. Only for one single localization element, the 
ASH1 E3 zipcode, the equilibrium dissociation constant (KD) was determined to be 
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210 nM ± 40 nM, indicating tight binding by She2p (Niessing et al., 2004). Since one She2p 
dimer contains two RNA-binding motifs, it is suggested that more than one RNA molecule 
can be bound by She2p. In fact, both a 1:1 and 1:2 ratio for the She2p dimer:RNA complex 
was found depending on the analyzed zipcode and may vary with the length of the zipcode 
(Niessing et al., 2004; Olivier et al., 2005). However, the affinity to remaining zipcodes as well 
as the She2p-binding mode remains elusive. 
In order to bind its mRNA target, She2p is actively imported into the nucleus by interaction 
with the importin α Srp1p. Nuclear import of She2p is driven by a recently identified non-
classical nuclear localization signal (NLS), which is located in a less conserved region at the 
side of each monomer (Figure 4 a-c, labeled in brown) (Shen et al., 2009). In addition to the 
basic helical hairpin, the upper surface region of She2p is remarkably interesting. This region is 
largely uncharged and contains a high degree of conserved, hydrophobic amino acids 
(Figure 4 c,e). Furthermore, this hydrophobic patch spans the surface of both monomers in 
the dimer (Niessing et al., 2004). Mutation of amino acids threonine 47 and leucine 130 into 
tyrosine significantly reduces She2p’s affinity to the ASH1-E3 zipcode (Niessing et al., 2004). 
This observation is consistent with the isolation of a yeast strain bearing a leucine 130 to 
serine mutation that is defective for ASH1-mRNA localization (Gonsalvez et al., 2003). 
Because both amino acids are located at the upper surface region of She2p, this region might 
be involved RNA binding. However, it is also speculated that the upper surface serves as the 
She3p-interacting region (see below, chapter 1.5.4). 
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1.5.4 She3p links the She2p:mRNA complex to the myosin-motor protein   
  Myo4p 
She3p serves as an adapter protein that connects the mRNA cargo to the actin cytoskeleton 
via its simultaneous interaction with the She2:mRNA complex and the unconventional type V 
myosin-motor protein Myo4p (Böhl et al., 2000; Long et al., 2000; Münchow et al., 1999; 
Takizawa and Vale, 2000). For the interaction with She2p, the C-terminal domain of She3p is 
responsible (Böhl et al., 2000; Long et al., 2000). Only in the presence of mRNA cargo, She3p 
interacts efficiently with She2p. Furthermore, She3p stabilizes the She2p:mRNA interaction 
(Böhl et al., 2000). These findings and the function of the upper hydrophobic surface region 
of She2p in mRNA binding and translocation (see chapter 1.5.3) led to the assumption that 
Figure 4: Crystal structure of the RNA-binding protein She2p. a)-c) Crystal structure of the She2p 
dimer in front view (a), side view (b) and top view (c). Each monomer is shown in light and dark blue, 
respectively. The basic helical hairpin RNA-binding motif is colored in yellow, the region comprising the 
nuclear localization signal is marked in brown. Relative to a), the structure in b) is rotated by 90 ° around the 
vertical axis, whereas c) is rotated by 90 ° around the horizontal axis with the top of the protein oriented to 
the reader. Images a)-c) were generated using PyMOL, DeLano Scientific, CA. d)-f) represent the 
electrostatic surface potential of the respective She2p cartoons shown in a)-c). The electrostatic potential is 
color-coded from red (negatively charged) to white (uncharged) to blue (positively charged) and was 
calculated using GRASP. Figures d)-f) are taken from Niessing et al., 2004. 
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She3p interacts with the hydrophobic surface of She2p in a mRNA-dependent manner, thus 
acting as a cargo sensor for mRNP assembly. The N-terminal domain of She3p binds to the 
coiled-coil region and the C-terminal tail in Myo4p, thereby forming a stable cytoplasmic 
complex (Böhl et al., 2000; Heuck et al., 2007; Long et al., 2000; Takizawa and Vale, 2000). 
However, in cells lacking She2p and thus, in the absence of correctly bound cargo, the 
She3p:Myo4p complex is equally distributed in mother and daughter cells (Gonsalvez et al., 
2003; Kruse et al., 2002). Surprisingly, asymmetric sorting can be restored by artificially 
tethering a heterologous mRNA to She3p, which then localizes correctly to the bud (Long et 
al., 2000). This finding confirms that Myo4p is recruited to the mRNA target via She3p, which 
itself associates with She2p. Upon mRNP assembly, the complex is transported by Myo4p 
along actin microfilaments to the tip of the daughter cell, where it becomes anchored in an 
actin-dependent manner (Beach et al., 1999; Takizawa et al., 1997). It is important to note that 
the localizing mRNA needs to be translationally repressed during transport ensuring spatially 
restricted protein synthesis (see chapter 1.5.5). 
In addition to mRNA transport, She3p and Myo4p function in the inheritance of cortical ER 
(Estrada et al., 2003; Schmid et al., 2006). This process is independent of She2p, but occurs in 
parallel with mRNA transport. ER inheritance can be blocked by deletion of the motor MYO4 
or by latrunculin-A treatment of yeast cells, which inhibits actin polymerization. This shows 
that ER transport directly depends on Myo4p (Estrada et al., 2003). As mentioned above in 
chapter 1.5.2, the major fraction of localized mRNAs in yeast encodes for membrane-
associated proteins, which are synthesized at the rough ER. This suggests that the processes of 
mRNA localization and ER transport might be coordinated. Indeed, a study by the laboratory 
of Prof. Ralf-Peter Jansen showed that She2p co-fractionates with ER membranes 
independently of Myo4p and She3p, suggesting a novel She2p:ER interaction (Schmid et al., 
2006). However, it remains unclear if She2p directly binds to the ER membrane or if this 
association is mediated by an ER-associated protein or mRNA. These results let assume that 
localizing mRNAs are co-transported with cortical ER tubules to the bud tip (Figure 5). 
 
1.5.5 Additional trans-acting factors involved in ASH1-mRNA localization  
Besides the She proteins described above, three additional trans-acting factors are required for 
efficient ASH1 translocation to the bud tip. 
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Loc1p is an exclusively nuclear protein with enrichment in the nucleolus. It plays roles in 
ribosome biogenesis as well as in ASH1-mRNA localization. So far, Loc1p was mainly 
described to function in rRNA processing and export of the 60S ribosomal subunit 
(Harnpicharnchai et al., 2001; Urbinati et al., 2006). However, Loc1p is a double stranded 
RNA-binding protein, which binds to the ASH1-E3 zipcode in the nucleus (Long et al., 
2001). The Loc1p:ASH1 E3 association was recently shown to depend on interaction of 
Loc1p with She2p, suggesting that She2p recruits Loc1p to the ASH1 transcript (Shen et al., 
2009). Interestingly, both a LOC1 knockout and exclusion of She2p from the nucleus result in 
ASH1-mRNA delocalization and symmetric distribution of Ash1p in mother and daughter 
cell (Du et al., 2008; Long et al., 2001; Shen et al., 2009). This suggests that Loc1p may 
function in translational control of ASH1 mRNA after recruitment by She2p. The exact 
mechanism by which nuclear Loc1p controls ASH1 translation is largely unknown but it was 
hypothesized that Loc1p might help to generate a specific subtype of ribosomes that are 
required for the translation of localized mRNAs (Komili et al., 2007). The RNA-binding 
protein Puf6p functions in translational repression of ASH1 mRNA (Gu et al., 2004; Shen et 
al., 2009). Puf6p is a member of the PUF family of RNA-binding proteins and recognizes a 
conserved PUF protein-recognition sequence (UUGU) in the ASH1-E3 zipcode (Gu et al., 
2004). In analogy to Loc1p, Puf6p interacts with She2p in the nucleus and is thereby recruited 
to the ASH1 mRNA (Shen et al., 2009). Deletion of PUF6 also results in premature ASH1 
translation and random distribution of Ash1p, demonstrating the role of Puf6 in translational 
control (Du et al., 2008; Gu et al., 2004; Shen et al., 2009). Furthermore, Puf6p is believed to 
assemble with the localizing mRNP in the cytoplasm. Here, Puf6p associates with the general 
translation factor Fun12p/eIF5B and thus inhibits 80S complex assembly (Deng et al., 2008). 
Upon mRNA localization to the bud tip, casein kinase II (CK2) phosphorylates Puf6p in the 
N-terminal region, which releases the translational repression. A similar mechanism of 
translational control also applies to the RNA-binding protein Khd1p (Irie et al., 2002). Khd1p 
is associated to the localizing mRNP by binding to the ASH1-E1 localization element (Irie et 
al., 2002). Simultaneously, Khd1p interacts with the C-terminal domain of the translation 
initiation factor eIF4G1, which suppresses translation initiation. At the bud-tip plasma 
membrane, the casein kinase Yck1p phosphorylates Khd1p, resulting in mRNP disassembly 
and ASH1 translation (Paquin et al., 2007). Taken together, the three trans-acting factors 
Loc1p, Puf6p and Khd1p have an important function in mRNA transport by preventing 
premature translation of the localizing ASH1 mRNA and thus, ensuring spatially restricted 
protein synthesis. 
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1.5.6 Current model of ASH1-mRNA localization 
The introductory part will conclude with the current model of the mRNA-translocation 
process in budding yeast (Figure 5). Although at least 24 mRNAs are transported in a She2p-
dependent manner, most details are known for the localization of ASH1 mRNA. Therefore, 
the model refers to the ASH1-localization process but does not exclude the possibility that 
the localization of other mRNAs is regulated by the same mechanisms. For further details 
regarding the individual steps and proteins involved, please refer to the figure legend and to 
chapters 1.5.1 to 1.5.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Current model of ASH1-mRNA localization. After nuclear import, She2p binds its RNA 
cargo very likely co-transcriptionally. Then, the She2p:ASH1 mRNA complex shuttles through the 
nucleolus, where She2p interacts with Loc1p and Puf6p. Traversing the nucleolus guarantees translational 
repression of ASH1 mRNA during the transport process to the bud tip. Following mRNA-dependent 
export of She2p, the She2p:ASH1 mRNA complex interacts with the cytoplasmically localized 
She3p:Myo4p complex and assembles into a functional mRNP. During the Myo4p-dependent transport 
along the actin cytoskeleton, ASH1 mRNA is translationally silenced mediated by ASH1-associated Khd1p 
and Puf6p. At the bud tip, the mRNP is anchored at the actin cytoskeleton. The translational repression is 
released upon phosphorylation of Khd1p by Yck1p and of Puf6p by CK2, respectively, Ash1p is 
synthesized and represses mating type switching in the daughter cell. Additionally, She3p and Myo4p are 
required for inheritance of cortical ER. This process is independent of She2p, although She2p alone is able 
to associate with ER membranes. These results suggest a coordinated movement of localizing mRNAs and 
ER tubules to the daughter cell.  
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1.6  Objectives 
Localization of mRNA is a widespread mechanism to spatially restrict protein synthesis in a 
cell. In higher eukaryotes, mRNAs destined for localization are packaged into transport 
particles of a highly complex architecture. These mRNPs usually comprise dozens of mRNAs 
and a number of proteins involved in mRNA binding, translational repression, and active 
transport (Angenstein et al., 2005; Kanai et al., 2004; Ohashi et al., 2002). For correct assembly 
of such transport complexes, precise and specific interaction of the individual components is 
indispensable. 
In the present study, the requirements for specific transcript binding and mRNP assembly 
were investigated using the ASH1 mRNP from S. cerevisiae as a model system (Figure 5). In 
this complex, the RNA-binding protein She2p binds more than 24 mRNAs and connects 
them via the adapter protein She3p to the motor protein Myo4p. So far, it is unclear how 
She2p recognizes its target mRNAs and incorporates them into translocation-competent 
mRNPs. The aim of this study was to identify the requirements for selective mRNA-cargo 
recognition by She2p in the nucleus and specific mRNP assembly in the cytoplasm. To 
achieve this, a multidisciplinary approach was chosen. Using a combination of biochemical 
and structural techniques, the mode of interaction of She2p and its target mRNAs is studied, 
and based on the crystal structure of She2p (Niessing et al., 2004), novel features required for 
mRNA binding are investigated. Finally, complementary studies in living yeast cells are used to 
analyze the role of She2p in mRNP assembly. 
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2  Results 
 
In this study, I aimed to perform a structural and functional characterization of the assembly 
of mRNA-transport complexes in Saccharomyces cerevisiae. Attempts to obtain structural 
information about the interaction between She2p and the ASH1 mRNA at atomic resolution 
are described in chapter 2.1. The requirements for the assembly of a functional mRNP have 
been comprehensively analyzed in vitro and in vivo and are described in chapter 2.2. 
 
2.1  Structural studies on the She2p:RNA interaction 
To date, only little structural information is available for individual components of mRNA-
transport complexes. The first almost complete atomic model of an integral RNA-binding 
protein from an mRNA-localization complex could be derived from the crystal structure of 
She2p from S. cerevisiae (see Figure 4 in chapter 1.5.3 and Figure 7 in 2.1.2) (Niessing et al., 
2004). However, the mode of interaction with its different RNA targets is largely unknown. 
Therefore, in the first part of my thesis I aimed at determining the three-dimensional structure 
of She2p in complex with one of its RNA cargoes by X-ray crystallography. From this, I 
hoped to obtain mechanistic insights into the She2p:RNA interaction. In a different approach, 
initial NMR experiments were performed with the intention to map the RNA-binding sites in 
She2p. 
 
2.1.1 Purification of She2p variants 
A number of She2p variants were used for structural studies (described in the present chapter 
2.1) and for biochemical analyses (see chapter 2.2). Without exception, all She2p variants were 
purified to near homogeneity using affinity chromatography, anion-exchange chromatography, 
and size-exclusion chromatography as described in chapter 4.9.4. A representative elution 
profile of wild-type She2p from a size-exclusion chromatography column is shown in 
Figure 6. 
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2.1.2 Designing She2p variants for crystallization 
The selection of appropriate She2p variants for crystallization in complex with RNA proved 
to be crucial. Previous studies revealed that full length-She2p yields only poor-quality crystals 
and that the four cysteine residues in She2p hamper crystallization (Niessing et al., 2004). 
Therefore, a mutated She2p fragment had been used for initial crystallization and structure 
determination of She2p alone (Figure 7) (Niessing et al., 2004). This protein fragment, termed 
She2p-(6-239)-ΔCys, lacks five amino acids at the very N-terminus and seven amino acids at 
the very C-terminus. In addition, all cysteine residues were exchanged by serine. Limited-
proteolysis experiments and RNA-binding studies suggested that the N-terminus of She2p is 
most likely disordered and functionally less relevant, whereas the C-terminus might be 
important for RNA binding (Niessing et al., 2004). These findings did not permit many 
variations in designing new She2p constructs for co-crystallization with RNA. Thus, the She2p 
variants She2p-(6-246)-ΔCys and She2p-(6-243)-ΔCys were created and analyzed for their 
ability to bind ASH1-zipcode elements (see chapter 2.1.3.1).  
Based on the She2p-crystal structure, two additional She2p variants were created for 
crystallization experiments, in which flexible or protruding regions were deleted (Figure 7). In 
general, deletion of unstructured or flexible regions is supposed to facilitate crystallization of 
molecules and therefore, crystallization of an She2p:RNA complex might be alleviated. The 
variant She2p-Δloop lacks residues 81 to 89 in context of full-length She2p. This loop-
containing region is located at the bottom of She2p. Since this region was not entirely visible 
in the electron density, it is most likely flexible (Figure 7) (Niessing et al., 2004). The second 
variant, She2p-ΔhelixE, has deleted amino acids 174 to 183 in context of full-length She2p. 
This deleted region comprises an α-helix (helix E), which protrudes at right angles out of the 
Figure 6: Elution profile of wild-type She2p 
from a Superdex S200 16/60 size-exclusion 
column. Absorbance at 280 nm was measured. 
Wild-type She2p elutes in a single peak at 60 ml 
retention volume. The inset shows SDS-PAGE 
analysis of a representative peak fraction. 
RESULTS 
26 
 
She2p dimer (Figure 7). In the crystal lattice, several crystallographic contacts between She2p 
dimers could be observed (see also chapter 2.2.17, Figure 29) (Niessing et al., 2004). In one 
case, crystal contacts formed between two She2p dimers in an upside-down orientation at the 
helix E-containing side. Only melting of the protruding helices E of both She2p dimers 
allowed for the formation of these dimer-dimer contacts in the crystal lattice. Deletion of this 
helix would result in an entirely globular molecule and thus, crystallization of She2p in 
complex with RNA might be promoted.  
 
 
 
 
 
 
 
 
 
 
2.1.3 Identification of suitable ASH1-RNA fragments for co-crystallization 
ASH1 mRNA, the best-characterized RNA target of She2p, contains four zipcode elements 
(E1, E2A, E2B, and E3), which fold into distinct-stem loop structures (Figure A1 in the 
appendix) and are specifically recognized by She2p (Böhl et al., 2000; Jambhekar et al., 2005; 
Long et al., 2000; Olivier et al., 2005). The affinity of wild-type She2p to the ASH1-E3 
zipcode was previously determined to be 210 nM ± 40 nM (Niessing et al., 2004). For co-
crystallization experiments however, it was indispensable to characterize the She2p:ASH1 
interaction more comprehensively. By this means, different shorter ASH1-mRNA fragments 
could be identified that are strongly bound by She2p and might therefore be suitable for 
crystallization. A detailed analysis of RNA binding by She2p, including all necessary controls, 
is presented in chapter 2.2. 
Figure 7: She2p crystal structure. Shown is the crystal structure of She2p (Niessing 
et al., 2004) with one monomer colored in light blue and the other monomer colored in 
dark blue. The cartoon shows the She2p dimer in front view (left) and side view (right). 
The crystal structure lacks five amino acids at the N-terminus and nine amino acids at 
the C-terminus. The positions of the N-terminus and the C-terminus are labeled by a 
red asterisk and a red arrow head, respectively. The loops at the bottom region and the 
protruding helix E, which were deleted for crystallization experiments, are labeled. 
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2.1.3.1 She2p-(6-246)-ΔCys is suitable for crystallization with ASH1-E3 RNA and 
  minimized ASH1 zipcodes 
At first, the equilibrium-dissociation constants (KD) of the variants She2p-(6-246)-ΔCys and 
She2p-(6-243)-ΔCys to the ASH1-E3 zipcode were determined and compared with the 
affinity of wild-type She2p (Table 2). The interaction between wild-type She2p and RNA has 
been investigated in detail and will be described in chapter 2.2. The E3 zipcode was bound 
strongly by the She2p variant comprising the complete C-terminus (She2p-(6-246)-ΔCys; 
KD=173 nM ± 12 nM). However, E3 was bound ten-fold weaker by the She2p variant that 
lacks three amino at the C-terminus (She2p-(6-243)-ΔCys; Table 2). This finding suggests that 
the complete C-terminus of She2p is required for proper recognition of the ASH1-E3 zipcode 
and therefore, only She2p-(6-246)-ΔCys was used for co-crystallization experiments (chapter 
2.1.4).  
It proved difficult to produce ASH1 RNAs by in vitro transcription in such a high amount and 
quality needed for crystallization. The length of the ASH1 zipcodes ranges from 58 to 118 
nucleotides. Since the maximum length for reliable chemical synthesis of RNA is about 50 
nucleotides, ASH1 zipcodes cannot be obtained by chemical synthesis. Previously, the ASH1-
E1 and ASH1-E2B zipcodes were minimized to a length of 49 nucleotides (E1min) and 36 
nucleotides (E2Bmin), respectively (Jambhekar et al., 2005; Olivier et al., 2005). These 
shortened zipcodes contain all features that are required for efficient ASH1-mRNA 
localization in vivo.  
Subsequently, She2p’s affinity to the minimized ASH1 zipcodes was determined. Wild-type 
She2p and She2p-(6-246)-ΔCys bound to the E1min RNA with binding constants of 
KD=456 nM ± 78 nM and KD=599 nM ± 52 nM, respectively (Table 2). A comparably higher 
affinity of both proteins to the E2Bmin zipcode was observed (KD=103 nM ± 38 nM and 
KD=174 nM ± 12 nM, respectively; Table 2). Again, She2p-(6-243)-ΔCys bound significantly 
weaker to minimized zipcodes than She2p-(6-246)-ΔCys (Table 2). I also narrowed down the 
ASH1-E2B zipcode to a length of 21 nucleotides, comprising only the upper part of the stem 
loop (appendix, Figure A1). This RNA, termed E2Bmin-21, was bound by She2p-(6-246)-
ΔCys with considerable affinity (KD=259 nM ± 60 nM; Table 2).  
Taken together, the She2p variant She2p-(6-246)-ΔCys was selected for co-crystallization 
studies with the RNA oligonucleotides ASH1-E3, E1min, E2Bmin, and E2Bmin-21. 
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RNA KD wild-type She2p KD She2p-
(6-246)-ΔCys
KD She2p-
(6-243)-ΔCys
KD She2p-Δloop KD She2p-ΔhelixE
ASH1 E1 236 nM ± 14 n.d. n.d. n.d. 2.3 µM ± 0.2
ASH1 E2A 258 nM ± 46 n.d. n.d. n.d. 0.94 µM ± 0.15
ASH1 E2B 308 nM ± 3 n.d. n.d. n.d. 6.8 µM ± 2.1
ASH1 E3 102 nM ± 16 173 nM ± 12 1.7 µM ± 0.5 129 nM± 12 0.76 µM ± 0.06
E1min 456 nM ± 78 599 nM ± 52 942 nM ± 253 630 nM ± 121 n.d. 
E2Bmin 103 nM ± 38 174 nM ± 12 461 nM ± 92 144 nM ± 9 n.d. 
E2Bmin-21 n.d. 259 nM ± 60 150 nM ± 31 2.56 µM ± 0.9 n.d. 
 
 
 
 
2.1.3.2 Binding studies with She2p-Δloop and She2p-ΔhelixE  
The variant She2p-Δloop bound to the ASH1-E2Bmin RNA with near wild-type affinity only 
(KD=144 nM ± 9 nM; Table 2). Thus, only the E2Bmin oligonucleotide was chosen for co-
crystallization experiments. 
She2p-ΔhelixE showed a significantly impaired affinity to all ASH1-localization elements 
compared to wild-type She2p (Table 2), rendering this variant inappropriate for crystallization 
experiments in complex with RNA. A detailed investigation of RNA binding by She2p-
ΔhelixE is described in chapter 2.2. 
 
2.1.4 Co-crystallization experiments with ASH1-E3, E1min, and E2Bmin RNA 
She2p-(6-246)-ΔCys and She2p-Δloop were each concentrated to 4 mg/ml and incubated with 
a 1.5 molar excess of RNA. Since the stoichiometry of She2p and different ASH1 zipcodes is 
not completely clarified, a 1:1 stoichiometry (one RNA zipcode per She2p monomer) was 
assumed and a molar excess of RNA was used in the co-crystallization experiments. Initial 
crystallization screens were set up in 96-well plates with 1 µl drops consisting of 0.5 µl 
protein:RNA solution and 0.5 µl precipitant solution. A number of different commercially 
available 96-well initial screens were tested, but unfortunately no crystals were obtained with 
She2p-(6-246)-ΔCys in complex with ASH1-E3, E1min, or E2Bmin RNA, respectively. Small 
Table 2: RNA-binding studies with She2p-wild type and She2p variants. The table summarizes the 
equilibrium-dissociation constants (KD) obtained with indicated She2p variants. The label “n.d.” indicates that 
this experiment was not performed. For further details, please refer to main text. A detailed analysis of RNA 
binding by She2p, including control experiments, is shown in chapter 2.2.
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crystals of the She2p-Δloop:E2Bmin complex were obtained in JBScreen Classic-I, #D12 
(20 % (w/v) PEG 4000, 20 % 2-propanol, 100 mM sodium citrate) and could be refined to a 
maximum size of 35 µm x 20 µm x 10 µm in 20 % (w/v) PEG 4000, 14 % 2-propanol, 
100 mM sodium citrate. Unfortunately, crystals were not uniformly shaped, mostly two-
dimensional, and did not diffract X-rays when tested at DESY (Hamburg). 
 
2.1.5 Crystallization of She2p in complex with ASH1 E2Bmin-21 variants 
Crystallization trials with She2p-(6-246)-ΔCys in complex with E2Bmin-21 RNA were 
performed by mixing 0.25 µl of protein solution (4 mg/ml) with 0.25 µl of E2Bmin-21 RNA 
(1.5-molar excess) and 0.5 µl precipitant solution in 96-well plates. Microcrystals and crystals 
of irregular shape were obtained in a few initial conditions, which mostly contained PEG. 
Microcrystals grown in JBscreen Classic-I, # F8 (30 % (w/v) PEG 6000, 1 M lithium chloride, 
100 mM sodium acetate) were subjected to extensive refinement of pH and the PEG/salt 
concentration, as well as by adding different salts or glycerol. Finally, larger crystals of an 
irregular shape could be obtained with a maximum size of 30 µm x 20 µm x 20 µm. But still, 
the crystal quality was insufficient for diffracting X-rays when tested at several beamlines at 
DESY (Hamburg) and at the ESRF (Grenoble).  
When She2p or RNA was omitted from the crystallization set-up no crystals were obtained, 
indicating that in the JBS-I-F8 condition the She2p:E2Bmin-21-RNA co-complex was 
crystallized. Therefore, the E2Bmin-21-RNA sequence was modified in order to increase 
crystal quality. These modifications included the generation of 3’ or 5’ overhangs, variations in 
the length of the stem, or exchanging base-paired nucleotides in the stem. In total, nine 
additional RNAs (termed E2Bshort 01 to 09, see Table A1 in the appendix) were generated 
based on the E2Bmin-21 RNA and used in crystallization experiments with She2p-(6-246)-
ΔCys. Three-dimensional crystals could be obtained with three different RNAs (E2Bshort-01, 
E2Bshort-04, E2Bshort-05; Figure 8). Interestingly, crystals of the different complexes grew in 
very similar conditions, but their quality and their shape were completely different. In no case, 
crystals were obtained when protein or RNA was omitted from the crystallization experiment, 
indicating that She2p:RNA co-complexes were crystallized. Crystals of the She2p:E2Bshort-04 
complex were grown to small plates and showed no diffraction when tested at the ESRF 
(Figure 8 a). Elliptic crystals with a maximum size of 40 µm x 15 µm x 15 µm were obtained 
for the She2p:E2Bshort-05 complex (Figure 8 b). At best, these crystals diffracted to 10 Å 
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resolution at different beamlines at the ESRF. The best crystals were obtained in complex 
with the E2Bshort-01 RNA (Figure 8 c). The maximum size of the cubic crystals never 
exceeded 35 µm x 25 µm x 25 µm. When tested at the ESRF, they diffracted to a maximum 
resolution of only 9 Å. Considerable effort was made to improve the diffraction quality of the 
crystals. This included further optimization of the growth condition to increase the crystal 
size, the use of additive screens, soaking the crystals with different heavy-metal compounds, 
shifting the temperature to 4 °C, using different cryoprotectants, and improving the crystal 
freezing technique. However, none of these attempts resulted in better diffraction of the 
crystals and no data sets could be collected. 
In summary, diffracting crystals were obtained for She2p-(6-246)-ΔCys in complex with two 
different RNA variants of the ASH1-E2B zipcode. Unfortunately, the crystal quality was not 
high enough to record any data set and therefore, no atomic model of She2p in complex with 
an RNA target could be derived. 
 
 
 
 
 
 
 
 
 
2.1.6 Can She2p crystals be soaked with RNA? 
Another idea for obtaining a crystal structure of She2p in complex with RNA was to 
reproduce the original She2p crystals (Niessing et al., 2004) and to soak them with short RNA 
oligonucleotides. The previously identified conserved sequence elements of 3 to 9 bases in 
ASH1 zipcodes (Jambhekar et al., 2005; Olivier et al., 2005) were used as target RNAs, 
because they should be small enough to diffuse into the crystal lattice. First, the affinity of 
Figure 8: Crystals of She2p:RNA co-complexes. a) Crystals of She2p-(6-246)-ΔCys in complex 
with the E2Bshort-04 RNA were obtained in 26 % (w/v) PEG 6000, 0.7 M LiCl2, 100 mM sodium 
acetate. b) Elliptic crystals of the She2p-(6-246)-ΔCys: E2Bshort-05 co-complex were grown in 
22 % (w/v) PEG 6000, 0.8 M LiCl2, 100 mM sodium acetate. c) Cubic crystals were obtained for 
the She2p-(6-246)-ΔCys: E2Bshort-01 co-complex in 24 % (w/v) PEG 6000, 0.5 M LiCl2, 100 mM 
sodium acetate. At best, these crystals diffracted X-rays to a maximum resolution of 9 Å. 
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She2p-(6-239)-ΔCys (see chapter 2.1.2) to short biotinylated RNA oligonucleotides was 
measured by Surface Plasmon Resonance (SPR) using a Biacore 3000 system. Surprisingly, 
She2p-(6-239)-ΔCys was not able to bind to any of those RNA sequences in contrast to wild-
type She2p, which bound with equilibrium-dissociation constants of 18.6 µM and 20.7 µM to 
the 9-mer (CGACGAAAA) and the 6-mer sequences (CGACGA), respectively (see chapter 
2.2.4). The observed weak affinities imply that for efficient RNA binding a minimal length and 
most likely secondary-structure elements are necessary. For that reason, the planned soaking 
experiments were not performed.  
 
2.1.7 Exploratory NMR experiments with She2p 
Nuclear Magnetic Resonance (NMR) data were acquired and analyzed by Dr. Bernd Simon 
from the laboratory of Prof. Michael Sattler (EMBL Heidelberg/Helmholtz Zentrum 
München).  
In parallel to crystallization experiments, NMR experiments were performed with She2p with 
the intention to map the RNA-binding region in She2p. Therefore it was planned to perform 
NMR-titration experiments with the ASH1-E2Bmin zipcode. This RNA was chosen because 
of its strong affinity to She2p, its relatively small size, and its availability in high amount by 
chemical synthesis. Significant binding of RNA to She2p would result in chemical-shift 
perturbations in a two-dimensional 1H-15N-HSQC spectrum. From the titration data, I 
planned to calculate the equilibrium dissociation constant of the She2p:RNA interaction and 
to identify residues interacting with ASH1-E2Bmin RNA. Unfortunately, the 2D 1H-15N-
HSQC spectrum recorded for 15N-labeled wild-type She2p resulted in only a few peaks 
rendering She2p inappropriate for NMR measurements (appendix, Figure A2). This result is 
most likely due to the relatively large molecular weight of the She2p oligomer, which was 
determined by me in later experiments (see chapters 2.2.14 to 2.2.18). Thus, the planned 
RNA-titration experiments with ASH1-E2Bmin RNA could not be performed by NMR.  
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2.2  Functional analysis of mRNP assembly 
 
The RNA-binding protein She2p couples the mRNA cargo to the motor Myo4p via its 
interaction with the adapter protein She3p. For that reason, She2p is believed to be 
responsible for the selection of the correct RNA cargoes and their incorporation into the 
transport particles. However, the mechanistic details underlying this selection process are still 
unknown. Therefore, in the second part of my thesis, the requirements for the assembly of a 
functional ASH1 mRNP and for ASH1-mRNA localization in S. cerevisiae have been 
investigated.  
 
2.2.1 She2p binds to zipcode elements with nanomolar affinity 
In S. cerevisiae, more than 30 mRNAs are localized in a She2p-dependent manner, but only for 
a small subset of these RNAs the zipcode elements are identified. Surprisingly, only She2p’s 
affinity to the ASH1-E3 zipcode has been quantified to date (Niessing et al., 2004), whereas 
the affinity to the other zipcodes is unknown. I performed RNA filter-binding assays in order 
to quantify the binding of wild-type She2p to all four ASH1 zipcodes (E1, E2A, E2B, E3), to 
the zipcode of the EAR1 mRNA, and to the N-terminal zipcode of the WSC2 mRNA 
(WSC2N) (Figure 9). Before the experiments, RNA integrity was always checked in native 
polyacrylamide gels (not shown). All She2p variants used for biochemical and biophysical 
analysis were purified as described in chapter 2.1.1. 
 
 
 
 
 
 
 
Figure 9: Illustration of RNA-localization elements used in this study. The table in a) lists the 
position of the different zipcodes in the respective mRNAs relative to the start codon. Schematic 
drawing in b) represents the location of the zipcodes in the respective mRNA as listed in a). The 
exact lengths of the 5’ and 3’ untranslated regions (UTR) are unknown and therefore the UTRs are 
displayed with an arbitrary size. 
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Secondary-structure predictions revealed that these zipcodes fold into specific stem-loop 
structures (Chartrand et al., 2002; Gonzalez et al., 1999; Jambhekar et al., 2005; Olivier et al., 
2005). The secondary structures of all RNAs used in this study were predicted with the MC-
Fold algorithm (Parisien and Major, 2008) and are shown in Figure A1 in the appendix. In 
order to measure RNA binding, serial dilutions of the respective protein (all protein 
concentrations used for RNA-binding studies are listed in chapter 4.11.4) were incubated with 
a constant amount of radiolabeled RNA for 20 minutes at 20 °C and then blotted onto a 
nitrocellulose membrane using a 96-well microfiltration apparatus. The nitrocellulose 
membrane binds only protein and protein:RNA complexes, respectively, whereas unbound 
RNA is not retained. Protein-bound RNA was quantified by phosphoimaging and 
equilibrium-dissociation constants (KD) were calculated using the Langmuir isotherm. The 
binding assays showed that wild-type She2p binds to all zipcode elements with affinities 
between 0.10 µM and 0.77 µm (Figure 10 a). Strongest binding was observed to the ASH1-E3 
element with a KD=0.10 µM ± 0.02 µM (Figure 10 a, b), which was an even stronger 
association than described previously (Niessing et al., 2004). The weakest binding was 
calculated for the interaction of She2p with the EAR1 zipcode (KD=0.77 µM ± 0.24 µM) 
(Figure 10 a). Taken together, the binding constants measured with wild-type She2p 
demonstrate tight binding to zipcode elements of three different bud-localizing mRNAs from 
S. cerevisiae. 
 
 
 
 
 
 
 
 
 
 
Figure 10: RNA-binding studies with wild-type She2p. The table in a) summarizes the results 
of RNA filter-binding experiments performed with wild-type She2p. She2p binds to zipcodes of 
bud-localized mRNAs with equilibrium-dissociation constants between 0.1 µM (ASH1 E3) and 
0.77 µM (EAR1). Binding to the unrelated stem-loop forming RNAs HIV-1 TAR and U1snRNA 
hairpin II is about two- to ten-fold weaker, whereas the unrelated MS2-stem loop and single 
stranded poly(A) RNA are not bound by She2p. Shown is the mean of at least three independent 
experiments, ± shows the standard deviation. The label “no binding” indicates that at the highest 
protein concentration measured, no significant binding was observed (MS2 stem loop: 6 µM; 
poly(A)20: 32 µM). b) depicts a representative curve fit of RNA-binding experiments performed 
with wild-type She2p and the ASH1-E3 zipcode. The curve was fitted using the Langmuir 
isotherm. 
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2.2.2 She2p has considerable affinity to stem-loop containing RNAs 
Control experiments with a linear, unstructured RNA consisting of 20 adenine nucleotides 
(poly(A)20) revealed no detectable She2p binding (Figure 10 a). However, wild-type She2p 
bound to the unrelated stem loops of HIV-1 TAR RNA (16 nucleotides) and U1snRNA (22 
nucleotides) with a KD=1.4 µM ± 0.3 µM and a KD=1.1 µM ± 0.3 µM, respectively 
(Figure 10 a). These affinities are only two- to ten-fold weaker than the affinity to the specific 
zipcode RNAs. A longer stem loop of HIV-1 TAR comprising 57 nucleotides was bound with 
a KD=1.6 µM ± 0.3 µM, indicating that the length of the unrelated stem-loop containing RNA 
has no significant influence on She2p binding. In contrast, wild-type She2p failed to bind to 
the MS2 hairpin, another unrelated and thus non-specific stem-loop RNA, at concentrations 
up to 6 µM (Figure 10 a). Taken together, these findings suggest that She2p is able to bind 
non-specifically to a subset of unrelated RNAs, which fold into stem-loop structures.  
 
2.2.3 She2p monomers do not bind to RNA 
A previous study has shown that She2p needs to dimerize for RNA binding (Niessing et al., 
2004). Mutation of amino acids that are located in the dimer interface of She2p abolished 
ASH1-E3 binding in vitro (C68Y and S120Y, respectively) and ASH1 localization in vivo 
(S120Y). Here, I extended the binding studies with the variant She2p-S120Y (Figure 11 a, b) 
and analyzed the binding to all ASH1 zipcodes E1, E2A, E2B, and E3, as well as to the 
unrelated stem-loop containing RNAs HIV-1 TAR (16 bases) and U1snRNA hairpin II. Using 
filter-binding experiments, no binding of She2p-S120Y to any of those RNAs could be 
observed at a concentration up to 12 µM and no binding constants could be calculated 
(Figure 11 c). These findings are consistent with the previous study (Niessing et al., 2004) and 
indicate that She2p dimers are required for binding to both specific target RNA (ASH1) and 
non-specific RNA-stem loops (HIV-1 TAR, U1snRNA). Furthermore, it can be assumed that 
ASH1-mRNA localization in vivo completely depends on oligomeric She2p. 
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2.2.4 She2p has low affinity to a short zipcode-consensus sequence  
The observation that She2p can bind to unrelated stem-loop containing RNAs with significant 
affinity raised the question how She2p selectively recognizes its mRNA targets in the nucleus. 
Stem-loops are abundant secondary structures in any kind of RNAs (Svoboda and Di Cara, 
2006). Thus, She2p could in principle bind to a number of mRNAs, tRNAs, or rRNAs in the 
nucleus, translocate them to the cytoplasm and incorporate them into the translocation 
complex. The only modest difference in affinity of She2p to specific and non-specific RNAs is 
unlikely to explain how She2p discriminates between bud-localizing mRNA and non-specific 
RNA.  
One possibility is that She2p selects bud-localizing RNAs by recognizing conserved sequence 
motifs of 3 to 9 nucleotides in length within the zipcode, as it was recently proposed by 
Jambhekar et al. 2005 and Olivier et al., 2005. To test if She2p interacts with these short 
motifs alone, electrophoretic mobility shift assays (EMSA) were performed. Wild-type She2p 
was incubated with the respective radiolabeled RNA oligonucleotide and the RNA:protein 
complexes were separated from unbound RNA in a native polyacrylamide gel. As shown in 
Figure 12, She2p was able to bind to each of the short sequence elements, but the interaction 
was barely visible in EMSA experiments. Furthermore, a significant amount of unbound RNA 
was noticed, although a 2000-fold molar excess of protein was used in the individual reactions. 
This observation indicates that the monitored She2p:RNA association might be a rather 
transient interaction.  
Figure 11: She2p dimerization is indispensable for RNA binding. The cartoons in a) and b) highlight in 
red serine 120 in the dimer interface that was mutated to tyrosine. a) shows She2p from the front and b) from 
the top. c) The mutant protein She2p-S120Y neither binds to any ASH1 zipcode nor to the stem-loop 
containing RNAs HIV-1 TAR and U1snRNA. The graph shows a representative plot of the relative bound 
E3-RNA fraction by She2p-S120Y compared to the RNA fraction that is bound by wild-type She2p. No 
dissociation constant of She2p-S120Y to any RNA could be determined (maximum protein concentration 
measured: 12 µM).  
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In order to quantify the identified interactions and to analyze their stability, I performed SPR 
experiments using a Biacore 3000 system (see also chapter 2.1.6). RNA oligonucleotides (9-
mer, 6-mer, 3-mer) with a 5’ biotin tag were immobilized on a streptavidin-coated chip surface 
and She2p was floated over the surface. If any interaction occurs, an increase in the response 
signal can be monitored. Analysis of the obtained sensorgrams revealed a fast association and 
dissociation of the complex (Figure 13 a). From the measured response curves no on-rates 
(Kon) or off-rates (Koff) could be derived in order to calculate the equilibrium-dissociation 
constant KD (KD= Koff/ Kon). However, the binding constant was calculated from steady state 
response signals of multiple injections with increasing protein concentrations by plotting the 
response signals at the equilibrium against the respective protein concentration. The 
experiments revealed that She2p bound to the 9-mer motif and the 6-mer motif with a binding 
constant of 18.6 µM and 20.7 µM, respectively (Figure 13 a-c). In contrast, no detectable 
binding was observed to the 3-mer motif (CGA) up to a protein concentration of 200 µM 
(Figure 13 c). I cannot exclude the possibility that the 3-mer RNA failed to bind due to its 
close proximity to the dextran matrix of the chip. In comparison to She2p’s affinity to “full-
length” zipcodes (chapter 2.2.1), the binding constants measured to these short RNA 
sequences are significantly weaker. These findings indicate that short RNA motifs alone are 
unable to mediate specific She2p binding. However, it cannot be excluded that they act in 
combination with other nucleic acid features like secondary- and tertiary-structure elements to 
achieve specific zipcode recognition by She2p.  
To test whether the combination of secondary-structure elements and an RNA-consensus 
motif results in a zipcode element, a rather simple approach was chosen: nucleotides in the 
Figure 12: She2p binding to short 
RNA-consensus sequences can be 
detected. Electrophoretic mobility 
shift assays using a native 7 % 
polyacrylamide gel revealed binding 
of wild-type She2p to a 3-mer, 6-mer, 
7-mer, and 9-mer RNA 
oligonucleotide (indicated by an 
asterisk). In the experiment, a 2000-
fold molar excess of protein was 
used. However, a large amount of 
unbound RNA was detected, which 
might reflect a transient interaction. 
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upper region of the HIV-1 TAR stem loop were replaced by the conserved 6-mer motif 
(CGACGA) in a way that preserved the predicted secondary structure. If the RNA motif 
would function in combination with a simple secondary structure, an affinity would be 
expected that is comparable to the affinity to zipcodes. As a control, the RNA motif was 
inserted in antisense orientation (GCUGCA), for which no increase in affinity would be 
expected. Secondary-structure predictions of both “artificial” zipcodes are shown in Figure A1 
in the appendix. RNA filter-binding experiments revealed that wild-type She2p binds with 
similar affinity to both “artificial” zipcodes (KD=1.2 µM ± 0.2 µM and KD=1.0 µM ± 0.2 µM, 
respectively) as to the “wild-type” HIV-1 TAR RNA (compare Figure 13 c with Figure 10 a). 
This finding indicates that the nature of a zipcode is much more complex and cannot be 
simply generated by combining a conserved RNA motif with secondary-structure elements.  
 
 
 
 
 
 
 
 
 
 
 
 
2.2.5 Identification of conserved regions in She2p for mutational analysis 
Besides features on the RNA level, specificity to bud-localizing mRNAs must also be achieved 
by She2p itself. To test the requirements of She2p for mRNA localization, conserved regions 
in She2p that are potentially involved in RNA binding were selected for mutational analysis 
Figure 13: She2p has low affinity to short RNA motifs in zipcode elements. a) shows the response signals 
(in response units) of the She2p:9-mer RNA interaction obtained by SPR experiments. The response curves 
represent multiple experiments with increasing protein concentrations. Please note the rapid dissociation of the 
protein:RNA complex when protein injection to the chip surface was stopped (marked by an arrow head). b) 
Plot of the response units at equilibrium against the respective She2p concentration. The binding constant was 
calculated by fitting the curve using the Langmuir isotherm. The table in c) summarizes the results of SPR 
experiments and filter-binding experiments performed with wild-type She2p and short RNA motifs and 
modified TAR-stem loops. For She2p’s interaction with the 9-mer and the 6-mer motif, a KD of 18.6 µM and 
20.7 µM was calculated, respectively. No affinity could be measured to the 3-mer motif up to protein 
concentration of 200 µM. Insertion of the 6-mer motif in any orientation into the HIV-1 TAR-stem loop did not 
result in increased affinity of She2p compared to the binding to the unmodified TAR-stem loop (KD=1.4 µM 
± 0.3; Figure 10 a). 
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(Figure 14). In a previous study the basic helical hairpin motif was already described as an 
unusual RNA-binding motif in She2p (Niessing et al., 2004). In addition, mutation of 
threonine 47 and leucine 130 in the upper surface region of She2p resulted in reduced affinity 
to ASH1 E3 (Niessing et al., 2004). Both regions are highly conserved throughout other yeast 
species (Figure 14 a, b and Figure A3 in the appendix), suggesting that other conserved 
regions in She2p might be functionally relevant as well. Two additional conserved surface 
features could be identified in She2p. The small helix E that protrudes at right angles out of 
the globular helical bundle and the very C-terminus of She2p both show a high degree of 
sequence conservation (Figure 14 c, d and Figure A3 in the appendix). The C-terminal nine 
amino acids of She2p were not visible in the crystal structure, most likely due to their 
flexibility. All four regions in She2p mentioned above were mutated (Figure 14 e-h) and the 
respective mutant proteins were tested for their binding to zipcode RNAs and to unrelated 
stem-loop containing RNAs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Identification of conserved surface regions in She2p. a)-c) The sequence conservation of 
She2p was plotted onto the surface of the She2p X-ray crystallographic model. Cartoons show She2p in front 
view (a), top view (b), and side view (c). d) shows a close-up of the C-terminal region from the She2p-
sequence alignment (Figure A3 in the appendix). Residues deleted for mutational analysis are marked by a red 
box. The color code ranging from yellow to green represents 40 % to 100 % sequence identity. e)-h) show 
cartoons of She2p mutants, which were created according to the analysis of sequence conservation. Mutated 
regions are labeled in red and represent the mutation of N36 and R63 in the basic helical hairpin (e), mutation 
of L130 (f), deletion of helix E (g), and deletion of the C-terminal 6 amino acids (h).  
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2.2.6 The basic helical hairpin motif provides a general binding platform for  
  stem-loop containing RNA 
In order to completely abolish RNA binding by the basic helical hairpin motif, asparagine 36 
was mutated to serine and arginine 63 was mutated to lysine, resulting in the double mutant 
She2p-N36S-R63K (Figure 14 a, e and Figure 15 a). Mutation of both residues was already 
described to impair ASH1-mRNA binding in vitro and ASH1-mRNA localization in vivo 
(Gonsalvez et al., 2003; Niessing et al., 2004). Binding of the mutant protein to the ASH1 
zipcodes, the EAR1 zipcode, and to the unrelated RNAs HIV-1 TAR and U1snRNA 
hairpin II, respectively, was assessed by filter-binding experiments. She2p-N36S-R63K 
completely failed to bind to any RNA, regardless if target or non-target RNA (Figure 15 b, c). 
This result suggests that the positively charged basic helical hairpin motif acts as general RNA-
binding platform. This finding is further supported by the observation that the She2p-N36S-
R63K mutant has completely lost its ability to localize ASH1 mRNA in vivo (Du et al., 2008).  
 
 
 
 
 
 
 
 
 
 
2.2.7 The upper uncharged surface region is also required for recognition of  
  stem-loop containing RNAs 
Mutation of leucine at position 130 was described before to reduce She2p’s affinity to the 
ASH1-E3 zipcode and to impair the She2p:She3p interaction in vivo (Gonsalvez et al., 2003; 
Niessing et al., 2004). However, no binding constants were calculated. Therefore, leucine 130 
Figure 15: The basic helical hairpin motif provides a binding platform for stem-loop containing 
RNA. The cartoon in a) highlights in red asparagine 36 and arginine 63 in the basic helical hairpin motif that 
were mutated to serine and lysine, respectively. b) and c) The mutant protein She2p-N36S-R63K has affinity 
neither to zipcode-containing RNAs nor to the stem-loop containing RNAs HIV-1 TAR and U1snRNA. The 
graphs show the relative bound RNA fraction by She2p-N36S-R63K compared to the RNA fraction that is 
bound by wild-type She2p. A dissociation constant of She2p-N36S-R63K to neither RNA could be 
determined (maximum protein concentration measured: 32 µM).  
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was mutated to tyrosine (Figure 14 b, f and Figure 16 a) and the binding of the mutant She2p-
L130Y to zipcode-containing RNAs and unrelated stem-loop RNAs was assessed using filter-
binding experiments (Figure 16 b-d). A significantly reduced affinity of She2p-L130Y to all 
zipcode elements was observed, ranging from a 2-fold reduction (EAR1) to an almost 30-fold 
reduction (WSC2N) (Figure 16 b). No binding could be measured to the unrelated stem-loops 
of the HIV-1 TAR RNA and the U1snRNA up (Figure 16 b-d). These findings show that 
mutation of a single hydrophobic residue in the upper surface region of She2p drastically 
impairs the binding to target and non-target RNAs, respectively. Thus, it can be concluded 
that the upper surface of She2p is required for the recognition of stem-loop containing RNAs 
as it was observed also for the basic helical hairpin motif (chapter 2.2.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: The upper surface region of She2p is required for recognition of stem-
loop containing RNA. The cartoon in a) highlights leucine 130 (red) on both She2p 
monomers, which was mutated to tyrosine. The table in b) summarizes the RNA-binding 
experiments performed with She2p-L130Y in comparison to the respective binding 
constants obtained for wild-type She2p. She2p-L130Y binds significantly weaker to ASH1 
zipcodes and to WSC2N compared to wild-type She2p, but has an only two-fold reduced 
affinity to the EAR1 zipcode. No significant binding was measured to the stem loops HIV-
1 TAR and U1snRNA hairpin II up to a protein concentration of 32 µM. Graphs in c) and 
d) show the relative bound fraction by She2p-L130Y of HIV-1 TAR RNA and U1snRNA, 
respectively, compared to the relative bound RNA fraction by wild-type She2p. 
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2.2.8 Helix E is required for recognition of ASH1 zipcodes 
The mutant She2p-ΔhelixE was created by deleting amino acids 174 to 183 in context of full-
length She2p (Figure 14 c, g and Figure 17 a; see also chapter 2.1.2). To ensure that this 
deletion in She2p did not result in protein aggregation or instability, the size-exclusion 
chromatography profiles of wild-type She2p and She2p-ΔhelixE were compared. As shown in 
Figure 17 b, wild-type and mutant protein eluted in a single peak from a Superdex 200 16/60 
size-exclusion column at almost identical volumes of 58 ml and 57.8 ml, respectively, 
indicating that the mutant protein is properly folded. Filter-binding experiments revealed that 
deletion of helix E severely reduced She2p’s affinity to all ASH1-zipcode elements and to the 
WSC2N zipcode by factor 4 to 20 (Figure 17 c). However, binding of She2p-ΔhelixE to the 
EAR1 zipcode was only modestly impaired (Figure 17 c). These findings suggest that the 
protruding helix E is important for the recognition of ASH1 and WSC2 mRNA-localization 
elements. Surprisingly, deletion of helix E had no significant influence on binding to the 
unrelated stem-loop containing RNAs HIV-1 TAR and U1snRNA (Figure 17 c). These results 
suggest that helix E in She2p specifically recognizes at least a subset of bud-localizing mRNAs 
and might function as a cargo sensor to discriminate between target and non-target RNAs. 
However, because EAR1-zipcode binding is only modestly impaired upon deletion of helix E, 
this sensing mechanism may not apply to all bud-localizing mRNAs in S. cerevisiae. 
 
 
 
 
 
 
 
 
 
 
Figure 17: Helix E in She2p is required for ASH1-zipcode recognition. The cartoon in a) highlights the 
protruding helix E (red) on both She2p monomers, which was deleted to create She2p-ΔhelixE. b) Comparative 
size-exclusion chromatography of wild-type She2p and She2p-ΔhelixE shows that both variants elute at the 
same volume from a Superdex 200 16/60 column, suggesting intact folding of She2p-ΔhelixE. The table in c) 
summarizes the RNA-binding experiments performed with She2p-ΔhelixE in comparison to the respective 
binding constants obtained for wild-type She2p. Deletion of helix E results in a four- to 20-fold reduced affinity 
to ASH1 and WSC2N zipcodes. The binding to the EAR1 zipcode is only two-fold reduced, whereas the 
unrelated stem-loop RNAs HIV-1 TAR and U1snRNA hairpin II are equally bound by She2p-ΔhelixE and wild-
type She2p. Affinity to U1snRNA always varied between different sets of RNA-binding experiments with 
different She2-mutant proteins. For that reason, the results obtained from comparative experiments performed 
in parallel were included (marked by an asterisk).
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2.2.9 The She2p C-terminus also contributes to ASH1-mRNA binding 
In order to investigate the role of the She2p C-terminus in RNA binding, a variant was created 
lacking the C-terminal 6 amino acids of She2p (Δ241-246) (Figure 14 d, h and Figure 18 a). 
Size-exclusion chromatography of this variant, termed She2p-ΔC-term, revealed no signs of 
aggregation or instability (Figure 18 b). When the elution profiles of wild-type She2p and 
She2p-ΔC-term were compared, a slight shift in the retention volume towards a smaller 
molecular weight was observed, which might reflect impaired oligomerization of She2p 
(Figure 18 b; see chapter 2.2.14). In filter-binding experiments, She2p-ΔC-term showed a 
significantly reduced affinity to the ASH1-E1, E2B and E3 zipcodes and binding to the 
ASH1-E2A zipcode could not be measured up to a protein concentration of 32 µM (Figure 
18 c). The binding of She2p-ΔC-term to the EAR1 and WSC2N zipcodes remained 
unaffected or was even slightly increased for the unrelated HIV-1 TAR RNA and U1snRNA 
hairpin II (Figure 18 c). From these experiments it can be concluded that the flexible C-
terminus of She2p contributes to ASH1-mRNA binding, but seems not to be involved in 
recognition of the bud-localizing mRNAs EAR1 and WSC2 or of unrelated stem-loop RNAs.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: The C-terminus of She2p contributes to ASH1-zipcode binding. The cartoon in a) marks the 
position of the flexible C-terminus (red), which was not part of the She2p-crystal structure. b) Comparative 
size-exclusion chromatography of wild-type She2p and She2p-ΔC-term shows a slight shift in the elution 
volume of She2p-ΔC-term towards a smaller molecular weight. However, no aggregation of the mutant protein 
could be observed. In this experiment, a Superose 12 10/300 GL column was used. The table in c) summarizes 
the RNA-binding experiments performed with She2p-ΔhelixE in comparison to the respective binding 
constants obtained for wild-type She2p. Deletion of the She2p C-terminus results in a significantly reduced 
affinity to ASH1 zipcodes. Binding to the EAR1 and the WSC2N zipcodes as well as binding to unrelated 
RNAs HIV-1 TAR and U1snRNA hairpin II remains almost unaffected by the C-terminal truncation. Affinities 
to U1snRNA varied between different sets of RNA-binding experiments with different She2-mutant proteins. 
The results obtained from comparative experiments performed in parallel are shown (marked by an asterisk).  
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In summary, using in vitro RNA-binding experiments four regions in She2p were identified to 
which two distinct RNA-binding properties of She2p could be attributed. General binding of 
RNA stem-loop structures is mediated by the basic helical hairpin motif (chapter 2.2.6). In 
addition, the upper surface region of She2p is required for the binding of RNAs that contain 
stem-loop secondary structures (chapter 2.2.7). In contrast, the protruding α-helix E and the 
very C-terminus of She2p mediate the recognition of the specific target mRNA ASH1 
(chapters 2.2.8 and 2.2.9). This implies that ASH1 is bound by She2p in a different manner 
than unspecific non-target RNAs. However, She2p binding to the bud-localizing mRNAs 
EAR1 and WSC2 was not affected by the C-terminal deletion and only WSC2N binding was 
clearly dependent on helix E, suggesting that She2p might bind specific target RNAs in at least 
two distinguishable ways. 
In the next step, the possible roles of the identified She2p-surface regions in cytoplasmic 
She2p and ASH1-mRNA localization, and on transport-complex assembly were analyzed in 
vivo.  
 
2.2.10 Reduction of basic RNA binding abolishes bud-tip localization of She2p in 
  vivo 
Since She2p links more than 24 different zipcode-containing RNA cargoes to the motor 
protein Myo4p (Oeffinger et al., 2007; Shepard et al., 2003; Takizawa and Vale, 2000), She2p’s 
ability to bind RNA-stem loops should be a prerequisite for the mRNA-localization process in 
S. cerevisiae. In vitro, selective mutation of the amino acids N36 and R63 in the basic helical 
hairpin motif completely abolished binding to specific and non-specific RNAs (chapter 2.2.6). 
Recently, it was shown that the double mutant She2p-N36S-R63K accumulates in the 
nucleolus of S. cerevisiae indicating that She2p is trapped in the nuclear subcompartment 
whenever it is unable to bind its target RNA (Du et al., 2008). Thus, cytoplasmic localization 
cannot be assessed for She2p-N36S-R63K.  
The upper surface region of She2p was also shown to be required for basic RNA binding in 
vitro (chapter 2.2.7). Cytoplasmic localization of She2p-L130Y in comparison to the 
localization of wild-type She2p was analyzed by indirect immunofluorescence using a 
polyclonal α-She2p antibody. Yeast strains were generated that express either wild-type or 
mutant She2p under its endogenous promoter. Western-blot analysis of yeast-cell extracts 
confirmed an equal expression level of the respective proteins in vivo (Figure 19).  
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In immunostaining experiments I observed that wild-type She2p localizes in 69.2 % of all cells 
(n = 3 x ≥ 100 cells) to the tip of the daughter cell (Figure 20 a-c, m). In contrast, the RNA-
binding mutant She2p-L130Y localized to the bud tip in only 2.9 % of inspected cells (n > 100 
cells) (Figure 20 d-f, m). This finding indicates that disruption of basic RNA binding by 
mutating the upper surface of She2p results in mislocalization of She2p. This further suggests 
that also the localization of She2p-dependent mRNA should be impaired.  
 
2.2.11 Selectively impaired ASH1-mRNA binding results in mislocalization of  
  She2p in vivo 
In vitro, binding of She2p to the target mRNA ASH1 was shown to depend on the protruding 
α-helix E and the very C-terminal amino acids of She2p (chapters 2.2.8 and 2.2.9). However, 
She2p’s affinity to the target mRNA EAR1 was only moderately impaired by deletion of 
helix E and even not affected by the She2p C-terminal deletion. These findings let me assume 
that the in vitro observed specificity for target mRNA might be applicable only to ASH1 
mRNA or to a subset of ASH1-like mRNAs. In vivo transport of other bud-localizing mRNAs, 
like the EAR1 mRNA, might be unaffected by these mutations. However, such a scenario 
would require proper She2p localization at the bud tip. Thus, a loss of She2p localization in 
vivo would be a good indication for a total loss of mRNA localization.  
In order to analyze the general roles of helix E and the C-terminus on She2p localization, 
yeast strains were generated expressing She2p-ΔhelixE or She2p-ΔC-term under the control 
of the endogenous promoter. Western-blot analysis of yeast-cell extracts confirmed that 
expression levels of the mutant proteins are comparable to the levels of wild-type She2p 
(Figure 19). Indirect immunofluorescence microscopy using an α-She2p antibody revealed 
that, in contrast to wild-type She2p, She2p-ΔhelixE completely failed to localize to the bud tip 
(0 % localization in n > 100 cells) (Figure 20 g-i, m). Similarly, She2p-ΔC-term localized in 
Figure 19: She2p mutants used for 
immunostaining experiments are expressed at 
wild-type She2p level in vivo. Cell extracts of 
wild-type She2p- and mutant She2p-expressing 
yeast strains were prepared and subjected to 
western-blot analysis using the monoclonal α-
She2p-1C3 antibody. All three She2p mutants are 
expressed at levels comparable to wild-type She2p. 
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only 1 % of inspected cells (n > 100 cells) to the tip of the daughter cell (Figure 20 j-l, m). 
These experiments show that selective impairment of ASH1-mRNA binding results in a 
complete mislocalization of She2p in vivo. Since no RNA-binding mutant showed any 
significant bud-tip localization, it can be concluded that mRNA localization might be generally 
affected in these mutants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Impaired RNA binding by She2p results in disrupted bud-tip localization of She2p.
Indirect immunofluorescence against She2p revealed that wild-type She2p efficiently localizes to the bud tip 
(a-c) in 69.2 % of inspected cells (n = 3 x ≥ 100 cells) (m). In contrast, localization of the RNA-binding 
deficient She2p variants She2p-L130Y (d-f), She2p-ΔhelixE (g-i), or She2p-ΔC-term (j-l) was never 
observed in more than 2.9 % of all budding cells (n ≥ 100 cells) (m). She2p was immunostained with α-
She2p (323/4) (a, d, g, j) and nuclei were visualized by Hoechst staining (b, e, h, k). Images in c, f, i, l display 
merged signals of the respective α-She2p and nuclei stainings. The chart in m) represents the results of 
counting the number of cells with She2p bud-tip localization. For analysis, only budding yeast cells were 
counted. In she2Δ cells, no antibody staining was observed (not shown).  
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2.2.12 Impaired ASH1-mRNA binding by She2p results in mislocalization of  
  ASH1 mRNA in vivo  
To further confirm the loss of ASH1-mRNA localization in She2p-ΔhelixE mutant cells, in 
situ hybridization experiments using oligonucleotides directed against ASH1 mRNA were 
performed. This collaborative experiment was carried out by Maria Schmid from the 
laboratory of Prof. Ralf-Peter Jansen. Since these are not my own results, the outcome of this 
experiment is described here, but the respective figure is shown in the appendix (Figure A4). 
The experiment revealed that, in contrast to a wild-type She2p background, ASH1-mRNA 
localization was completely abolished upon deletion of helix E (0 % localization in n ≥ 100 
cells; Figure A4). Diffuse distribution of ASH1 mRNA is consistent with the observation that 
She2p-ΔhelixE is uniformly distributed and not localized to the bud tip. Considering the 
findings, that none of the RNA-binding mutants localized to the bud tip (chapter 2.2.10) and 
that ASH1 mRNA is delocalized in one of these mutants, no further in situ hybridization 
experiments against ASH1 mRNA were performed.  
 
2.2.13 Impaired RNA binding by She2p affects translocation-complex assembly 
Immunostaining and in situ-hybridization experiments described in chapters 2.2.11 and 2.2.12 
suggested that the identified surface regions in She2p have to act in an orchestrated fashion to 
allow for She2p localization and thus, for mRNA localization. However, the inability of She2p 
RNA-binding mutants to localize to the bud tip raised the question if these mutants still 
assemble with She3p and Myo4p into translocation complexes. To analyze cytoplasmic 
transport-complex assembly, myc-tagged She2p was subjected to immunoprecipitation with a 
monoclonal α-myc 9E11 antibody coupled to magnetic Protein-G beads. By western blotting, 
co-immunoprecipitation of the adapter protein She3p was analyzed and the respective She2p-
associated fraction of She3p was quantified. The fractions that co-immunoprecipitated with 
She2p were not analyzed for the presence of the motor protein Myo4p, since She3p and 
Myo4p have been shown to form a stable cytoplasmic complex (Böhl et al., 2000; Heuck et al., 
2007; Long et al., 2000; Takizawa and Vale, 2000). she2Δ yeast cells were transformed with 
plasmids encoding for C-terminally myc-tagged She2p variants, which were expressed under 
its endogenous promoter. For visualization of She3p, it was genomically tagged with an N-
terminal HA tag. Western blotting against She2p in yeast strains expressing the respective 
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She2p variants revealed that the expression level of the She2-mutant proteins was comparable 
to the level of wild-type She2p (Figure 21).  
 
 
 
 
 
As shown in Figure 22, wild-type She2p efficiently co-precipitated She3p (Figure 22 a, upper 
panel, IP lanes). The different She2p mutants co-precipitated She3p less efficiently, which is 
indicated by a lower She3p-signal intensity in the respective IP fractions (Figure 22 a, upper 
panel, IP lanes). The lower panel in Figure 22 a shows the She2p input (Input lanes) and the 
unbound She2p fraction (Flow-through lanes). Apparently, unequal amounts of the respective 
She2p variants were bound to the beads, since the She2p signals in the flow-through fraction 
vary (Figure 22 a, lower panel, flow-through lanes). In order to draw quantitative conclusions 
of this experiment, the relative amount of She3p that is bound to She2p had to be calculated. 
Therefore, the She2p signals in the flow-through fractions were subtracted from the She2p-
input signals (Figure 22 a, lower panel). The resulting value represented the total bead-bound 
fraction of She2p, which served as the effective input for co-immunoprecipitation. This value 
was then used to normalize She3p signals. The She3p amount that was co-precipitated by 
wild-type She2p was set to 100 % (Figure 22 b). Compared to the She3p association with wild-
type She2p, She2p-L130Y assembled into 48.6 % of She3p-containing transport complexes 
(Figure 22 b). However, when considering the complete loss of She2p-L130Y bud-tip 
localization observed in vivo (Figure 20), it has to be concluded that the complexes assembled 
with She2p-L130Y are unstable and are not efficiently transported to the bud tip. In contrast, 
the She2p variants She2p-ΔhelixE and She2p-ΔC-term, which are impaired in specific mRNA 
binding, failed to associate with She3p in vivo above background levels (Figure 22 b). This 
suggests that specific mRNA target recognition by She2p triggers the assembly of functional 
mRNA-translocation complexes.  
Taken together, the co-immunoprecipitation experiments show that the She2p:She3p 
association is significantly impaired when She2p’s affinity to RNA is reduced, indicating that 
mRNA binding by She2p is a prerequisite for mRNP assembly.  
Figure 21: She2p mutants used for Co-IP 
experiments are expressed at wild-type She2p 
level in vivo. Cell extracts of wild-type She2p-
3myc- and mutant She2p-3myc-expressing yeast 
strains were prepared and subjected to western-
blot analysis using the monoclonal α-She2p-1C3 
antibody. All three She2p mutants are expressed 
at levels comparable to wild-type She2p. 
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2.2.14 She2p forms homo-oligomers through the upper surface region 
During protein purification I observed that wild-type She2p elutes from size-exclusion 
columns at a volume far above the calculated volume of a She2p dimer (Figure 23). The 
molecular weight of a She2p dimer is 57.2 kDa, which would correspond to a retention 
volume of about 81 ml from a calibrated Superdex S200 16/60 size-exclusion column. 
However, for wild-type She2p typically a retention volume of 60 ml was observed correlating 
with a molecular weight of 320 kDa (Figure 23). This finding raised the question whether the 
She2p dimer observed in the crystal structure indeed represents the native oligomerization 
state of She2p. In addition, I found that the variant She2p-L130Y elutes at a volume 
corresponding to a significant lower molecular weight of about 110 kDa (Figure 23), indicating 
that mutation of the upper surface region of She2p disrupts the potential oligomeric state.  
 
Figure 22: mRNP assembly is impaired in She2p RNA-binding mutants. a) Co-immunoprecipitation 
experiments of myc-tagged She2p and HA-tagged She3p. She2p and She3p were monitored by western blotting 
using α-myc 9E10 and α-HA 3F10 antibodies (lower and upper panel, respectively). Input fractions show that 
She3p expression was not influenced in She2p-mutant expressing yeast cells (upper panel). Upper panel, right: 
Wild-type She2p efficiently co-immunoprecipitated She3p. Complex assembly was consistently impaired in all 
She2p mutants as indicated by a lower She3p-signal intensity in the IP fractions. The band in the Δshe2 lane 
indicates unspecific background binding of She3p to protein G-beads. Lower panel, right: The amount of the 
She2p input and the unbound She2p-3myc fraction is shown (Input and Flow-through lanes). For quantification 
of the She2p:She3p association the total bead-bound fraction of She2p was calculated by subtracting the 
unbound She2p fraction from the She2p-input fraction (lower panel). The respective bead-bound fractions of 
She2p were used to normalize She3p signals. b) Quantification of two independent experiments revealed that 
She2p-L130Y assembles into destabilized transport complexes, whereas She2p-ΔhelixE and She2p-Δ-C-term 
almost failed to associate with She3p.  
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2.2.14.1 Dynamic Light Scattering indicates large She2p particles 
Using Dynamic Light Scattering (DLS), I determined the hydrodynamic radius (RH) of wild-
type She2p. The hydrodynamic radius represents the effective size of a molecule as detected 
by its diffusion. Thus, additional information on the She2p-particle size can be obtained. Wild-
type She2p was measured at different concentrations in two different buffer compositions 
(HEPES and Tris based, respectively; Table 3). The measurements revealed that wild-type 
She2p indeed forms large particles with a RH ranging from 9.5 nm to 13.5 nm (Table 3). It was 
observed that the particle size increases with higher protein concentrations, indicating a 
concentration-dependent oligomerization of She2p. Secondly, the overall size of the She2p 
oligomers seemed to significantly depend on the buffer composition, since smaller RH values 
were obtained in a Tris-buffered solution. However, a concentration-dependent increase in 
particle size was also observed in Tris buffer. For comparison DLS measurements were 
performed with the variant She2p-L130Y, which was shown to elute at a smaller molecular 
weight from a size-exclusion column (Figure 23). She2p-L130Y was analyzed only in a Tris-
based buffer. In contrast to wild-type She2p, She2p-L130Y forms significantly smaller 
particles with RH values ranging from 5.3 nm to 7.4 nm (Table 3), indicating that the L130Y 
mutation indeed disrupts She2p-oligomer formation. However, She2p-L130Y was measured at 
a lower concentration range, but even at comparable protein concentrations a clearly different 
RH was observed (Table 3). 
 
Figure 23: Preparative size-exclusion 
chromatography indicates a difference in 
molecular weight of wild-type She2p and 
She2p-L130Y. Wild-type She2p elutes from a 
Superdex 200 16/60 column at a volume of 
about 60 ml corresponding to a molecular weight 
of 320 kDa, indicating a higher oligomeric state 
than a She2p dimer (57.2 kDa). A significant shift 
in the elution volume of the She2p-L130Y 
variant towards a smaller molecular weight of 
110 kDa was observed, suggesting an 
oligomerization defect. The theoretical retention 
volume of dimeric She2p (81 ml) is marked by an 
arrow head. The size-exclusion column was 
calibrated with a molecular weight marker kit. 
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Protein Buffer Conc. (mg/ml) RH (nm) 
wild-type 
She2p 
10 mM HEPES, 
125 mM NaCl, 1 mM 
DTT; pH 7.5 
3.5 
7.5 
11.5 
13.5 
wild-type 
She2p 
20 mM Tris, 125 mM 
NaCl, 1 mM DTT; 
pH 7.5 
3.9 
7.7 
14.4 
9.5 
11.3 
12.4 
She2p-
L130Y 
20 mM Tris, 125 mM 
NaCl, 1 mM DTT; 
pH 7.5 
1.7 
2.3 
3.1 
5.3 
6.2 
7.4 
 
Taken together, the DLS experiments suggest that She2p oligomerizes to higher molecular 
weight particles, which is dependent on the protein concentration and the surrounding 
solution. The oligomerization appears to be specific, because it can be impaired by mutating a 
single amino acid (leucine 130) in the upper surface region of She2p.  
 
2.2.14.2  Analytical ultracentrifugation identifies She2p decamers that   
   assemble through the upper surface region 
In order to analyze the oligomerization state of She2p more precisely, I decided to use the 
technique of analytical ultracentrifugation (AUC). These experiments were performed in 
collaboration with Dr. Klaus Richter from the Department of Chemistry at the Technical 
University Garching, who also analyzed the data. Since the AUC experiments proved to be 
essential for subsequent experiments, the results are shown in this section.  
To characterize the oligomeric state of both wild-type She2p and She2p-L130Y, analytical 
ultracentrifugation experiments were performed. Both She2p variants were pre-treated with 
RNase A to prevent unspecific RNA-mediated oligomerization and then analyzed in the Tris-
based size-exclusion buffer 2 (see chapter 4.9.4). Sedimentation-velocity experiments 
performed with wild-type She2p at a concentration of 16 µM revealed one single oligomeric 
species (Figure 24 a). From the sedimentation profile of wild-type She2p (appendix, Figure 
A5) a sedimentation coefficient of 9.6 Svedberg (S) was determined (Figure 24 a). 
Subsequently, sedimentation-velocity experiments were performed with She2p-L130Y, for 
which a smaller particle size and thus, a smaller sedimentation coefficient were assumed. 
She2p-L130Y was analyzed in three different concentrations (4.9 µM, 12.9 µM, 32.0 µM) to 
identify potentially different oligomeric species. Indeed, the mutant protein sedimented in a 
Table 3: Dynamic light 
scattering indicates She2p-
oligomer formation. DLS data 
show that wild-type She2p forms 
significantly larger particles than 
the mutant She2p-L130Y, 
suggesting that the upper surface 
region of She2p is involved in 
oligomerization.   
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concentration-dependent manner between 4.2 S and 7.5 S (Figure 24 b) with an average of 
5.6 S (Figure 24 a). However, even at the highest protein concentration the sedimentation 
coefficient of She2p-L130Y was still substantially smaller than the one obtained for wild-type 
She2p at an intermediate concentration of 16 µM (Figure 24 a, b). These results clearly 
indicate different oligomeric states of wild-type and mutant She2 protein.  
In order to calculate the molecular weight of wild-type and mutant She2p, sedimentation-
equilibrium experiments were performed. Both proteins were measured at nine different 
concentrations ranging from 1.7 µM to 30.7 µM (wild-type She2p) and 1.9 µM to 32.0 µM 
(She2p-L130Y) (see chapter 4.10.3) to investigate concentration-dependent oligomerization 
events. For wild-type She2p, a molecular weight of approximately 290 kDa was determined 
(Figure 24 c), which is consistent with the molecular weight derived from size-exclusion 
chromatography and also with the large hydrodynamic radius measured by DLS. In contrast to 
the DLS measurements, no concentration-dependent oligomerization could be observed in 
the sedimentation-equilibrium experiments. However, the protein concentration range used in 
both experiments significantly differed. The maximum concentration measured in AUC 
experiments was 0.9 mg/ml, whereas due to the low detection limit in DLS experiments 
higher protein concentrations had to be used. This might suggest that at a certain protein 
concentration She2p tends to form non-specific higher molecular-weight complexes. 
Considering a molecular weight of a She2p dimer of 57.2 kDa the oligomer observed in AUC 
experiments corresponds to a complex consisting of ten She2p monomers. Since it is well-
proved that She2p forms dimers with a buried surface area of 2015 Å2 per monomer (Niessing 
et al., 2004), a complex built of five She2p dimers can be suggested.  
Sedimentation-equilibrium experiments performed with She2p-L130Y revealed that it 
oligomerizes concentration-dependently as it was already observed in the DLS experiment and 
in the sedimentation-velocity experiment. For an intermediate protein concentration of 
11.1 µM a molecular weight of 76.1 kDa was calculated (Figure 24 d), which corresponds to an 
oligomerization state between a dimer (57.2 kDa) and a tetramer (114.4 kDa). From this 
finding it can be concluded that mutation of leucine 130 interferes with She2p 
oligomerization.  
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Figure 24: Analytical-ultracentrifugation experiments suggest that She2p oligomerizes via its upper 
surface region. a) In sedimentation-velocity experiments wild-type She2p sediments at 9.6 S. In contrast, 
She2p-L130Y sediments concentration-dependently with an average of 5.6 S. The reduced sedimentation 
coefficient for She2p-L130Y is consistent with a reduced molecular weight. b) Sedimentation-velocity 
experiments with She2p-L130Y at different protein concentrations show a concentration-dependent change 
in sedimentation. However, even at a protein concentration of 32 µM, the sedimentation coefficient of wild-
type She2p is not reached. c) Sedimentation-equilibrium experiments with wild-type She2p at different 
protein concentrations indicate a concentration-independent oligomer of 290 kDa. Shown are two 
representative curves that could be fitted to the same molecular weight. d) Sedimentation-equilibrium 
experiments with She2p-L130Y at an intermediate concentration of 11.1 µM revealed a molecular weight of 
76 kDa, confirming that higher molecular weight oligomers are disrupted by this mutation. 
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In summary, analytical ultracentrifugation experiments confirmed that She2p forms higher-
order oligomers via the upper surface region of the She2p dimer. Together with the RNA-
binding experiments and in vivo studies, these results indicate that She2p oligomerization is 
important for the binding of stem-loop containing RNAs and that, in turn, RNA binding by 
She2p oligomers is required for efficient mRNP translocation to the bud tip.  
 
2.2.14.3  Electron microscopy suggests She2p oligomers smaller than a   
   decamer 
If the She2p oligomer of 290 kDa observed in analytical ultracentrifugation experiments was 
true, visualization of the complex by electron microscopy should be possible. Therefore, 
negative-stain images of wild-type She2p were recorded by the laboratory of Prof. Roland 
Beckmann (Gene Center Munich). Unfortunately, uniform particles could not be identified, 
but some of the observed particles showed a stretched shape of about ten nanometers in 
length (not shown). However, for a protein of 290 kDa a much larger particle size would be 
expected. The protein concentrations that are used in electron-microscopy experiments are 
very low (100 µg/ml, corresponding to 3.5 µM She2p). This might be an indication that She2p 
forms smaller particles at more physiological concentrations, which are below the detection 
limit of the biophysical methods that were used so far.  
 
2.2.15 She2p is tetrameric at physiological protein concentrations 
In order to analyze She2p oligomerization at near-physiological protein concentrations I 
performed analytical size-exclusion experiments with wild-type She2p and She2p-L130Y. For 
the analysis, a Superose 12 10/300 size-exclusion column was used, which was calibrated to 
allow for molecular-weight determination. The estimated physiological concentration of She2p 
in vivo was calculated to be 230 nM (Niessing et al., 2004). Therefore, various protein dilutions 
were chosen covering concentrations below and above the assumed physiological 
concentration (Figure 25). The proteins were purified under high-salt conditions to prevent 
any unspecific RNA-mediated oligomerization. The respective protein samples were applied 
to the column and analyzed in size-exclusion buffer 3 (chapter 4.9.4). To account for sample 
dilution on the size-exclusion column, She2p-containing peak fractions were integrated over 
the peak volume. Thereby, the approximate protein concentration on the column could be 
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calculated. As shown in Figure 25 a and b, the respective applied and estimated protein 
concentrations differed roughly by factor 2.5 to 3.  
Considering sample dilution, wild-type She2p formed a distinct oligomeric complex up to an 
experimental concentration of 0.78 µM with an average molecular weight of 125.5 kDa 
corresponding to a She2p tetramer (4 x 28.6 kDa = 114.4 kDa) (Figure 25 a, c). Importantly, 
this tetrameric complex was determined for protein concentrations around or even above the 
physiological She2p concentration of 230 nM. This finding suggests that She2p forms larger 
oligomers than the dimer observed in the crystal structure and that a She2p tetramer might be 
the oligomerization state in vivo. Up to an experimental protein concentration of 3.5 µM, the 
molecular weight of wild-type She2p slightly increased to 145 kDa (Figure 25 a, c). However, 
at higher concentrations She2p formed larger complexes of almost 200 kDa (Figure 25 a, c), 
which reflects the concentration-dependent oligomerization observed in dynamic light 
scattering (chapter 2.2.14.1). 
In contrast, She2p-L130Y failed to form oligomers corresponding to a putative tetramer 
(Figure 25 b, c). Instead, up to an experimental concentration of 330 nM a molecular weight 
of 58 kDa was calculated (Figure 25 b, c), which exactly matches the molecular weight of a 
She2p dimer (57.2 kDa). This result strongly suggests that mutation of leucine 130 at the 
upper surface region disrupts She2p-tetramer formation at physiological protein 
concentrations. With higher protein concentrations, an increase of molecular weight of She2p-
L130Y was observed, being consistent with previous observations (chapters 2.2.14.1 and 
2.2.14.2). But not even at the highest protein concentration measured the oligomeric state of 
wild-type She2p was reached (Figure 25 c).  
In previous chapters, a number of functional defects were observed for She2p-L130Y. This 
mutant has an impaired RNA binding (chapter 2.2.7), it does not localize to the bud tip 
(chapter 2.2.10), and it shows defects in transport-complex assembly in vivo (chapter 2.2.13). 
Further I have shown by various techniques that mutation of leucine 130 to tyrosine disrupts 
She2p oligomerization. Therefore, I conclude that wild-type She2p forms tetramers at 
physiological concentrations via its upper uncharged surface region and that these tetramers 
are functionally relevant in vivo.  
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Figure 25: Analytical size-exclusion chromatography 
reveals tetramer formation of She2p at physiological 
protein concentration. a) Wild-type She2p forms a distinct 
oligomeric complex corresponding to a tetramer at 
concentrations up to 0.78 µM. Up to a concentration of 3.5 µM 
the particle size increases only slightly, but at higher 
concentrations larger oligomers are observed. b) In contrast, 
the mutant She2p-L130Y shows impaired oligomerization over 
the entire concentration range. In addition to the protein 
concentration loaded, the estimated protein concentration after 
sample dilution on the column is listed. Molecular weights were 
calculated from peak elution volumes. c) Graphical 
representation of the results from a) and b), using the estimated 
sample concentration on the column. Dashed lines indicate 
either the molecular weight of a She2p dimer (57.2 kDa) or of a 
tetramer (114.4 kDa). 
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2.2.16 Small Angle X-ray Scattering (SAXS) studies identify She2p tetramers 
By using several techniques described above (dynamic light scattering, analytical 
ultracentrifugation, and analytical size-exclusion chromatography) I observed that She2p 
forms larger oligomers than the dimer described in the crystal structure (Niessing et al., 2004). 
In order to analyze the oligomeric state from a structural point of view, I performed Small 
Angle X-ray Scattering (SAXS) experiments with wild-type She2p and the oligomerization-
defective variant She2p-L130Y.  
SAXS is a powerful technique that can be used to obtain low-resolution structural information 
on biological macromolecules (reviewed in Putnam et al., 2007). SAXS experiments are 
performed in solution and therefore, the sample can be measured in a number of different 
buffer conditions, preferably in a buffer reflecting the physiological composition. In advantage 
to X-ray crystallography, SAXS can also provide structural information on flexible parts of a 
protein. Combining SAXS-scattering data with the crystal structure of a given protein provides 
a potential tool to obtain more accurate and complete models of protein complexes in 
solution. In addition, SAXS has been successfully used to determine the molecular masses of 
proteins with an average error below 10 % (Mylonas and Svergun, 2007). Scattering data of 
monodisperse samples are usually collected at the highest possible protein concentration 
without observing any aggregation of the protein. In order to obtain reliable information from 
the scattering data, the minimal protein concentration must be higher than 1 mg/ml, since 
otherwise the signal-to-noise ratio is too low.  
 
2.2.16.1  Identification of suitable buffer conditions for SAXS measurements 
At a protein concentration of 1 mg/ml (34.9 µM) She2p oligomerizes into a larger complex 
than the tetramer that is formed at a physiological protein concentration (chapter 2.2.15). 
Therefore, a buffer condition had to be identified, in which She2p is present as a stable, 
physiological oligomer at protein concentrations higher than 1 mg/ml. Using DLS, a number 
of different buffers were screened for their influence on She2p’s solubility and oligomerization 
(Table 4). Besides variations in salt or buffer composition, also several detergents were tested, 
which are known to function in SAXS experiments at concentrations below the critical 
micelle-forming concentration (http://bl1231.als.lbl.gov/). As shown in table 4, the individual 
buffer composition had a strong effect on She2p’s particle size and its solubility. In most 
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conditions, a hydrodynamic radius (RH) between 9 nm and 11 nm was observed (Table 4), 
which is comparable to the radii measured for wild-type She2p in previous DSL experiments 
(chapter 2.2.14.1). Aggregation of She2p was especially provoked by the addition of detergents 
to the solution. In contrast, in buffers with a high ionic strength (#2 and #4) She2p formed 
smaller particles with an RH between 5.6 nm and 6.1 nm (Table 4). This finding indicates that 
She2p exists in different oligomeric states in solution and that She2p oligomerization strongly 
depends on the buffer condition. Importantly, the size of the She2p oligomer observed in 
buffers #2 and #4 increased only slightly with higher protein concentrations rendering these 
conditions promising for following SAXS measurements.  
 
# Buffer Conc. 
(mg/ml) 
RH 
(nm) 
Sample 
aggregation? 
Suitable for 
SAXS? 
1 20 mM Tris, 150 mM NaCl, 2 mM DTT; pH 7.5 
 
2.6 
6.3 
8.7 
10.7 
- 
- 
+ 
2 20 mM Tris, 300 mM NaCl, 2 mM DTT; pH 7.5 2.6 
5.7 
5.7 
6.1 
- 
- 
+ 
3 20 mM Tris, 150 mM NaCl, 2 mM DTT, 5 % glycerol; pH 
7.5 
2.6 
4.9 
10.1 
12.0 
+ 
- 
- 
4 50 mM NaH2PO4/Na2HPO4, 150 mM NaCl, 2 mM DTT; 
pH 7.4 
2.6 
6.5 
5.6 
5.9 
- 
- 
+ 
5 20 mM Tris, 150 mM NaCl, 2 mM DTT, 5 mM β-octyl 
glucoside; pH 7.5 
2.4 
3.9 
10.0 
9.7 
- 
-/+ 
-/+ 
6 20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.1 % CHAPS; 
pH 7.5 
2.1 
3.7 
10.0 
10.5 
- 
- 
+ 
7 20 mM Tris, 150 mM NaCl, 2 mM DTT, 1.5 mM Decyl-β-
D-maltoside; pH 7.5 
2.8 
6.2 
10.2 
11.2 
+ 
+ 
- 
8 20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.2 % DDMAB; 
pH 7.5 
2.0 
2.9 
>63.7 
>23.1 
+ 
+ 
- 
9 20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.4 % DDAO; 
pH 7.5 
2.2 
3.0 
>22.5 
>58.4 
+ 
+ 
- 
 
 
 
 
 
Table 4: Dynamic light scattering with wild-type She2p identified suitable buffer conditions for 
SAXS experiments. Summarized are the results from DLS experiments that were performed with wild-type 
She2p at the indicated protein concentrations in different buffer conditions. Generally, two different particle 
sizes of average 10 nm (#1, #3, #5, #6, #7) and 6 nm (#2, #4) were detected, indicating that She2p 
oligomerization strongly depends on the surrounding solution. Addition of detergents often induced 
aggregation of She2p. In buffers with a higher ionic strength (#2, #4) significantly smaller particles were 
observed with a constant RH at high protein concentrations.  
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2.2.16.2  SAXS confirms tetramer formation in solution 
SAXS experiments were performed with wild-type She2p in five different conditions and with 
She2p-L130Y in three different conditions, respectively (Table 5). The scattering data were 
primarily analyzed with PRIMUS from the ATSAS program package for the presence of 
aggregation or intermolecular forces between the molecules. With exception of data collected 
in buffer #4, all scattering data were inappropriate for further processing due to 
concentration-dependent oligomerization or protein aggregation (Table 5). This finding 
demonstrates the sensitivity of SAXS measurements compared to the technique of dynamic 
light scattering, as in the DLS experiments no sample aggregation could be detected in these 
buffer conditions (chapter 2.2.16.1).  
Wild-type She2p  She2p-L130Y    
SAXS data 
collection? 
Data 
processing? 
SAXS data 
collection? 
Data 
processing?
# Protein buffer 
+ Not possible. 
Tends to 
aggregate. 
+ Partially 
possible. 
1 20 mM Tris, 150 mM NaCl, 2 mM DTT; pH 7.5 
+ Partially 
possible. 
+ Partially 
possible. 
2 20 mM Tris, 300 mM NaCl, 2 mM DTT; pH 7.5 
+ Yes + Yes 4 50 mM NaH2PO4/Na2HPO4, 150 mM NaCl, 
2 mM DTT; pH 7.4 
+ Not possible. 
Protein 
aggregation. 
- - 5 20 mM Tris, 150 mM NaCl, 2 mM DTT, 5 mM 
β-octyl glucoside; pH 7.5 
+ Not possible. 
Protein 
aggregation. 
- - 6 20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.1 % 
CHAPS; pH 7.5 
 
 
 
 
Analysis of the scattering curves of wild-type She2p and She2p-L130Y which were measured 
in sodium phosphate-containing buffer (#4), revealed no signs of aggregation or 
intermolecular forces between the particles (Figure 26). Numerous consecutive measurements 
of each sample revealed no sensitivity of She2p towards long exposure to high energy X-ray 
radiation. The scattering curves obtained at the different concentrations show a good overlap 
Table 5: Summary of SAXS-scattering data collected for wild-type She2p and She2p-L130Y. The table 
summarizes in which buffer conditions SAXS scattering data were collected (“+”) and if the scattering data 
could be processed. “Partially possible” indicates that not all measured data gave a meaningful result and 
therefore, were not further processed. Numbering of the protein buffers is identical to Table 4. Please note, that 
for comparison of the SAXS data, only scattering data were completely processed that were obtained for both 
She2p variants in identical buffer conditions (buffer #4). 
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over long distances. However, the respective scattering curves measured at high protein 
concentration differed to some extent from the data obtained at lower concentrations, which 
might indicate a concentration-dependent behavior of the proteins. Therefore, all scattering 
curves were analyzed individually.  
 
 
 
 
 
 
 
 
 
The Kratky plot can be directly calculated from the scattering curves (s2*I(s) as a function of s) 
and allows for evaluating the folding of the measured samples. Typically, folded peptides show 
a peak with a roughly parabola-like shape. In contrast, unfolded or unstructured peptides lack 
this characteristic peak and are linear with respect to s at large angles or the curve is slightly 
increasing in the larger s-range. Analysis of wild-type She2p revealed a clear peak and no 
increase of the curve at large angles, indicating proper folding of the molecule (Figure 27 a). 
The Kratky plot of the mutant She2p-L130Y also shows a parabola-like peak, but in contrast 
to wild-type She2p, the protein might contain unstructured portions as the slope increases in 
the larger s-region (Figure 27 b). 
 
Figure 26: SAXS-scattering curves of 
wild-type She2p and She2p-L130Y 
measured in sodium-phosphate 
buffer. Shown are the scattering curves 
of both wild-type She2p and She2p-
L130Y that were obtained for three 
concentrations each in sodium 
phosphate-containing buffer. The buffer 
was already subtracted from the 
individual curves. The scattering intensity 
I is plotted logarithmically against the 
scattering angle s.  
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For molecular-mass determination of the individual complexes, the scattering intensities (I) 
were extrapolated to zero angle (I0). The forward scattering intensity I0 depends only on the 
square of the number of electrons and is independent on its shape. In an ideal sample the 
detected scattering is linearly related to the number of particles. With known sample 
concentration and by using reference samples like bovine serum albumin and lysozyme, the 
molecular weight of a molecule can be determined. For wild-type She2p a molecular weight 
between 107.9 kDa and 116.3 kDa was calculated (Table 6). This clearly corresponds to a 
tetramer (114.4 kDa) and confirms the results from analytical size-exclusion experiments 
(chapter 2.2.15). Corresponding analysis of She2p-L130Y showed that it associates 
concentration-dependently to complexes between 79.6 kDa and 102.2 kDa (Table 6), 
confirming the oligomerization defect of this mutant. Even at the highest protein 
concentration (6.9 mg/ml) She2p-L130Y fails to assemble into wild-type like oligomers, but 
instead forms an equilibrium between a dimeric and a tetrameric state (Table 6). 
Figure 27: Kratky plot indicates proper folding of wild-type She2p and potentially unstructured 
regions in She2p-L130Y. The Kratky plot in a) shows a single peak, indicating proper folding of wild-type 
She2p. The plot in b) reveals that the mutant She2p-L130Y is predominantly folded, but might contain 
unstructured regions. Kratky plots were calculated directly from the scattering curves measured at 
intermediate protein concentrations (wild-type She2p: 2.8 mg/ml; She2p-L130Y: 3.75 mg/ml). Plotted is 
s2 * I(s) as a function of the scattering angle s. 
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Protein Conc. 
(mg/ml) 
Conc. 
(µM) 
MW 
(kDa) 
Rg (Å) Dmax
(Å) 
Average Rg 
(Å) 
Average Dmax
(Å) 
wild-type She2p 1.37 47.8 107.9 45.6 160.0 49.4± 8.8 172.5 ± 10.9 
2.8 97.7 115.8 49.5 180.0 
5.92 206.5 116.3 53.2 177.5 
She2p-L130Y 2.0 69.8 79.6 36.8 137.5 38.8 ± 2.2 138.6 ± 5.9 
3.75 130.8 91.7 38.3 133.3 
6.9 240.7 102.2 41.2 145.0 
 
 
 
 
In order to obtain information on the shape and the overall dimensions of She2p, the radii of 
gyration (Rg) were determined from the scattering curves. The radius of gyration is calculated 
from the Guinier approximation that is only valid for scattering at small angles (s  0). The 
Guinier plot, in which ln(I(s)) is plotted versus s2, should give a linear function, from which I0 
and Rg can be extracted. The Guinier approximation is valid in the range of s * Rg < 1.3 and 
must be iteratively estimated. Rg is defined as the square root of the average squared distance 
of each scattering molecule from the center of the particle and therefore depends on the size 
and the shape of a particle. For wild-type She2p, an Rg ranging between 45.6 Å and 53.2 Å 
with an average of 49.4 Å was calculated (Table 6). In contrast, the radius of gyration obtained 
for the She2p-L130Y mutant was significantly smaller and was determined to be between 
36.8 Å and 41.2 Å with an average of 38.8 Å (Table 6). Both proteins exhibited a 
concentration-dependent increase in Rg values, as it was already suggested in primary data 
analysis (see above). However, the respective average Rg values clearly differed from each 
other (Table 6), indicating different shapes of wild-type She2p and She2p-L130Y.  
 
2.2.17 SAXS indicates that She2p forms an elongated tetramer 
Calculation of the pair-distribution function P(r) gives additional information on the overall 
shape of a molecule. The P(r) function is calculated through a Fourier transform of the 
scattering curve I(s) and provides information about the distances between electrons in the 
scattering particles. Importantly, the P(r) function is valid over the entire s-range and thus, 
represents a real-space approximation of the scattering particles. Theoretically, the P(r) 
Table 6: Structural parameters calculated from SAXS-scattering curves of wild-type She2p and She2p-
L130Y. Summarized are the structural parameters that were derived from SAXS analysis of both wild-type and 
mutant She2p at indicated protein concentrations. Rg: radius of gyration; Dmax: maximum dimension of the 
particle. By comparing the individual parameters of wild-type and mutant She2p, a significantly different overall 
size of both molecules can be observed. 
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function is zero at r = 0 and at r ≥ Dmax. Dmax corresponds to the maximum linear dimension 
in the scattering particle. For transformation of the scattering data into the P(r) function, the 
Dmax value has to be iteratively determined and the resulting P(r) functions have to be analyzed 
for their fit to the experimental scattering. Subsequently, I determined the Dmax values of wild-
type She2p to range between 160 Å and 180 Å, whereas for She2p-L130Y Dmax values 
between 133.3 Å and 145 Å were determined (Table 6). Consistently with the Rg values, also 
the Dmax values of both proteins increased concentration-dependently.  
I calculated the P(r) functions from all scattering data assuming the respective iteratively 
determined Dmax values (Table 6, Figure 28). The P(r) function of wild-type She2p shows the 
typical skewed shape of an elongated molecule having a peak at short distances and an 
extended tail (Figure 28 a). In contrast, the P(r) function of She2p-L130Y is rather symmetric 
with a single peak and shows the shape of a more globular molecule (Figure 28 a). It was 
observed that the P(r) functions calculated for different concentrations of the respective 
proteins are not completely identical (Figure 28 b). Considering the differences in the Dmax 
values, on which the calculation of the P(r) function relies, this finding was expected. 
Interestingly, the fact that the molecular weight of She2p-L130Y increases concentration-
dependently without reaching the particle size of wild-type She2p can also be demonstrated 
with the P(r) functions of She2p-L130Y. With increasing concentrations of She2p-L130Y, its 
P(r) functions approached the shape of the wild-type She2p curves without ever merging with 
it (Figure 28 b). 
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The experiments performed so far suggest that She2p forms tetramers, most likely comprising 
two dimeric subunits, and that these complexes can be disrupted by mutation of leucine 130. 
This amino acid is located in a conserved region on the upper hydrophobic surface of She2p. 
Therefore, She2p tetramers might form through the upper surface. In the published crystal 
structure contacts between She2p dimers could be observed (Figure 29) (Niessing et al., 2004). 
I decided to re-examine the potential role of these contacts for She2p-tetramer formation. 
Among the several crystallographic contacts, only two dimer interactions buried surface areas 
large enough to be potentially relevant in solution. One contact involves the basic helical 
hairpin-containing surface at the front of She2p and buries a surface area of 778 Å2 per dimer 
(Figure 29 a). This potential assembly was termed globular tetramer. The second dimer 
interaction involves the upper, uncharged surface region of She2p. It buries a surface area of 
743 Å2 per dimer and was termed elongated tetramer (Figure 29 a, b). Leucine 130 is located 
exactly in this region and therefore, formation of an elongated tetramer was suggested 
(Figure 29 c, d).  
Figure 28: Pair-distribution functions of wild-type She2p and She2p-L130Y indicate different particle 
shapes. a) and b) show the P(r) functions calculated from the SAXS-scattering data measured at the indicated 
protein concentrations of wild-type She2p and She2p-L130Y. a) The P(r) function of the wild-type protein 
shows the typical shape of an elongated molecule, whereas the P(r) function of She2p-L130Y suggests a 
globular molecule. b) P(r) functions of wild-type and mutant protein demonstrate the concentration-dependent 
behavior of She2p-L130Y. With increasing concentration the P(r) function approaches the shape of the wild-
type P(r) function, but does not merge with it. Also wild-type She2p shows a slight concentration dependency, 
but to a lower extent. 
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Figure 29: Crystallographic contacts of She2p. a) In the published crystal structure (PDB ID: 
1XLY) a stable She2p dimer (green) was observed with a large buried surface interface of about 
2015 Å2/monomer. Among the several crystallographic contacts (blue) only two dimer contacts have 
significant buried surface interfaces. One interaction involves the basic-helical hairpin-containing side 
on two She2p dimers, resulting in an upside-down orientation and was termed “globular tetramer”. 
The other interaction occurs through the uncharged upper surface in a head-to-head conformation 
and was termed “elongated tetramer”. b) Structural arrangement from a) rotated by roughly 90°. On 
the right side of the green dimer, weak crystallographic interactions with other dimers are visible. 
These contacts fail to bury significant surface areas and are unlikely to be relevant for oligomerization 
in solution c) The elongated tetramer with amino acid leucine 130 is shown with its side chains in red. 
Leucine 130 is located at the dimer-dimer interface. d) Close-up of the tetramer-interaction surface 
shown in c). 
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Subsequently, I analyzed if one of these crystallographic tetramers is consistent with the 
experimental SAXS-scattering curves of wild-type She2p. Using CRYSOL (Svergun et al., 
1995) I calculated the theoretical scattering curves of the She2p dimer and of the two potential 
tetramers and compared them with the experimental curve of wild-type She2p at intermediate 
protein concentration (2.8 mg/ml) (Figure 30). The theoretical scattering curve of the 
elongated She2p tetramer fits reasonably well to the experimental data of wild-type She2p 
(Figure 30 a). In contrast, the theoretical scattering curve of the She2p dimer fit to a lesser 
extent and the curve of the globular tetramer differs substantially from the experimental data 
(Figure 30 b). Thus, formation of a globular tetramer can be excluded. This finding is 
consistent with previous mutational analysis of the lateral crystallographic contacts, for which 
no effect on oligomerization could be observed (Dierk Niessing, personal communication). In 
summary, it is unlikely that She2p exists preferentially as a dimer or as a globular tetramer, but 
it can be concluded that the elongated tetramer is the preferential assembly in solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: CRYSOL analysis suggests an elongated She2p tetramer in solution. a) The theoretical 
scattering curve of the elongated She2p tetramer (see inset) shows a good fit with the experimental 
scattering data of wild-type She2p at a concentration of 2.8 mg/ml. b) In contrast, neither the theoretical 
scattering curve of the globular She2p tetramer (see inset) nor the theoretical curve of a She2p dimer 
matches the experimental curve of She2p. Both tetramer models were generated from the She2p crystal 
structure as shown in Figure 29. 
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2.2.18 Low resolution models of wild-type She2p 
Solution structures of wild-type She2p were determined with the ab initio dummy residue 
approach using the program GASBOR (Svergun et al., 2001). GASBOR compares thousands 
of configurations of a chain of dummy residues to the measured scattering curve. Dummy 
residues represent a string of beads of the size of an average amino acid. The number of 
dummy residues used for data fitting is equivalent to the number of amino acids in a given 
protein. Therefore it is very useful to know the oligomerization state of the measured sample. 
GASBOR is always run in at least ten cycles to generate one bead model per cycle. The 
resulting models are aligned and averaged to a final shape using the programs SUPCOMP and 
DAMAVER (Volkov and Svergun, 2003).  
In order to produce reasonable models, a number of input files with different constraints were 
generated from the wild-type She2p SAXS data. Because a She2p tetramer with a potential 
symmetry axis was expected, different solution structures were calculated assuming either no 
symmetry (P1) or a two-fold symmetry (P2). The bead models were calculated by two 
different GASBOR programs, which fit the dummy residues to either the P(r) function 
(GASBORp) or to the non-transformed scattering intensity I (GASBORi) and might produce 
different models. All GASBOR runs were repeated 10 times with identical parameters and the 
resulting bead models were aligned and averaged.  
Only bead models that were calculated without symmetry constraints (P1) from data measured 
at low and intermediate concentration fit to the experimentally determined maximum 
dimensions of She2p (Table 6). In order to determine, which of the two possible tetrameric 
assemblies of She2p is present in solution, both crystallographic tetramers were overlaid with 
different ab initio solution structures using the program SUPCOMB (Figure 31). The elongated 
She2p tetramer fits quite reasonable to the dimensions of the SAXS solution structures with a 
length of approximately 145 Å and a width of approximately 50 Å (Figure 31). This 
corresponds roughly to the length of two She2p dimers (135 Å) with the constant width of 
one She2p dimer and thus, strongly suggests that the observed elongated tetramer is indeed 
the preferential She2p conformation in solution. However, apparently all solution structures 
show a specific bend in the middle of the particle, which is not consistent with the straight 
conformation of the crystallographic tetramer (Figure 31). In addition, significant parts of the 
crystal structure stick out of the bead models. This finding suggests that either the observed 
crystallographic contacts were enforced by the crystallization process or that the SAXS 
scattering data did not provide sufficient information for fully reasonable ab initio modeling. 
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Taken together, the overall dimension and the shape of various ab initio solution structures 
agree well with the elongated She2p tetramer that was modeled according to crystallographic 
contacts. Thus, a globular She2p tetramer can be excluded. Furthermore, the elongated 
tetramer forms most likely through the uncharged upper surface region of She2p. This 
conclusion is supported by the observed oligomerization defect of the mutant She2p-L130Y 
and the hence resulting impaired RNA binding in vitro and mRNP assembly in vivo.  
Unfortunately, attempts to obtain reasonable solution structures of the She2p-L130Y mutant 
were not successful. However, I observed that She2p-L130Y forms smaller particles of a 
rather globular shape with an extended region on one side of the particle (not shown). Such an 
extension is consistent with the observation from the Kratky plot. 
Figure 31: Ab initio modeling indicates an elongated tetramer of wild-type She2p. Depicted are three 
selected ab initio models of SAXS-solution structures of wild-type She2p. Bead models were calculated using 
either GASBORp or GASBORi from scattering data measured at the indicated protein concentration. For each 
model, 10 independent structures were aligned and averaged. The final bead models were aligned to the 
elongated She2p tetramer, which was derived from the She2p crystal structure. The scale bar represents 135 Å 
and matches roughly the length of the crystallographic She2p tetramer. In total, more than 20 different SAXS-
solution structures were calculated and all of them exhibited a similar dimension and overall shape, yet never 
perfectly matched the crystallographic elongated tetramer. 
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In conclusion, low-resolution ab initio models could be calculated from SAXS experiments. 
The bead models confirm all observations that She2p homo-oligomerizes to complexes larger 
than the reported dimer from the crystal structure. Most likely, tetramers are the physiological 
oligomerization state. However, in different buffer compositions She2p was observed to form 
larger particles than a tetramer. Thus, it cannot be excluded that higher-order oligomers might 
be important for mRNA binding and mRNP assembly in vivo, but She2p tetramers are the 
likely building blocks for such potentially larger complexes. 
 
2.2.19 Attempt to obtain an atomic model of tetrameric She2p 
As described above, the SAXS-solution structures do not perfectly match the elongated She2p 
tetramer, which was modeled according to existing crystallographic contacts (Figure 31). 
Therefore, I attempted to obtain a high-resolution structure by X-ray crystallography of She2p 
in its native oligomerization state. For crystallization experiments the variant She2p-ΔhelixE 
was used. Deletion of helix E was shown not to affect oligomerization of She2p (chapter 
2.2.8) and is believed to favor crystallization (chapter 2.1.2). 
She2p-ΔhelixE was crystallized in 96-well plates with a total precipitant volume of 50 µl by 
combining 0.5 µl protein solution (4 mg/ml) and 0.5 µl precipitant solution. Initial protein 
crystals were obtained in conditions #A9 (0.1 M Bis-Tris pH 5.5, 3 M NaCl), #C11 (1 M 
ammonium sulfate, 0.1 M HEPES pH 7.0, 0.5 % (w/v) PEG 8000) and #C12 (15 % (v/v) 
Tacsimate pH 7.0, 0.1 M HEPES pH 7.0, 2 % (w/v) PEG 3350) from the Hampton Index 
screen. Crystals obtained in #C11 could not be further optimized. Refining the #A9 growth 
conditions yielded as best results thick adherent plates of a maximum size of 40 µm x 40 µm x 
5 µm (Figure 32 a). Variation of #C12 resulted in growth of relatively large elliptic crystals 
with a maximum size of about 100 µm x 25 µm x 20 µm (Figure 32 b). Several crystals derived 
from #A9 and #C12 were tested for diffraction at the ESRF, but no diffraction pattern was 
obtained for any of them. Further optimization of both crystal forms was not successful.  
 
 
 
 
Figure 32: Crystals of She2p-ΔhelixE. 
Crystals of She2p-ΔhelixE were 
obtained in optimized conditions a) 
0.1 M HEPES pH 7, 3 M NaCl and b) 
15 % (v/v) Tacsimate pH 7, 0.1 M 
HEPES pH 7, 1 % (w/v) PEG 3350. 
Both crystal forms showed no X-ray 
diffraction.  
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3  Discussion 
 
mRNAs destined for subcellular localization are transported as part of large messenger 
ribonucleoprotein particles (mRNPs). These mRNPs usually contain a number of proteins 
that mainly function in mRNA binding, translational silencing of the mRNA, and active 
transport of the particle (Martin and Ephrussi, 2009). The most comprehensively understood 
mRNA-transport complex is the ASH1 mRNP from Saccharomyces cerevisiae. It comprises 
ASH1 mRNA and the three protein-core factors She2p, She3p, and Myo4p (Böhl et al., 2000; 
Jansen et al., 1996; Long et al., 2000; Takizawa and Vale, 2000). Recent studies suggested that 
besides ASH1 mRNA more than 23 additional mRNAs are transported in a She2p-dependent 
manner (Oeffinger et al., 2007; Shepard et al., 2003; Takizawa and Vale, 2000). The RNA-
binding protein She2p is assumed to be responsible for specific incorporation of target 
mRNAs into the translocation complex (Böhl et al., 2000; Kruse et al., 2002; Long et al., 
2000), but thus far, the molecular mechanisms underlying She2p-dependent mRNP assembly 
are poorly understood. In this study, the requirements for specific incorporation of target 
mRNA into a functional mRNP were investigated. 
 
3.1  She2p binds RNA through a composite binding site 
RNA-binding studies revealed that She2p binds to the zipcodes of ASH1, EAR1, and WSC2 
with affinities ranging between 100 nM (ASH1 E3) and 770 nM (EAR1) (Figure 10). Earlier it 
was suggested from Electophoretic Mobility Shift Assays that She2p binds apparently with 
varying affinities to the respective ASH1 zipcodes (Böhl et al., 2000; Long et al., 2000), thus 
corroborating the differences in affinity I have measured. The observed affinities are 
comparable with a binding constant of KD=200 nM that was measured for the interaction of 
the neuronal Fragile X-mental Retardation Protein (FRMP) with one of its targets, the non-
coding RNA BC1 (Zalfa et al., 2005), suggesting a similar range of affinity. In contrast, the 
chick Zipcode Binding Protein 1 (ZBP1) binds remarkably stronger to its target mRNA β-actin 
with a KD=10 nM (Farina et al., 2003). However, the above mentioned RNA:protein 
complexes are two of the rare examples for which binding constants are known. Most 
RNA:protein interactions within mRNA-localization complexes are not quantified to date. 
Therefore, it is not clear what affinities are required for efficient mRNA transport. 
Furthermore, affinity does not necessarily correlate with complex stability, which might 
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suggest that for She2p-dependent mRNA transport additional factors are needed to stabilize 
the She2p:mRNA complex and to compensate for a lower affinity (see chapter 3.4).  
Surprisingly, She2p can also bind to a subset of unrelated stem-loop containing RNAs with an 
affinity in the lower micromolar range (Figure 10). In contrast, no binding was measured to an 
unstructured poly(A) RNA, suggesting that She2p preferentially recognizes double-stranded 
RNA (dsRNA) or single-stranded regions in context of a stem-loop structure, which are well 
proven features of RNA-localization elements (Jambhekar and DeRisi, 2007). Apparently, 
She2p is able to discriminate between target and non-target RNAs and raised the question, 
which factors mediate specific interactions between She2p and the number of mRNA cargoes 
in yeast. 
She2p was proposed to specifically recognize a degenerate RNA motif in various zipcodes of 
bud-localizing mRNAs (Jambhekar et al., 2005; Olivier et al., 2005). Sequence-specific RNA 
recognition is a common feature of RNA-binding proteins that have well-defined RNA-
binding motifs like double-stranded RNA-binding domains (dsRBDs), RNA-recognition 
motifs (RRMs), hnRNP K-homology (KH) domains, or the Pumilio/FBF (PUF) domain 
(Auweter et al., 2006; Lunde et al., 2007). RNA-binding proteins implicated in mRNA 
localization, like Drosophila Staufen, chick ZBP1, or human Pumilio, usually contain at least 
one type of the above mentioned RNA-binding motifs (Farina et al., 2003; St Johnston et al., 
1992; Zamore et al., 1997). However, She2p lacks any homology to known RNA-binding 
proteins and its RNA-binding surface, though rich in conserved arginine residues could not be 
attributed to any class of RNA-binding motifs (Niessing et al., 2004). Investigation of She2p’s 
binding to short RNA-consensus sequences, which were taken out of their structural context, 
revealed an only weak affinity compared to full-length zipcode binding (Figure 13). This 
finding demonstrates that RNA-sequence elements alone do not provide specificity for She2p 
binding. It is rather likely that She2p recognizes the degenerate RNA motifs in context of 
secondary structures as corroborated by She2p’s affinity to stem-loop structures in general.  
By mutational analysis, several conserved regions in She2p were identified, to which distinct 
RNA-binding features of She2p could be attributed. Firstly, the positively charged basic helical 
hairpin motif was shown to provide a platform for basal RNA binding, since mutations in the 
basic helical hairpin (N36S and R63K) resulted in a complete loss of RNA binding in vitro 
(Figure 15). This result is consistent with previous studies, in which ASH1-E3 binding in vitro 
and ASH1-mRNA localization in vivo was abolished upon mutation of single amino acids in 
the basic helical hairpin (Gonsalvez et al., 2003; Niessing et al., 2004). In contrast to 
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observations made by Gonsalvez et al. (2003), She2p becomes trapped in the nucleolus when 
it completely fails to bind RNA (Du et al., 2008). Such a nucleolar accumulation was also 
reported for the mammalian Staufen 2 protein, which is implicated in neuronal mRNA 
localization and becomes enriched in nucleoli upon mutation of its RNA-binding domain 
(Macchi et al., 2004). Since the double mutant She2p-N36S-R63K is also unable to bind to 
non-specific RNAs (Figure 15), it can be assumed that She2p’s nucleolar entrapment is caused 
by the loss of RNA binding and not by any unspecific interaction with nucleolar RNA species 
such as rRNAs or snoRNAs. Along with a previous study (Kruse et al., 2002), this finding 
confirms that She2p is exported to the cytoplasm in an mRNA-dependent fashion. Thus, 
mRNA binding by She2p might be a prerequisite for export of She2p and further indicates 
that the assembly of a functional mRNP begins in the nucleus with the selection of the 
mRNA cargo (see chapter 3.4). 
Secondly, the small protruding helix E and the very C-terminus of She2p were identified to be 
required for specific recognition of individual ASH1 zipcodes, but not for binding to 
unrelated stem-loop structures in vitro (Figures 17 and 18). Respective She2p mutants fail to 
assemble into She3p-containing transport complexes and thus, do not localize to the bud tip in 
vivo. This strongly suggests that She2p selects its target mRNA ASH1 through two conserved 
regions, the helix E and the C-terminus, and by this means, discriminates between specific 
bud-localizing mRNA and non-specific RNA. Importantly, the observed failure in mRNP 
assembly indicates that functional transport complexes only assemble when the correct target 
mRNA is bound by She2p, supporting an mRNA-dependent complex assembly. This is 
confirmed by previous studies in which an ASH1 mRNA-dependent association of She2p 
with the cytoplasmic She3p-Myo4p complex was postulated (Böhl et al., 2000; Long et al., 
2000).  
As mentioned above the RNA-binding mutant She2p-N36-R63K accumulates in the 
nucleolus and is not exported to the cytoplasm. However, immunostaining experiments 
showed cytoplasmic localization of She2p variants with impaired ASH1-mRNA binding 
(She2p-ΔhelixE and She2p-ΔC-term) (Figure 20). This raised the question why these mutants 
were not enriched in the nucleus although RNA binding is impaired. Two explanations are 
possible. Firstly, ASH1-mRNA binding by She2p-ΔhelixE and She2p-ΔC-term was only 
reduced and unrelated RNAs could be bound with unaltered affinity. In contrast, RNA 
binding by the basic helical hairpin mutant was completely abolished. Since both helix E and 
the C-terminus specifically recognize ASH1 mRNA, one RNA-binding region might be able 
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to compensate for the loss of the second RNA-binding surface. As a consequence, reduced, 
but specific RNA binding may be sufficient for mRNA-mediated export. The second 
possibility is that the mutants She2p-ΔhelixE and She2p-ΔC-term are never imported into the 
nucleus. Nuclear import of She2p was shown to depend on the importin α Srp1p (Shen et al., 
2009). For this, She2p interacts with Srp1p through a non-classical nuclear localization signal 
that is located on the side of the She2p dimer (Figure 4). Since the deletion of helix E or the 
C-terminus interferes in no way with the NLS, both She2p mutants are likely to be imported 
into the nucleus. However, in order to address this question thoroughly, nuclear She2p 
localization could be assessed by immunostaining experiments against She2p mutants upon 
block of mRNA export in a mex67-5ts strain (Hurt et al., 2000). Enrichment of She2p in the 
nucleus would be a clear indication for proper She2p import.  
Because deletion of helix E influenced only binding to EAR1 mRNA and deletion of the C-
terminus had no effect on either EAR1-mRNA or WSC2-mRNA binding, these two bud-
localizing mRNAs are likely to be recognized by She2p in a different way than ASH1 mRNA, 
(Figures 17 and 18). This finding suggests that besides ASH1-like mRNAs there is at least one 
other class of RNA, which is bound by She2p in a different manner. This hypothesis is 
supported by a recent publication, in which the PUF protein Puf-11 from C. elegans was shown 
to recognize three different classes of RNAs by using multiple binding modes (see also 
chapter 3.5) (Koh et al., 2009). However, it remains unclear how specific She2p binding to 
these mRNAs is achieved. Nevertheless, selective disruption of ASH1-specific recognition 
motifs in She2p (helix E and C-terminus) completely abolishes She2p localization and mRNP 
formation in vivo. Thus, it affects all She2p-dependent mRNAs. 
The identified regions required for RNA binding cover large surface areas on both sides of the 
She2p dimer (Figure 33 a, b). Together, the three individual binding motifs form a composite 
binding site, each consisting of the positively charged basic helical hairpin motif, the small 
protruding α-helix E, and the very C-terminus that was not visible in the She2p-crystal 
structure and is most likely unstructured (Figure 33 a, b) (Niessing et al., 2004). In order to 
find out if this composite binding region is able to accommodate double-stranded RNA, the 
missing C-terminus was modeled by fusing an unstructured loop of nine alanine residues to 
amino acid 237 of the crystallographic model (Figure 33 a-c). Assuming that the C-terminus is 
flexible, the regions required for RNA binding form a gripper-like surface feature with a cleft 
of about 23 Å to 25 Å in diameter. Double-stranded RNA has an average diameter of 
approximately 20 Å. Thus, I conclude that zipcode RNAs fit into the modeled RNA-binding 
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cleft, even taking into consideration the structural variability of zipcodes having unpaired 
nucleotides in context of double-stranded regions. To visualize this conclusion, a random 
double stranded RNA was taken from the Protein Data Bank (PDB) and manually docked 
into the binding cleft. As shown in Figure 33 c, the stem loop of the RNase P ribozyme P4 
domain (27 bases; PDB-ID: 2CD1) indeed fits into the cleft and is able to contact all three 
RNA-binding motifs. In analogy to a gripper, the binding cleft could accommodate RNAs of 
different conformations, which could directly contact the protruding helix E and the basic 
helical hairpin on one side. In addition, cooperative binding by the flexible C-terminus could 
account for different tertiary structures of the respective zipcode RNA. In summary, the 
individual binding motifs in She2p form a distinct RNA-binding cleft on each side of the 
She2p homodimer. This composite binding site is required for specific recognition of ASH1-
like mRNAs.  
 
 
 
 
 
 
 
 
 
 
 
 
In order to explain how She2p exactly binds to several target mRNAs, three-dimensional 
structures at atomic resolution are required. In this study, She2p was crystallized with three 
different stem-loop RNAs that were derived from the ASH1-E2B zipcode. Unfortunately, the 
crystals of the different She2p:RNA co-complexes diffracted X-rays to maximum resolution 
Figure 33: Composite RNA-binding site in She2p. a)-c) Depicted is a model of the composite gripper-like 
RNA-binding region in a She2p dimer. Regions required for RNA binding are marked in red (helix E and the 
basic helical hairpin (BHH)). The C-terminus (C-term), for which no structural information is available, was 
modeled with an unstructured nine-alanine loop and is labeled in beige. a) shows She2p in front view, b) in top 
view, and c) in front view with a slight rotation to the left. The composite binding motif forms a cleft with a 
diameter of 23-25 Å and is large enough to accommodate double-stranded RNA. c) The RNase P ribozyme P4 
domain was manually aligned onto the basic helical hairpin motif between helix E and the modeled, 
unstructured She2p C-terminus. 
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of only 9 Å, which was not sufficient to obtain any structural information. Crystallization of 
respective She2p:RNA co-complexes turned out to be very challenging, since the complex 
RNA-binding mechanism by She2p significantly restricted the number of potential She2p 
constructs for crystallization (chapter 2.1.2). In addition, also the number of RNA targets was 
limited due to the length of the different zipcodes (up to 120 nucleotides), which made a 
chemical synthesis impossible. This technical problem could in future be circumvented for 
potential crystallization studies by using the tRNA-scaffold approach (Ponchon and Dardel, 
2007). This technique enables the production of longer RNAs in high amount by in vivo 
transcription in E. coli cells. During this study, I established this method and indeed, obtained 
in a tentative experiment several milligrams of different zipcodes, which can be purified using 
standard size-exclusion chromatography (data not shown). Thus, the tRNA-scaffold approach 
represents a powerful method for the generation of RNA in large scale and may help to 
overcome technical limitations in chemical synthesis of RNAs. So far, this technique was not 
applied for crystallization studies with She2p and ASH1 RNAs, but may provide the basis for 
further experiments. However, a crucial point for successful crystallization of an She2p:RNA 
complex is the complex stability. In RNA-binding experiments, I observed that complexes 
formed between She2p and different ASH1 zipcodes are rather transient, even though the 
RNA is bound with high affinity. The low complex stability is very likely to account for the 
difficulties in crystallizing She2p with RNA. One possibility could be to test longer RNAs 
produced by the tRNA-scaffold method that might bind to a larger surface area in She2p than 
shorter hairpin RNAs do. The best possibility, however, for obtaining a stable complex is to 
crystallize a trimeric complex consisting of RNA, She2p, and the adapter protein She3p. For 
this purpose, She3p has to be expressed in insect cells or yeast cells, because, at least in my 
hands, the She2p-interacting region of She3p cannot be produced by recombinant expression 
in E. coli cells (data not shown). Taken together, considerable effort will have to be made to 
obtain insights into the interaction of She2p with one of its mRNA cargoes at the atomic 
level. 
The observation that She2p binds RNA through a large surface area is supported by the fact 
that many RNA-binding proteins have a modular structure (Lunde et al., 2007). They are 
composed of multiple RNA-binding domains (see above), which are presented in various 
structural arrangements to expand the functional landscape of the protein (Burd and Dreyfuss, 
1994). These domains act in a cooperative fashion in order to accommodate the structural 
diversity of the RNA substrates. As a consequence, such a concerted effort results in RNA 
recognition with a specificity and affinity that would not be achieved by a single RNA-binding 
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domain. Specific RNA recognition is often mediated by two binding motifs in tandem, which 
are connected by a linker and undergo extensive interdomain arrangements upon RNA 
binding, thus providing an extended RNA-binding surface. For instance, this mechanism has 
been observed for the two RRMs of the yeast Hrp1 protein as well as for the two KH 
domains in the transcription factor NusA (Beuth et al., 2005; Perez-Canadillas, 2006; Worbs et 
al., 2001). Such an RNA-dependent conformational change could in principle also apply to the 
flexible C-terminus of She2p in order to deal with different structural conformations of 
various zipcodes. Another prominent example of a modular domain protein is Staufen. 
Staufen comprises five dsRBDs, three of which (dsRBDs 1, 3, and 4) bind to double-stranded 
RNA (Micklem et al., 2000; St Johnston et al., 1992). Interestingly, the interaction of isolated 
dsRBDs with dsRNA is very weak (µM or weaker) (Ramos et al., 1999; Ramos et al., 2000), 
suggesting that the target mRNAs are bound by the three dsRBDs in a concerted manner or 
that additional stabilizing factors join the mRNA:protein complex. However, it remains to be 
proven if the three domains act cooperatively in vivo, since the individual dsRBDs bind to 
RNA in vitro and, thus far, only the RNA-binding activity of dsRBD 3 was shown to be 
essential for the interaction of Staufen with oskar and bicoid mRNA in vivo (Ramos et al., 2000). 
Besides Staufen, also Drosophila Bruno binds to oskar mRNA, yet to distinct Bruno Response 
Elements (BREs) and thereby represses translation of non-localized oskar (Chekulaeva et al., 
2006; Kim-Ha et al., 1995; Nakamura et al., 2004; Webster et al., 1997; Wilhelm et al., 2003). 
Bruno contains three RRMs, which form two distinct RNA-binding modules (Snee et al., 
2008; Webster et al., 1997). Similar to helix E and the C-terminus in She2p, each binding 
domain of Bruno can bind to BRE-containing RNA, but both are required for maximal 
binding in vitro and full translational repression activity in vivo (Snee et al., 2008). One of the 
most sophisticated mechanisms of cooperative binding, however, is represented by the 
Pumilio domains, which are arranged in tandem repeats (Zamore et al., 1997). Each domain 
can recognize a single nucleotide on its own, but by combining multiple repeats, up to eight 
nucleotides can be specifically bound with high affinity (Wang et al., 2002). Thus, the Pumilio-
repeat proteins likely provide the most extreme example of an extended composite RNA-
binding site. 
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3.2  She2p tetramers are the functional units 
The crystal structure of She2p as well as previous analytical ultracentrifugation experiments 
revealed that She2p forms homo-dimers (Niessing et al., 2004). However, these studies were 
performed with a variant of She2p (She2p-(6-239)-ΔCys; see chapter 2.1.2) that was created to 
facilitate crystallization. In my hands, this variant has lost its affinity to short degenerate RNA 
motifs (chapter 2.1.6) most likely due to the C-terminal truncation. Since ASH1 binding 
strongly relies on a functional C-terminus (chapter 2.2.9), I conclude that also ASH1-zipcode 
binding is disrupted in this mutant. In addition I observed that truncation of the C-terminus 
apparently impairs the oligomeric state of She2p (Figure 18 b). In summary, it has to be 
assumed that the crystallized She2p might not represent the functionally active form in vivo.  
In order to investigate the oligomeric state of She2p, several experiments were performed in 
this study. Analytical ultracentrifugation (AUC) studies revealed that She2p forms large 
particles of approximately 290 kDa, corresponding to a decameric complex (Figure 24). For 
symmetry constraints, however, also octameric or dodecameric complexes would be possible. 
Identification of the variant She2p-L130Y led to the conclusion that She2p assembles into 
higher-order oligomers through the upper uncharged surface region, because this mutant 
protein failed to form wild-type like complexes (Figure 24). However, the AUC experiments 
were performed at protein concentrations that are far above the physiological concentration of 
She2p in vivo (230 nM; Niessing et al., 2004). Furthermore, She2p turned out to assemble into 
large particles dependent on the protein concentration and the buffer composition as judged 
by Dynamic Light Scattering (Tables 3 and 4). Therefore, I determined the oligomeric state of 
She2p at protein concentrations below and above the calculated physiological concentration 
of 230 nM using analytical size-exclusion chromatography. I found that She2p is a stable 
tetramer above and, importantly, even below the physiological protein level (Figure 25). 
Analysis of the She2p-L130Y mutant revealed a clear dimer with the tendency to form larger 
particles at higher protein concentrations, thus confirming that She2p oligomerizes through its 
upper surface. From these results I conclude the following: Firstly, the crystallographic dimer 
most likely does not represent the physiological oligomerization state of She2p. The dimers 
are rather subunits of the identified She2p tetramer. Secondly, the large complexes observed in 
AUC experiments probably result from a high protein concentration. Thirdly, She2p tetramers 
are presumably the functional units in vivo, since mutation of the upper surface abolishes 
She2p localization and mRNP assembly (Figures 20 and 22, respectively). The observed 
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reduction in RNA binding in vitro (Figure 16) can be explained to result directly from 
disruption of the oligomeric state. 
SAXS analysis confirmed that She2p forms tetrameric complexes of an elongated shape, most 
likely through the upper surface area. Analysis of crystallographic dimer contacts revealed two 
possible tetrameric assemblies, resulting in either a globular tetramer or an elongated tetramer 
(Figure 29). The calculated scattering curve of the elongated tetramer matches well with the 
experimental scattering curve of She2p, indicating an elongated shape (Figure 30). This is 
further supported by the P(r) function of She2p, which suggests a stretched shape (Figure 28). 
In contrast, the She2p-L130Y mutant formed smaller molecules of a rather globular shape, 
indicating that the elongated tetramer was disrupted (Figure 28). Such a disruption can be 
explained by the mutation of the small hydrophobic leucine 130 into the large tyrosine that 
results in a steric clash in the dimer interface and prevents the association of the 
complementary dimer. The constantly observed concentration-dependent oligomerization of 
She2p-L130Y is easily explained by the fact that only one residue in the dimer interface was 
mutated. Such a single mutation is apparently not sufficient to completely disrupt oligomer 
formation, which is apparently forced at higher protein concentrations. In order to achieve a 
complete dissociation of the tetramer into dimeric subunits, mutations of additional residues 
within the dimer interface would be required. A promising candidate to analyze is threonine 
47. Next to leucine 130, threonine 47 is located at the upper surface region (Figure 34) and its 
mutation into tyrosine is supposed to disrupt She2p oligomerization as it was observed in size-
exclusion chromatography (Dierk Niessing, personal communication).  
 
 
 
 
 
 
 
 
Figure 34: Contacts in the upper 
surface region of She2p. Depicted is 
the elongated tetramer, which was 
derived from the She2p-crystal structure 
(compare with Figure 29). Amino acids 
in the dimer interface that interfere with 
She2p-tetramer formation upon 
mutation are shown. Leucine 130 is 
shown with its side chains in red, 
threonine 47 is shown in blue.  
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Thus, She2p is likely to form an elongated tetramer through an asymmetric head-to-head 
interaction, for which an atomic model can be derived (Figures 35, see also Figure 29). In this 
model, the different RNA-binding motifs form a continuous binding surface on both sides of 
the molecule. Thus, an extended surface area is provided in order to deal with the number of 
structural variations of different bud-localizing mRNAs. Since the exact conformation and 
orientation of the She2p C-terminus is unknown, it was omitted from the tetrameric model. 
However, the flexible C-terminal region of She2p might change its conformation in response 
to the respective mRNA cargo that binds to She2p. This assumption would also be consistent 
with the observation that the bud-localizing mRNAs EAR1 and WSC2 are not recognized by 
the C-terminus of She2p and are apparently bound in a different manner than ASH1 mRNA.  
 
 
 
 
 
 
 
 
 
 
 
In principle, also a tail-to-tail or head-to-tail orientation of two She2p dimers would result in 
an elongated shape of the tetramer. Since mutation of the upper surface region disrupts the 
oligomeric state of the tetramer, the tail-to-tail orientation can be excluded. A head-to-tail 
association would still involve the upper surface of one dimer, but also the less conserved 
loop-containing bottom region of She2p. In this model, mutation of leucine 130 to tyrosine 
could lead to disruption of the tetramer, which in turn would be also assumed upon deletion 
of the bottom loops. However, when I purified a respective She2p mutant, which was 
Figure 35: She2p tetramers provide 
an extended RNA-binding region. 
Depicted is a surface representation of 
the elongated tetramer from the front 
(a) and from the side (b, rotated by 
about 90°). The RNA-binding motifs 
basic-helical hairpin and helix E are 
highlighted in red. For a better 
overview, the modeled C-terminus of 
She2p from Figure 33 is not shown. 
Instead, its position is indicated on two 
monomers each per tetramer by arrow 
heads. 
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intended for crystallization (She2p-Δloop, chapter 2.1.2), I did not observe any 
oligomerization defect, rendering this type of association unlikely. Likewise important, in a 
head-to-tail orientation no extended RNA-binding surface would be provided. For these 
reasons, I can exclude both a tail-to-tail and a head-to-tail association and refer to the head-to-
head-orientation as the most likely model.  
As shown in Figure 35, the extended RNA-binding surface of the She2p tetramer forms only 
when the two dimeric subunits are skewed to each other as a direct result from the 
crystallographic contacts. One can only speculate if the orientation of the crystallographic 
tetramer is entirely correct or if the observed contacts were enforced during the crystallization 
process. This example shows that it is meaningful to prove, if the obtained crystal structure 
indeed represents the native conformation. For this purpose, SAXS can be used to calculate ab 
initio models of the protein and compare them with the crystal structure. For She2p, a number 
of different ab initio models were calculated that all roughly matched the shape of the 
crystallographic elongated tetramer (Figure 31).  
The overall dimension of the SAXS-solution structures was consistent with the one of the 
elongated tetramer. However, all ab initio models exhibited a significant bend in their central 
region and thus, differed from the straight conformation of the elongated tetramer. One 
possible explanation is that crystal packing and the lack of the C-terminus in the crystal 
structure modified the exact conformation of the crystallographic tetramer, implying that the 
model determined in solution is correct. The second possibility is that the SAXS data did not 
provide sufficient information for exact calculation of the shape of the molecule. This might 
be likely since the scattering curves that were measured at different protein concentrations 
were not completely identical. Regardless which of both possibilities is true, the overall 
conclusion that She2p forms an elongated tetramer is beyond all question. Interestingly, 
calculations with symmetry constraints (P2) did not produce any trustworthy models. This 
might be explained by the screwed conformation of the dimers to each other, which does not 
reflect a two-fold symmetry. The third possibility is that both the in solution model and the 
crystallographic tetramer is correct. In this case one could speculate that She2p forms a bent 
shape without an mRNA ligand, which is reflected by the SAXS model. Upon mRNA 
binding, She2p might change its conformation into an elongated shape with an extended 
RNA-binding surface, which was accidentally trapped in the crystal structure.  
It is very important to carefully interpret the structural models obtained from SAXS 
measurements. SAXS scattering data represent the averaged data from all possible orientations 
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of the molecule in solution. In order to calculate a three-dimensional model ab initio from the 
two-dimensional scattering curve it is very useful to compare the resulting model with 
structural data that were obtained with a different technique, for instance X-ray 
crystallography. In case of the She2p tetramer, SAXS was helpful to dissect the potential 
tetrameric assemblies and by this means, to identify an elongated shape in solution. However, 
the ab initio models of the She2p tetramer did not perfectly match the elongated 
crystallographic tetramer. A significant disadvantage of SAXS is that no real parameter for 
quality control exists, which allows one to estimate the reliability of a calculated structure. In 
crystallography, the R-factor gives information about the significance of a structural solution. 
From SAXS data, however, a three-dimensional model can always be calculated. To 
summarize, SAXS is extremely powerful to obtain information of the solution structure of the 
protein when additional structural information of the protein are available. SAXS-solution 
structures calculated using the ab initio approach then have to be analyzed carefully for their 
reliability to make sure that no artifacts were generated. 
 
3.3  She2p-tetramer formation allows simultaneous binding of   
  different RNAs 
She2p variants with a defect in oligomerization (She2p-L130Y and She2p-ΔC-term, 
respectively) also showed impaired RNA binding. This result suggests that specific RNAs 
interact with both dimer subunits simultaneously along the extended binding surface of the 
She2p tetramer. In total, a She2p tetramer has four gripper-like RNA-binding motifs (two on 
each dimer), which in turn form two large surface areas for RNA binding (Figure 35). 
Previous studies suggested for the interaction of a She2p dimer with ASH1-mRNA zipcodes a 
molar ratio of either 1:1 or 1:2, depending on the analyzed zipcode (Niessing et al., 2004; 
Olivier et al., 2005). When these molar ratios are translated into a She2p tetramer, one 
tetramer would bind to either two or four zipcode RNAs. Two zipcodes can be easily 
positioned on one tetramer when each zipcode is bound along the extended binding surface at 
each side of the tetramer. Binding of four zipcodes to one tetramer can be explained by the 
four gripper-like motifs binding to one zipcode each. The distance between the two 
protruding helices that confine the binding surfaces on each side of the tetramer is about 
55 Å. Assuming an average diameter of a zipcode RNA of less than 25 Å, two zipcodes can be 
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accommodated next to each other without steric clashes on each side of the tetramer, resulting 
in four bound molecules.  
These considerations suggest that zipcodes from different bud-localizing mRNAs can be 
bound by She2p simultaneously. This assumption is consistent with the observation that 
several different bud-localizing mRNAs are transported together in the same particle (Lange et 
al., 2008). For instance, ASH1 has been shown to move to the bud tip together with IST2 and 
WSC2, respectively. Due to technical limitation only pairs of mRNAs could be visualized in a 
single particle, but it is very likely that more than two mRNAs are transported simultaneously. 
This idea is supported by the fact that overexpression of ASH1 mRNA results in the 
formation of fewer but larger ASH1 mRNPs in vivo (Bertrand et al., 1998; Lange et al., 2008). 
Therefore, the formation of higher-order mRNPs by cross-linking individual She2p tetramers 
can be suggested. Such an interconnection of several She2p molecules could be achieved by 
association of She2p with mRNAs that contain multiple zipcode elements, like ASH1 or 
WSC2. Thus, it is unlikely that She2p-dependent mRNPs have a defined size, but are rather 
heterogeneous in their RNA composition and dimension. 
It is well proven that mRNPs implicated in mRNA localization contain an increasing number 
of mRNAs. For instance, the neuronal mRNP component FMRP associates with hundreds of 
mRNAs, whereas Staufen I, Staufen II and YB-1 are reported to co-purify with even 
thousands of RNAs (Darnell et al., 2005; Evdokimova et al., 2006; Furic et al., 2008). These 
findings do not necessarily imply that this vast amount of mRNAs is found in the same 
mRNP at the same time. It is rather likely that these mRNAs have been co-purified from a 
heterogeneous population of mRNPs, suggesting that the effective number of transcripts per 
particle is much smaller. However, at least a significant number of mRNAs will be transported 
in the same mRNP, which in turn leads to the assumption that the respective RNA-binding 
proteins are interconnected through their interaction with various mRNA cargoes.  
The assembly of oligomeric mRNPs was also demonstrated for oskar-containing mRNPs in 
Drosophila. The splicing process of oskar mRNA is essential for the localization of oskar at the 
posterior pole of the oocyte (Hachet and Ephrussi, 2004). However, also intron-less reporter 
mRNAs bearing the oskar 3’ UTR localized to the posterior by “hitch-hiking” with 
endogenous oskar mRNA, providing experimental evidence that two different RNAs are 
transported in the same particle (Hachet and Ephrussi, 2004). This 3’ UTR-dependent mRNA 
oligomerization is mediated by the polypyrimidine tract binding protein (PTB) and is required 
for effective translational repression of oskar mRNA (Besse et al., 2009). Consistently, it was 
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shown that oligomerization of oskar mRNA depends on Drosophila Bruno and likewise results 
in the formation of large translationally silenced particles (Chekulaeva et al., 2006). Similarly, 
the formation of large She2p-dependent mRNPs might help to maintain a translational 
repressed state of all transported mRNAs, thereby supporting the previously described 
mechanisms for translational silencing of ASH1 mRNA (Deng et al., 2008; Du et al., 2008; 
Paquin et al., 2007; Shen et al., 2009).  
 
3.4  How are She2p-dependent priming complexes stabilized? -  
  Implications for She2p-dependent mRNP assembly in    
  S. cerevisiae 
As described in chapter 3.1, She2p can bind to non-specific stem-loop containing RNAs. 
Surprisingly, the difference in affinity between specific bud-localizing mRNAs and non-
specific unrelated RNAs was only moderate. The protruding helix E and the very C-terminus 
of She2p were shown to participate in ASH1-mRNA binding, and thus, provide RNA-binding 
specificity. Furthermore, bud-localizing mRNAs are bound by an extended surface region on 
She2p tetramers provided by the distinct RNA-binding motifs. Selective, but moderate 
reduction of ASH1-mRNA binding completely abolishes formation of a cytoplasmic transport 
complex and prevents mRNA localization in vivo. Thus, I conclude that She2p mediates the 
specificity for the interaction with ASH1 mRNA.  
However, it is absolutely clear that the complex of She2p and bud-localizing mRNAs must be 
stabilized during mRNP assembly in vivo. This assumption is supported by the observation that 
complexes consisting of only She2p and RNA are rather transient in vitro (this study). It is 
likely that the She2p:mRNA association is stabilized already in the nucleus. She2p is proposed 
to bind ASH1 mRNA co-transcriptionally (Du et al., 2008), which might result in the 
formation of an unstable priming complex (Figure 36). Potential candidates for joining such a 
priming complex are the proteins Loc1p, Puf6p, and Khd1p. All of them are found in the 
nucleus, are reported to bind to ASH1 mRNA, and are required for translational silencing of 
ASH1 (Deng et al., 2008; Du et al., 2008; Gu et al., 2004; Irie et al., 2002; Long et al., 2001; 
Paquin et al., 2007; Shen et al., 2009). However, none of these proteins is known to bind to all 
four ASH1-localization elements. Thus, it remains unclear how the She2p:mRNA interaction 
might be stabilized in the nucleus. Preliminary studies indicate that the strictly nucleolar 
protein Loc1p interacts with all ASH1 zipcodes (this study, data not shown). Loc1p in turn, 
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was recently identified to interact with She2p in vivo (Shen et al., 2009) and in vitro (this study, 
data not shown). Thus, one can assume that Loc1p might stabilize the interaction of She2p 
with its target mRNA, potentially by remodeling the mRNP complex. Puf6p binds to the 
ASH1-E3 zipcode as well as to She2p (Gu et al., 2004; Shen et al., 2009), whereas Khd1p 
binds to sequences adjacent to the ASH1-E1 zipcode (Irie et al., 2002). Their potential nuclear 
role in stabilization of She2p:mRNA complexes, however, remains unknown. Both proteins 
are also supposed to accompany the cytoplasmic translocation complex, thereby preventing 
premature ASH1 translation (Gu et al., 2004; Paquin et al., 2007). By this means, Khd1p and 
Puf6p could positively affect the complex stability of She2p and the E1 and E3 zipcode, 
respectively (Figure 36).  
In the cytoplasm, the adapter protein She3p is proposed to strengthen the She2p:mRNA 
complex through interaction of its C-terminal domain with She2p (Figure 36) (Böhl et al., 
2000; Long et al., 2000). However, a stabilizing effect of She3p on mRNA binding by She2p 
remains to be demonstrated in vitro. Unfortunately, any attempt to purify stable She3p 
fragments for corresponding in vitro studies failed due to rapid protein degradation (data not 
shown). Likewise, short She3p peptides, which were apparently identified to interact with 
She2p by screening a She3p-peptide library, could not be bound to She2p (data not shown). 
Thus far, the She3p-interacting region of She2p is unknown. It was suggested previously that 
She3p interacts with a heterologous region consisting of the hydrophobic upper surface of 
She2p and mRNA (Gonsalvez et al., 2003; Niessing et al., 2004). This idea is based on the 
identification of a yeast strain encoding a She2p variant with an exchange of amino acid 
leucine 130 into serine (Gonsalvez et al., 2003). The She2p mutant failed to interact with 
She3p in vivo. Consistently with this, the She2p-L130Y mutant showed reduced ASH1-E3 
binding (Niessing et al., 2004 and this study). However, with the identification of She2p-
tetramer formation through the upper surface region, I conclude that the previously observed 
functional defects directly resulted from a disrupted oligomerization state of She2p. Thus, the 
upper surface of She2p is extremely unlikely to interact directly with She3p.  
Besides the upper surface, there is only one additional small hydrophobic patch remaining that 
could be involved in She3p binding. Interestingly, this region is located on the lower half of 
She2p and involves parts of the recently identified non-classical nuclear localization signal 
(Figure 4) (Shen et al., 2009). In principle, She2p could interact through a similar surface 
region both with the importin α Srp1p and She3p, since both associations would be restricted 
to different time points during mRNP assembly. In this scenario, cargo-free She2p is imported 
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into the nucleus via its interaction with Srp1p. In the nucleus, She2p selectively recognizes 
bud-localizing mRNAs, traverses the nucleolus, and is exported to the cytoplasm in an mRNA 
cargo-dependent manner. In the cytoplasm, the She2p:mRNA complex is stabilized by 
interaction with She3p through a hydrophobic patch at the lower half of She2p. However, it is 
also possible that She3p interacts with a different region in She2p. Likewise, She3p might 
recognize a heterologous surface of She2p and mRNA, which may be located not on the top 
of She2p, but rather on the side.  
 
 
 
 
 
 
 
 
 
 
 
 
The idea that an RNA-priming complex might form upon mRNA recognition might also 
apply to Drosophila Staufen. In a fundamental study, Staufen was reported to bind to RNA 
with extensive secondary structures, such as U1 and U2 RNAs, adenoviral VA1 RNA, and the 
3’ UTR of bicoid mRNA (St Johnston et al., 1992). RNAs without any predicted secondary 
structures were not bound. Interestingly, comparable attributes also apply to She2p (chapter 
3.1). In vivo injection experiments in Drosophila embryos using a variety of RNAs showed that 
Staufen-containing mRNPs only form and localize efficiently upon injection of the bicoid 
3’ UTR, the target mRNA of Staufen (Ferrandon et al., 1994). Injection of highly concentrated 
heterologous stem-loop RNAs resulted in the formation of a few, yet immobile particles. 
Figure 36: Sequential ASH1-mRNP assembly in S. cerevisiae. Step 1: She2p binds ASH1 mRNA co-
transcriptionally to form a priming complex. Step 2: The priming complex is passed through the nucleolus 
and is read-out by the trans-acting factors Loc1p, Khd1p, and Puf6p, which results in assembly of a 
translationally silent mRNP. Before the pre-mRNP is exported into the cytoplasm, Loc1p dissociates from 
the complex and remains in the nucleolus. Step 3: In the cytoplasm, the ASH1 pre-mRNP associates with 
She3p, which stabilizes the complex. She3p itself is bound to Myo4p, which then transports the stable, 
translationally repressed mature mRNP to the bud tip.  
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Based on this finding the authors concluded that the interaction of Staufen with bicoid is 
specific and that the interaction of Staufen with non-specific RNAs occurs in a fundamentally 
distinct way. Thus, it might be possible that also Staufen forms an initial and specific priming 
complex, which is interpreted and stabilized by accessory factors during mRNP assembly.  
 
3.5  She2p binds RNA in multiple modes 
Members of the Pumilio/FBF (PUF) family of RNA-binding proteins are known to recognize 
distinct variations of the PUF consensus sequence in the 3’ UTR of their target mRNAs 
(Wickens et al., 2002). DNA-microarray analyses of five PUF proteins from S. cerevisiae 
indicate that each of them binds to a distinct and highly specific subset of 40 to 220 mRNAs 
(Gerber et al., 2004). Thus, it can be assumed that the respective PUF proteins bind to its 
different target mRNAs with high specificity. Analysis of the binding specificity of yeast Puf4p 
revealed that it has an only two-fold higher affinity for its native RNA target than for a Puf3p-
specific target site (Miller et al., 2008). Similarly, recombinant Puf4p bound with 25-fold 
higher affinity to its own target than to a Puf5p (Mpt5p) target (Hook et al., 2007). Puf5p, in 
turn, displayed an only 3.5-fold preference for its own site. These findings indicate that the 
observed high specificity of PUF proteins for target mRNAs in vivo does not directly result 
from a high-affinity interaction. It is rather suggested that PUF proteins achieve specificity for 
their target mRNAs by applying a distinct binding mode, which might be further strengthened 
by association of accessory factors in vivo. This idea is supported by the recent finding that a 
single PUF protein from C. elegans (PUF-11) recognizes three different classes of RNAs by 
employing distinct RNA-binding modes with different RNAs (see also chapter 3.1) (Koh et 
al., 2009). The individual binding modes of PUF-11 rely on the flexibility in the central region 
of the protein and base flipping of the RNA and are adjusted according to the nucleotide 
composition in the respective RNA target.  
The above mentioned examples of the PUF-protein family demonstrate a mechanism how a 
single RNA-binding protein achieves specificity to a number of different RNA targets. 
Although PUF proteins recognize specific nucleotides in the target RNA, they are still able to 
bind to large set of RNAs and to discriminate between different classes of RNAs. A 
comparable mechanism of RNA binding might also apply to She2p for the specifical binding 
of a number of bud-localizing target mRNAs in vivo. In analogy to PUF-11 (Koh et al., 2009), 
it is rather unlikely that She2p achieves high affinity to a number of targets by accomplishing 
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several well-defined atomic contacts to every single zipcode. Instead, less coordination on the 
atomic level would be required for selective target recognition on the basis of an extended 
RNA-binding surface with moderate affinity. In addition, secondary structural features in the 
respective target mRNA might support specific interaction with She2p. Also potential 
influence of a degenerate RNA motif, as proposed by Jambhekar et al., 2005 and Olivier et al., 
2005, cannot be excluded, even though to a lesser extent. Such an RNA-recognition mode 
would not require high sequence conservation on the zipcode level, which is supported by the 
observation that there is only little similarity on the sequence level among yeast zipcodes 
(Jambhekar et al., 2005; Olivier et al., 2005). Instead, a potentially conserved tertiary structure 
of bud-localizing mRNAs might be required for correct mRNA localization. The priming 
complex of RNA-bound She2p may then be stabilized by accessory factors, like cytoplasmic 
She3p, if the overall topology indicates specific mRNA binding. In this case, assembly with 
She3p triggers the formation of a functional mRNP.  
In a recent genome-wide study the RNA targets of selected 40 RNA-binding proteins (out of 
more than 500) in yeast were systematically analyzed (Hogan et al., 2008). They found that at 
least 33 of these 40 proteins, including She2p, associate with specific sets of a few to several 
hundred mRNAs each. Thus, specific mRNA recognition through multiple binding modes 
might be a more general mechanism that could account for the assembly of other mRNPs as 
well.  
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4  Materials and Methods 
 
4.1  Consumables and chemicals 
Unless specified otherwise, all common chemicals were obtained in the highest available 
quality from Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany), or Sigma 
(Deisenhofen, Germany). Enzymes and nucleotides for molecular biology and molecular 
weight markers for electrophoretic analyses were purchased from Fermentas (St. Leon-Rot, 
Germany), New England Biolabs (Frankfurt, Germany), Invitrogen (Karlsruhe, Germany), or 
Sigma (Deisenhofen, Germany). Reagents to prepare media for bacterial and yeast cultivation 
were obtained from Becton Dickinson (Heidelberg, Germany) and Sigma (Deisenhofen, 
Germany). Chromatography equipment, columns and media were purchased from GE 
Healthcare (Munich, Germany). Transfer membranes for western blotting and filter-binding 
experiments were obtained from Roth (Karlsruhe, Germany). Radioactive nucleotides (γ-32P-
ATP and 5’-32P-pCp) were obtained from GE Healthcare (Munich, Germany) and Hartmann 
Analytik (Braunschweig, Germany). Crystallization screens, crystallization grade reagents, and 
crystallization tools were purchased from Hampton Research (Aliso Viejo, USA), Qiagen 
(Hilden, Germany), and Jena Bioscience (Jena, Germany). DNA oligonucleotides were 
ordered from Thermo Fisher (Ulm, Germany). RNA oligonucleotides for crystallization and 
biochemical assays were synthesized by Thermo Fisher Scientific/Dharmacon (USA). 
 
4.2  Oligonucleotides 
4.2.1 DNA oligonucleotides 
# oligonucleotide sequence (5‘-3‘)
S2-1 She2p_Crev_XhoI TTACTCGAGTCAGTTTTTCAATTTACCAAATTTG 
S2-2 She2p_243rev_Stop_XhoI TAACTCGAGTTATTTACCAAATTTGTCATGCC 
S2-3 She2_Nfor_BamHI AAAGGATCCATGAGCAAAGACAAAGATATC 
S2-4 She2_aa173_rev TCTCCGATATTCGTTCCGTCAACTTCTAAATCTAGCAGGTTGCTGC 
S2-5 She2_aa184_for TGCTAGATTTAGAAGTTGACGGAACGAATATCGGAGAAACTG 
S2-10 She2_DloopBC_80_rev TACCTTGTCAAACGAATCTTCATTGATAAACTCTGATGCATT 
S2-11 She2_DloopBC_90_for TCAGAGTTTATCAATGAAGATTCGTTTGACAAGGTAATTTTACC 
S2-12 She2_S120Y_for CTGAACTATTATCTAACGCAGTacTTACAAAAGGAAATTTTATCTA
AAACTTTGAACG 
S2-13 She2_S120Y_rev CGTTCAAAGTTTTAGATAAAATTTCCTTTTGTAAgtACTGCGTTAG
ATAATAGTTCAG 
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# oligonucleotide sequence (5‘-3‘)
S2-17 She2_nt218_for_NsiI AAAAAATGCATCAGAGTTTATCAATGAAGG 
S2-18 She2_Crev_StuI AAAAAAGGCCTCAGTTTTTCAATTTACC 
S2-19 She2_Crev_XbaI  AAATCTAGAGTTTTTCAATTTACCAAATTTGTCATGC 
S2-20 She2_240rev_XbaI AAATCTAGATTTGTCATGCCATTTAGTAGCGAC 
S2-21 She2_240rev_StuI AAAAAAGGCCTCATTTGTCATGCCATTTAGTAGCGAC  
S2-22 She2_240rev_XhoI TAACTCGAGTTTGTCATGCCATTTAGTAGCGAC 
S2-23 She2_L130Y_for GGAAATTTTATCTAAAACTTACAACGAGGACCTAACGC 
S2-24 She2_L130Y_rev GCGTTAGGTCCTCGTTGTAAGTTTTAGATAAAATTTCC 
S2-26 XbaI_She2DHelix_3myc_r GTCTCTAGACAATTTACCAAATTTGTCATGCC 
S2-27 She2_6for_BamHI AAAGGATCCATGGATATCAAAGTCACTCCTGG 
 
4.2.2 RNA oligonucleotides 
RNA Base no. 
relative to 
start codon 
Sequence (5’-3’) Produced by 
ASH1 E1  623-701 AAGACUAUGUUAAAAUACGCGAAGAAGUGGCU
CAUUUCAAGCCAUUAAGUAUACCCAACUUAAC
UAAUAAUCAAAAUAA 
in vitro transcription (this 
study) 
ASH1 E2A  1109-1185 UUGCGAAUAGAGACAUUCUAUCGAACAAUUCC
AAAUCUAAUGUAAGGAAACCAUCUAAGAACAA
AAUCUCAAAGCAA 
in vitro transcription (this 
study) 
ASH1 E2B 
domain 1  
1263-1320 AUCUUCAUCUCCAUCUCCCUCCACACCGACGA
AAAGUGGCAAGAUGAGAUCAAGAUCA 
in vitro transcription (this 
study) 
ASH1 E3  1750-1867 GAGACAGUAGAGAAUUGAUACAUGGAUAACUG
AAUCUCUUUCAACUAAUAAGAGACAUUAUCAC
GAAACAAUUGUACAUUUCUCUCCUUGUCUGUG
CUAAAUAAACUACAAAUAAAAA 
in vitro transcription (this 
study) 
EAR1  1572-1621 CGAAGAUGAAAAUGAUCACGAGAGAGAUCCCG
AACAAUUUUCAGAAUUUG 
chemical synthesis 
(Dharmacon);  
5‘ biotinylated 
WSC2N 430-465 AGUUCAAAAACGUCCACGAAAUUGGACACGAA
AACU 
chemical synthesis 
(Dharmacon);  
5‘ biotinylated 
ASH1 E1min 635-683 AAAUACGCGAAGAAGUGGCUCAUUUCAAGCCA
UUAAGUAUACCCAACUU 
chemical synthesis 
(Dharmacon) 
ASH1 E2Bmin 
(36 bases) 
1279-1314 CCCUCCACACCGACGAAAAGUGGCAAGAUGAG
AUCA 
chemical synthesis 
(Dharmacon) 
ASH1 E2Bmin 
(21 bases) 
G+1283-
1303 
GCCACACCGACGAAAAGUGGC chemical synthesis 
(Dharmacon) 
E2Bshort-01  GGCCACACCGACGAAAAGUGGCC chemical synthesis 
(Dharmacon) 
E2Bshort-02  AGGCCACACCGACGAAAAGUGGCC chemical synthesis 
(Dharmacon) 
E2Bshort-03  GGCCACACCGACGAAAAGUGGCCA chemical synthesis 
(Dharmacon) 
E2Bshort-04  UCCACACCGACGAAAAGUGGA chemical synthesis 
(Dharmacon) 
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RNA Base no. 
relative to 
start codon 
Sequence (5’-3’) Produced by 
E2Bshort-05  CCACACCGACGAAAAGUGG chemical synthesis 
(Dharmacon) 
E2Bshort-06  CCACACCGACGAAAAGUGGC chemical synthesis 
(Dharmacon) 
E2Bshort-07  ACCACACCGACGAAAAGUGGU chemical synthesis 
(Dharmacon) 
E2Bshort-08  GCACACCGACGAAAAGUGC chemical synthesis 
(Dharmacon) 
E2Bshort-09  ACCCACCGACGAAAAGGGU chemical synthesis 
(Dharmacon) 
HIV-1 TAR (16 
bases) 
 CGAGCCUGGGAGCUCG chemical synthesis 
(Dharmacon) 
HIV-1 TAR (57 
bases) 
 GGUCUCUCUGGUUAGACCAGAUCUGAGCCUGG
GAGCUCUCUGGCUAACUAGGGAACC 
in vitro transcription (this 
study) 
U1snRNA 
hairpin II 
 UUAUCCAUUGCACUCCGGAUGU chemical synthesis 
(Dharmacon) 
MS2 stem loop  ACAUGAGGAUUACCCAUGU chemical synthesis 
(Dharmacon) 
Poly(A)20  AAAAAAAAAAAAAAAAAAAA chemical synthesis 
(Dharmacon) 
9-mer motif  CGACGAAAA chemical synthesis 
(Dharmacon);  
5‘ biotinylated for SPR 
analysis 
7-mer motif  ACGAAAA chemical synthesis 
(Dharmacon) 
6-mer motif  CGACGA chemical synthesis 
(Dharmacon);  
5‘ biotinylated for SPR 
analysis 
3-mer motif  CGA chemical synthesis 
(Dharmacon);  
5‘ biotinylated for SPR 
analysis 
TAR+6-mer 
motif (sense) 
 CGAGCCACUCCGACGAGCUCG chemical synthesis 
(Dharmacon) 
TAR+6-mer 
motif (antisense) 
 CGAGCCACUCGCUGCUGCUCG chemical synthesis 
(Dharmacon) 
 
4.2.3 DNA oligonucleotides to generate templates for in vitro transcription 
dsDNA templates for in vitro-transcription reactions were generated by PCR using the 
following oligonucleotides. Underlined sequences correspond to the T7 promoter-consensus 
sequence that was added to the 5’ end of the coding strand through the respective forward 
primer.
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# oligonucleotide sequence (5‘-3‘)
Tx-1 ASH1_E1_for TAATACGACTCACTATAGGGAGAAGACTATGTTAAAATACGCGAAG 
Tx-2 ASH1_E1_rev TTATTTTGATTATTAGTTAAGTTG 
Tx-3 ASH1_E2A_for TAATACGACTCACTATAGGGAGTTGCGAATAGAGACATTCTATCG 
Tx-4 ASH1_E2A_rev AGTTGCTTTGAGATTTTGTTCTTAC 
Tx-10 ASH1_E3_118nt_for TAATACGACTCACTATAGGGAGACAGTAGAGAATTGATACATGG 
Tx-11 ASH1_E3_118nt_rev TTTTTATTTGTAGTTTATTTAGC 
Tx-12 ASH1_E2B_D1_for TAATACGACTCACTATAGGGAGATCTTCATCTCCATCTCCCTCCAC 
Tx-13 ASH1_E2B_D1_rev TGATCTTGATCTCATCTTGCC 
Tx-28 TAR-57_up TAATACGACTCACTATAGGGGTCTCTCTGGTTAGACCAGATCTGAG
CCTGGGAGCTCTCTGGCTAACTAGGGAACC 
Tx-29 TAR-57_down GGTTCCCTAGTTAGCCAGAGAGCTCCCAGGCTCAGATCTGGTCTAA
CCAGAGAGACCCCTATAGTGAGTCGTATTA 
 
4.3  Plasmids  
4.3.1 Plasmids for protein expression in E. coli 
# insert vector restriction 
sites 
primer tag comments 
p01 She2p pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
full length (246 aa); 
(Niessing et al., 2004) 
p02 She2p-ΔCys pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
C14S, C68S, C106S, 
C180S; created by Dierk 
Niessing 
p03 She2p-(6-246)-
ΔCys 
pGEX-6P-1 BamH/XhoI S2-27 + S2-1 N-
GST 
Δaa1-5; C14S, C68S, 
C106S, C180S 
p04 She2p-(6-243)-
ΔCys 
pGEX-6P-1 BamH/XhoI S2-27 + S2-2 N-
GST 
Δaa1-5; Δaa244-246; C14S, 
C68S, C106S, C180S 
p05 She2p-(6-239)-
ΔCys 
pGEX-6P-1 BamH/XhoI S2-27 + S2-22 N-
GST 
Δaa1-5; Δaa240-246; C14S, 
C68S, C106S, C180S 
p06 She2p-(ΔC-term) pGEX-6P-1 BamH/XhoI S2-3 + S2-22 N-
GST 
Δaa241-246 
p08 She2p-L130Y pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
site-directed mutagenesis 
using oligos S2-23 +S2-24 
p09 She2p-S120Y pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
site-directed mutagenesis 
using oligos S2-12 +S2-13 
p10 She2p-
(N36S,R63K) 
pGEX-6P-1 BamH/XhoI - N-
GST 
(Du et al., 2008) 
p11 She2p-ΔhelixE pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
Δaa174-183; deleted using 
oligos S2-4 + S2-5 
p13 She2p-Δloop pGEX-6P-1 BamH/XhoI S2-3 + S2-1 N-
GST 
Δaa81-89; internal deletion 
created using oligos S2-10 
+ S2-11 
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4.3.2 Yeast plasmids 
# insert vector restriction 
sites 
template primer tag comments 
RJP132 ASH1 YEplac195  URA marker; (Long et 
al., 1997) 
RJP138  -   YCplac22  TRP marker; (Gietz and 
Sugino, 1988) 
RJP145  -  YCplac111  LEU marker; (Gietz and 
Sugino, 1988) 
RJP428 SHE2-3myc pUC9  C-
3xmyc 
(Jansen et al., 1996)
p15 SHE2-3myc YCplac22 HindIII RJP428 C-
3xmyc 
subcloned from RJP428 
via HindIII 
p16 SHE2-
L130Y-
3myc 
YCplac22 NsiI/XbaI p08 S2-17 + 
S2-19 
C-
3xmyc 
She2-L130Y-PCR 
fragment cloned into 
p15 
p17 SHE2-
ΔhelixE-
3myc 
YCplac22 NsiI/XbaI p11 S2-17 + 
S2-26 
C-
3xmyc 
SHE2-ΔhelixE-PCR 
fragment cloned into 
p15 
p18 SHE2-
Δ(C-term)-
3myc 
YCplac22 NsiI/XbaI p06 S2-17 + 
S2-20 
C-
3xmyc 
SHE2-Δ(C-term)-PCR 
fragment cloned into 
p15 
RJP916 SHE2 YCplac111  (Du et al., 2008)
p19 She2-
L130Y 
YCplac111 NsiI/StuI p08 S2-17 + 
S2-18 
- She2-L130Y-PCR 
fragment cloned into 
RJP916 
p20 SHE2-
ΔhelixE 
YCplac111 NsiI/StuI p11 S2-17 + 
S2-18 
- SHE2-ΔhelixE-PCR 
fragment cloned into 
RJP916 
p21 SHE2-
Δ(C-term) 
YCplac111 NsiI/StuI p06 S2-17 + 
S2-21 
- SHE2-Δ(C-term)-PCR 
fragment cloned into 
RJP916 
 
4.4  Bacterial strains 
Strain Essential genotype Source
XL-1 blue recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac
[F´ proAB lacIq ZΔM15 Tn10 (Tetr)] 
Stratagene (La Jolla, USA) 
BL21 Star (DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Invitrogen (Karlsruhe, Germany)
 
4.5  Yeast strains 
Strain Essential genotype Source 
RJY 2053  MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4 EUROSCARF 
(Frankfurt, 
Germany) 
RJY 3364 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2 
Gift from R.-P. 
Jansen (Tübingen) 
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Strain Essential genotype Source 
y01 MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4, YEplac195-
ASH1 (RJP132), YCplac111 (RJP145) 
this study 
y02 MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4, YEplac195-
ASH1 (RJP132), YCplac111-SHE2 (RJP916) 
this study 
y03 MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4, YEplac195-
ASH1 (RJP132), YCplac111-SHE2-ΔhelixE (p20) 
this study 
y04 MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4, YEplac195-
ASH1 (RJP132), YCplac111-SHE2-ΔC-term (p21) 
this study 
y05 MAT alpha; his3Δ1;leu2Δ0, lys2Δ0, ura3Δ0; she2::kanMX4, YEplac195-
ASH1 (RJP132), YCplac111-SHE2-L130Y (p19) 
this study 
y06 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2, YCplac22 (RJP138) 
this study 
y07 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2, YCplac22-SHE2-myc3(p15) 
this study 
y08 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2, YCplac22-SHE2-ΔhelixE-myc3 (p17) 
this study 
y09 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2, YCplac22-SHE2-ΔC-term-myc3 (p18) 
this study 
y10 MAT a, his3, leu2, ade2, trp1, ura3, HO-ADE2, HO-CAN1, HA3-SHE3, 
she2::natNT2, YCplac22-SHE2-L130Y-myc3 (p16) 
this study 
 
4.6  Media and supplements 
Medium Composition Purpose 
LB medium 1 % (w/v) bacto tryptone, 0.5 % (w/v) bacto 
yeast extract, 0.5 % (w/v) NaCl (+1.5 % (w/v) 
agar for plates) 
Growth medium for E. coli
Medium A (per liter) 100 ml M9 medium (10x), 10 ml trace elements 
solution (100x), 20 ml 20 % (w/v) glucose, 1 ml 
1 M MgSO4, 0.3 ml 1 M CaCl2, 1 ml biotin 
(1 mg/ml), 1 ml thiamin (1 mg/ml), appropriate 
antibiotic(s) 
Growth medium for E. coli; 
15N-labeling of proteins for 
NMR experiments 
YPD medium 1 % (w/v) yeast extract, 2 % (w/v) bacto 
peptone, 2 % (w/v) glucose (+2 % (w/v) agar 
for plates) 
Growth medium for S. cerevisiae
Synthetic Complete (SC) 
medium 
0.67 % (w/v) yeast nitrogen base (w/o amino 
acids), 2 % (w/v) glucose, 0.06 % (w/v) CSM 
dropout mix (includes all essential amino acids 
and nucleobases except the amino acids or 
nucleobases used as auxotrophy markers, i.e. 
leucine, tryptophane, histidine, adenine, and 
uracil) 
Selective growth medium for 
S. cerevisiae 
 
Supplement Stock solution Final concentration 
M9 medium (10x) (per 
liter) 
60 g Na2HPO4, 30 g NaH2PO4, 5 g NaCl, 5 g 
15NH4Cl 
1x (Supplement for medium A)
Trace elements solution 
(100x) (per liter) 
5 g EDTA, 0.83 g FeCl3 x 6 H2O, 84 mg ZnCl2, 
13 mg CuCl2 x 2 H2O, 10 mg CoCl2 x 6 H2O, 
10 mg H3BO3, 1.6 mg MnCl2 x 6 H2O 
1x (Supplement for medium A)
Adenine  7.5 g/l 75 mg/l 
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Supplement Stock solution Final concentration 
Uracil 2 g/l 20 mg/l 
Histidine 2 g/l 20 mg/l 
Leucine 10 g/l 100 mg/l 
Tryptophane 5 g/l 50 mg/l 
Ampicillin 100 mg/ml 100 mg/l 
Kanamycin 50 mg/ml 50 mg/l 
IPTG 1 M 0.3 mM 
 
4.7  Antibodies 
Primary antibody Source Dilution / Application Supplier
anti-HA (3F10) rat 1:1000 / Western Blot Roche Applied Science 
(Mannheim, Germany) 
anti-myc (9E10) mouse 1:1000 / Western Blot Roche Applied Science 
(Mannheim, Germany) 
anti-myc (9E11) mouse 100 µg antibody coupled to 
250 µl protein-G beads / Co-
IP 
Acris Antibodies (Herford, 
Germany) 
anti-She2p (323/4) rabbit 1:1000 / IF (Du et al., 2008) 
anti-She2p-1C3 rat  1:50 (hybridoma supernatant) 
/ Western Blot 
Generated in collaboration with 
E. Kremmer (Helmholtz Zentrum 
München, Germany) 
 
Secondary antibody Source Dilution / Application Supplier
Alexa®488 anti-rabbit-IgG goat 1:250 / IF MoBiTec (Göttingen, Germany)
anti-mouse-IgG-HRPO goat 1:3000 / Western BioRad (Munich, Germany) 
anti-rat-IgG-HRPO rabbit 1:10000 / Western Abcam (Cambridge, USA) 
 
 
4.8  Bioinformatic tools and software 
Physical and chemical parameters (molecular weight, theoretical isoelectric point, extinction 
coefficient) of recombinant proteins were calculated using the ProtParam tool from the 
ExPASy Proteomics Server (http://www.expasy.org/) (Gasteiger et al., 2003).  
Secondary structures of RNA were predicted using the MC-Fold algorithm 
(http://www.major.iric.ca/MC-Fold/) (Parisien and Major, 2008).  
RNA-filter binding experiments were analyzed and quantified using the ImageQuant software 
from GE Healthcare and the software KaleidaGraph from Synergy Software (Reading, USA). 
Co-immunoprecipitation experiments were quantified using the analysis software MultiGauge 
from FUJIFILM. 
SAXS data were analyzed and processed with different programs from the ATSAS 2.1 
software package (Konarev et al., 2006). Ab initio modeling was performed using GASBOR 
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(Svergun et al., 2001). Averaging of multiple GASBOR models and superposition of the 
She2p-crystal structure with SAXS models was performed with SUPCOMP and DAMAVER 
(Volkov and Svergun, 2003). 
All figures of protein structures were generated with the program PyMOL from DeLano 
Scientific (Palo Alto, USA) (DeLano, 2004).  
 
4.9  Cloning, expression and purification methods 
4.9.1 Cloning 
Standard methods for molecular biology were performed as described (Sambrook and Russell, 
2001). This includes polymerase chain reaction for amplification of DNA fragments, 
restriction digest of DNA, ligation of DNA fragments, generation of chemically competent 
Escherichia coli cells, transformation of plasmid DNA, isolation of plasmid DNA from E. coli 
cells, and analysis of DNA by agarose gelelectrophoresis. Generally, the isolation of plasmid 
DNA and the purification of DNA fragments was performed with the NucleoSpin-Plasmid 
and the NucleoSpin-Extract II kits from Macherey-Nagel (Düren, Germany), respectively. 
Likewise, restriction enzymes were used according to the manufacturer’s instruction. Point 
mutations and deletion of short fragments within a gene were generated by PCR-based site-
directed mutagenesis (Ho et al., 1989). DNA sequencing was performed by Eurofins 
Medigenomix (Martinsried, Germany). The cloning strategies for all plasmids used for either 
recombinant protein expression in E. coli or functional analysis in S. cerevisiae are summarized 
in chapter 4.3. A list of all oligonucleotides that were used for cloning is shown in chapter 
4.2.1. 
4.9.2 Recombinant protein expression in E. coli 
All variants of GST-She2-fusion proteins used in this study were recombinantly expressed in 
E. coli BL21 Star (DE3) cells. Cells were grown at 37 °C in LB medium with the appropriate 
antibiotics to an OD600 of 0.4-0.6 and then cooled down to 18 °C. Protein synthesis was 
induced by adding 0.3 mM IPTG and carried out at 18 °C for 12-16 hours. The cells were 
harvested by centrifugation at 4 °C, resuspended in lysis buffer (for all buffers, see chapter 
4.9.4), flash frozen in liquid nitrogen, and stored at -80 °C. 
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4.9.3 Isotopic 15N-labeling for NMR spectroscopy 
For exploratory NMR spectroscopy experiments, GST-She2p was 15N-labeled during protein 
expression in minimal medium containing 15NH4Cl. For the starter culture, 20 ml Medium A 
(see chapter 4.6) containing ampicillin was inoculated with a single colony of freshly 
transformed E. coli BL21 Star (DE3) cells carrying the plasmid p01 (chapter 4.3.1) and grown 
over night at 37 °C. With the 20 ml over-night culture, one liter of Medium A containing 
ampicillin was inoculated and grown at 37 °C to an OD600 of 0.8. After cooling the culture on 
ice, over-expression of GST-She2p was induced by adding 0.3 mM IPTG. The cells were 
grown for additional 16 hours at 18 °C and then harvested by centrifugation at 4 °C. The 
pellet was resuspended in lysis buffer (for all buffers, see chapter 4.9.4) and flash frozen in 
liquid nitrogen before storage at -80 °C. 
4.9.4 Purification of recombinant She2p variants 
All She2p variants used in this study (see chapter 4.3.1) were expressed as GST-fusion 
proteins. After harvesting of the cells and resuspending the pellet in lysis buffer (see table 
below), the cells were disrupted by sonication. Cell debris was removed by centrifugation at 
4 °C (SS34 rotor, 15000 rpm, 1 h). For affinity purification, the supernatant was applied onto 
an equilibrated GSTrap 5 ml column. Subsequently, the column was extensively washed with 
the GST-wash buffers 1 and 2. The washing step with 1 M NaCl-containing buffer proved to 
be essential for eliminating potential She2p-associated nucleic acids. The GST-fusion protein 
was eluted with GST-elution buffer. To remove the GST tag from She2p, 50 µg PreScission 
Protease (GE Healthcare, Munich) was added to the elution fraction, which was then dialyzed 
against dialysis buffer for 12 h at 4 °C. Afterwards, the cleaved tag was removed from the 
solution by applying the dialysis fraction onto a GSTrap column. The flow through fraction, 
which contains the untagged She2 protein, was loaded onto a HiTrap-Q column for anion 
exchange chromatography. Prior to the experiment, the ion exchange column was pre-
equilibrated with buffer A. The protein was eluted with a gradient of 20 column volumes 
ranging from buffer A to buffer B. Peak fractions were analyzed by SDS-PAGE (Laemmli, 
1970), pooled and concentrated using centrifugal filter devices (Amicon Ultra, Millipore, 
Billerica, US). For the final purification step, the concentrated protein solution was loaded 
onto a Superdex S200 16/60 size exclusion chromatography column equilibrated with size-
exclusion buffer. Different size-exclusion buffers were chosen dependent on the following 
experiment. After SDS-PAGE analysis, the peak fractions were concentrated and either 
subsequently used or flash frozen and stored at -80 °C. For crystallization experiments, She2p 
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was purified always directly prior the experiment, whereas for later biochemical analyses the 
protein was stored in small aliquots at -80 °C for a maximum duration of three months. For 
She2p:RNA co-crystallization experiments or for RNA-binding experiments, the protein 
samples should lack any RNase contaminants. To ensure this, the buffer for the final size-
exclusion chromatography step was prepared with RNase-free chemicals and RNase-free 
water (DEPC treated). In case of cysteine-free mutant proteins, DTT was omitted from the 
respective buffers. 
Buffer for She2p purification Composition
lysis buffer 20 mM HEPES, 1 M NaCl, 2 mM DTT, 1x Complete EDTA-free protease-
inhibitor cocktail (Roche Applied Science), pH 7.4 (8 °C) 
GST-wash buffer 1 20 mM HEPES, 0.5 M NaCl, 2 mM DTT, pH 7.4 (8 °C) 
GST-wash buffer 2 20 mM HEPES, 1 M NaCl, 2 mM DTT, pH 7.4 (8 °C) 
GST-elution buffer 20 mM HEPES, 0.5 M NaCl, 2 mM DTT, 30 mM glutathione, pH 7.4 
(8 °C) 
dialysis buffer 20 mM HEPES, 150 mM NaCl, 2 mM DTT, pH 7.9 (8 °C) 
buffer A 10 mM HEPES, 150 mM NaCl, 2 mM DTT, pH 7.9 (8 °C) 
buffer B 10 mM HEPES, 1 M NaCl, 2 mM DTT, pH 7.9 (8 °C) 
size-exclusion buffer 1 
(crystallization and RNA-
binding) 
10 mM HEPES, 100 mM NaCl, 2 mM DTT, pH 7.4 (8 °C) 
size-exclusion buffer 2 (AUC) 20 mM Tris, 150 mM NaCl, 5 mM DTT, 1 mM EDTA, pH 7.4 (8 °C)
size-exclusion buffer 3 (analytical 
SEC) 
20 mM Tris, 150 mM NaCl, 5 mM DTT, pH 7.4 (8 °C) 
size-exclusion buffer 4 (SAXS) 50 mM Na2HPO4/NaH2PO4, 100 mM NaCl, 2 mM DTT, pH 7.4 (8 °C)
size-exclusion buffer 5 (NMR) 20 mM Na2HPO4/NaH2PO4, 100 mM NaCl, 2 mM MgCl2, pH 6.8 (8 °C)
 
4.10 Methods for protein analysis 
4.10.1 Western blotting 
Following protein separation by SDS-PAGE (Laemmli, 1970), proteins were transferred onto 
a PVDF membrane for 2 h at 60 V using a wet-blotting apparatus (BioRad, Munich, 
Germany). After transfer, the membrane was blocked with 10 % (w/v) milk powder in TBS-T 
(10 mM Tris pH 8.0, 150 mM NaCl, 0.05 % Tween 20) and subsequently incubated with the 
primary antibody (diluted in 1x TBS-T containing 1 % milk powder) over night at 4 °C. After 
three washing steps with TBS-T, the membrane was incubated with the secondary antibody 
(diluted in 1x TBS-T containing 1 % milk powder) for 1 h at RT. Excess of antibody was 
removed by 3 washing steps with TBS-T. Immuno-stained proteins were visualized using an 
ECL kit (Pierce by Thermo Scientific) followed by exposure of the membrane to light-
sensitive films (GE Healthcare) and developing with a Kodak Xomat M35 developing 
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machine. Alternatively for the purpose of quantification, ECL-treated membranes were 
directly analyzed with the LAS-3000 mini imaging system (FUJIFILM).  
4.10.2 Dynamic Light Scattering 
Dynamic Light Scattering (DLS) can be used to determine the size distribution of small 
particles in solution. DLS functions by measuring the speed at which particles move under 
Brownian motion. In a DLS system, a laser passes through a measuring cell, which contains 
the protein sample, and the intensity of light scattered by the sample is measured. Since 
molecules in solution are constantly moving, the scattering intensity will vary. Using the 
autocorrelation function, the hydrodynamic radius of the particles can be determined. Thus, 
DLS can be used to directly evaluate the effect of the solvent on the behavior, e.g. the 
solubility, of a given molecule. This technique was successfully used to screen for appropriate 
buffer conditions for SAXS experiments. Before the measurement, purified She2p was 
dialyzed over night against various buffers containing different buffer substances, salt 
concentrations, or additives like glycerol and detergents. Immediately before the experiment, 
the protein samples were centrifuged at 20000x g for 30 minutes to separate unsoluble 
particles. The measurements were performed with a 70 µl sample volume-quartz cuvette at 
20 °C in a 802 DLS spectrometer (Viskotek Corp., Houston, USA). By testing a series of 
protein concentrations ranging from 1.7 mg/ml to 14.4 mg/ml, potential concentration-
dependent oligomerization effects or aggregation of the sample could be measured. 
4.10.3 Analytical ultracentrifugation  
Analytical ultracentrifugation (AUC) experiments with She2p-wild type and She2p-L130Y 
were performed in close collaboration with Dr. Klaus Richter from the department of 
chemistry at the Technical University Munich. Sample preparation was done in our laboratory, 
whereas the AUC runs and data evaluation was performed by Klaus Richter. AUC was 
performed using a Beckman XL-A instrument (Beckman Coulter, Krefeld, Germany) 
equipped with UV/VIS optical systems. For all experiments, proteins were measured in size-
exclusion buffer 2 (see chapter 4.9.4) and had been pre-treated with 20 µg/ml RNaseA 
(Fermentas, St. Leon-Rot, Germany). In order to investigate concentration-dependent 
oligomerization events, the following protein concentrations were used in sedimentation-
equilibrium experiments: wild type-She2p: 1.7 µM, 2.6 µM, 3.5 µM, 5.2 µM, 7.3 µM, 10.5 µM, 
15.0 µM, 21.6 µM, 30.7 µM, and She2p (L130Y): 1.9 µM, 2.6 µM, 3.7 µM, 5.2 µM, 7.7 µM, 
10.8 µM, 15.7 µM, 22.3 µM, 32.0 µM. 6-channel centerpieces were filled with 105 µl of sample 
volume and 15 µl heptacosafluorotributylamine. After 48 hours at 4°C, equilibrium conditions 
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were obtained for wild type-She2p (9000 rpm) and She2p -L130Y (12500, 18000, 23000 rpm), 
as judged from stable sedimentation profiles. Data were analyzed with the ULTRASCAN 9.8 
software package (Demeler, 2005). Sedimentation-velocity experiments were performed at 
50000 rpm and 20 °C with two channel centerpieces (Ti-60 rotor), and data were acquired at 
280 nm wavelength. The following protein concentrations were measured: She2p-wild type: 
16.0 µM; She2p-L130Y: 4.9 µM, 12.9 µM, 32.0 µM. For analysis of sedimentation traces, the 
dc/dt approach in the ULTRASCAN software package was used. In order to accurately 
determine S-values, resulting dc/dt curves were fitted in SigmaPlot (Systat Software, San Jose, 
USA) to a Gaussian function. Despite the potentially complex association model, this 
approach still resulted in consistent values with little non-stochastic residuals remaining after 
the data fitting. 
4.10.4 Analytical size-exclusion chromatography 
Analytical size-exclusion chromatography experiments were performed with a Superose 12 
10/300 GL column (GE Healthcare), which was calibrated for molecular weight calculation 
using the Molecular Weight Marker Kit (Sigma, Deisenhofen, Germany). For molecular 
weight determination, 0.5 ml protein solution of She2p-wild type and She2p-L130Y, 
respectively, at various protein concentrations was applied onto the column with a flow rate of 
0.5 ml/min and analyzed in size-exclusion buffer 3 (see chapter 4.9.4). The absorbance of 
eluted protein was measured at 280 nm and peak fractions were analyzed for presence of 
She2p by SDS PAGE or western blotting using an α-She2p-1C3 antibody (0.2 µM samples). 
She2p-containing peak fractions were integrated over the peak volume to calculate the real 
protein concentration on the column.  
4.10.5 Monoclonal antibodies 
In collaboration with Dr. Elisabeth Kremmer (Helmholtz Zentrum München), monoclonal 
antibodies from rat against GST-tagged She2p were generated using standard procedures. 
Antibodies were tested in an ELISA using recombinantly expressed GST-She2p or GST 
protein alone. Monoclonal antibodies reacting exclusively with GST-She2p were further 
analyzed in western blotting. Clones She2p-1C3, She2p-4G8 and She2p-5A1 (rat IgG2a) 
recognize wild-type and mutant She2p specifically. In this work, She2p-1C3 was used for 
detection of She2p variants in western blotting. 
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4.11 Biochemical analysis of She2p:RNA interactions 
4.11.1 In vitro transcription and RNA purification 
For working with RNA, only RNase-free water and RNase-free chemicals were used. RNase-
free water was prepared by treatment with the RNase inhibitor diethylpyrocarbonate (DEPC). 
In sterile bottles, DEPC was added to Millipore-H2O to a final concentration of 0.05 % (v/v), 
incubated over night in a 40 °C water bath and then autoclaved for 20 minutes at 121 °C. 
Chemically synthesized RNAs obtained from Thermo Fisher Scientific/Dharmacon (USA) 
(see chapter 4.2.2) were delivered in the stable 2’-ACE-protected form to prevent RNA 
hydrolysis. Deprotection of these oligonucleotides was performed according to the provided 
instructions. Then, the RNA was dissolved in RNase-free water and stored at -20 °C. 
ASH1-zipcode RNA (E1, E2A, E2B, and E3; see chapter 4.2.2) and the HIV-1 TAR RNA 
(57 bases) for biochemical studies were generated by in vitro transcription using the 
MEGAshortscript T7 Kit (Applied Biosystems/Ambion, Austin, USA). Double-stranded 
DNA templates for the respective transcription reactions were generated by PCR (ASH1 
zipcodes) or by hybridization of complementary DNA sequences (HIV-1 TAR-57) using 
oligonucleotides listed in 4.2.3. The transcription reactions were performed according to the 
provided protocol at 37 °C for 4 h. Subsequently, 10 units of Calf Intestine Alkaline 
Phosphatase CIAP (Fermentas, St. Leon-Rot, Germany) were added and the reaction was 
incubated at 37 °C for another 45 minutes. CIAP dephosphorylates the 5’ ends of the newly 
transcribed RNA molecules and generates compatible ends for radioactive 5’ end labeling of 
the RNA. In order to degrade the DNA template, 10 units of RNase free DNase I (provided 
in the MEGAshortscript T7 Kit) were added and the samples were incubated at 37 °C for 
20 minutes. The enzymatic reactions were either stopped by storing the samples at -20 °C or 
by subsequent purification using native polyacrylamide gelelectrophoresis (PAGE). Native 
PAGE was used to preserve the native folding state of the RNA and to check the 
homogeneity of the transcription reaction, since in native gels RNA molecules are separated 
according to their secondary structure. For purification, 6x RNA-sample buffer (final 
concentration 1x) was added to the samples, which were then loaded immediately onto a gel 
containing 10 % acrylamide and 1x TBE (for all buffers, see table below). The gel was run in 
1x TBE at RT for 45 minutes at 100 V. Afterwards, the RNA bands were visualized using UV 
shadowing. In case only a single band for each RNA preparation was visible, this band was cut 
into small pieces and transferred into an eppendorf tube. RNA was extracted from the gel 
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over night at 37 °C by adding 300 µl crush-and-soak solution. Next, the RNA-buffer solution 
was separated from the gel pieces by filtration (Amicon Ultrafree-MC centrifugal-filtration 
devices), the solution was concentrated using centrifugal filter devices (Amicon Ultra) and 
thereby the crush-and-soak buffer was exchanged with RNase-free water. The concentration 
of the RNA samples was determined using a NanoDrop spectrophotometer (PEQLAB, 
Erlangen, Germany) and the samples were stored at -20 °C.  
Buffer/Reagent for RNA purification Composition
10x TBE buffer 0.9 M Tris, 0.9 M boric acid, 20 mM EDTA 
gel running buffer 1x TBE in RNase-free H2O
6x RNA-sample buffer 60 mM Tris (pH 7.5), 60 % glycerol
crush-and-soak solution 0.3 M NaCl, 0.5 mM EDTA
 
4.11.2 Isotopic labeling of RNA oligonucleotides 
4.11.2.1  5’-end labeling 
To visualize the different RNA oligonucleotides that were used in RNA-binding assays, they 
were radioactively labeled at their 5’ end using γ-32P-ATP. A 20 µl-labeling reaction contained 
10 pmol of the respective RNA oligonucleotide, 15 µCi γ-32P-ATP, 10 units T4 Polynucleotide 
Kinase (Fermentas, St. Leon-Rot, Germany), and the supplied buffer A and was carried out 
for 45 minutes at 37 °C according to the provided protocol. The reaction was stopped by 
incubation at 70 °C for 10 minutes. Un-incorporated γ-32P-ATP was removed from the32P-
labeled oligonucleotides using Sephadex G-25 Quick Spin Columns (Roche Applied Science, 
Mannheim, Germany). Radiolabeled RNA could be stored at -20 ° for a maximum duration of 
2 weeks. 
4.11.2.2  3’-end labeling  
RNA oligonucleotides of the EAR1 and WSC2N zipcodes were synthesized with a biotin 
label at their 5’ end and thus, had to be radioactively labeled at the 3’ end using (5’-32P)-pCp 
and T4 RNA ligase. The labeling was carried out in a 20 µl reaction containing 30 pmol of the 
respective RNA oligonucleotide, 30 pmol (5’-32P)-pCp, 1 mM ATP, and 10 units T4 RNA 
ligase (Fermentas, St. Leon-Rot, Germany) in the provided reaction buffer. The reaction was 
incubated over night at 4 °C, heat inactivated at 70 °C for 10 minutes and finally separated 
from un-incorporated 32P-pCp using Sephadex G-25 Quick Spin Columns (Roche Applied 
Science, Mannheim, Germany). Radiolabeled RNA could be stored at -20 ° for a maximum 
duration of 2 weeks. 
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4.11.3 Electrophoretic mobility shift assay (EMSA) 
To analyze wild-type She2p binding to different short RNA oligonucleotides (ASH1 3-mer to 
9-mer motifs, see 4.2.2), EMSAs were performed. In a 20 µl reaction, 2 µM wild-type She2p 
was incubated with 1 nM of the respective 5’ 32P-labeled RNA oligonucleotide in reaction 
buffer (20 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM DTT, 5 mM MgCl2) for 20 minutes at 
20 °C. To each sample, 4 µl 6 x RNA-sample buffer (see 4.11.1) was added and the 
protein:RNA complexes were resolved on a native pre-run gel (7 % acrylamide in 1 x TBE). 
The gel was run in 1x TBE running buffer at 150 V for 3 h at 20 °C. After drying the gel was 
exposed to a Storage Phosphor Screen (GE Healthcare, Munich, Germany) for 1 h, scanned 
with a Storm Scanner (GE Healthcare, Munich, Germany), and analyzed using the 
ImageQuant software.  
4.11.4 RNA filter-binding assay 
Besides She2p binding to short RNA oligonucleotides, RNA binding was assessed using a 
nitrocellulose filter-binding assay (Wong and Lohman, 1993). Serial protein dilutions (see 
below) and a constant amount of radiolabeled RNA (0.5 nM) were incubated in 20 mM 
HEPES (pH 7.4), 100 mM NaCl, 2 mM DTT, 2 mM MgCl2 and 30 µg/ml yeast tRNA at 
20 °C for 20 minutes. 80 µl of the reaction mixture was applied on the membrane in a Bio-
Dot microfiltration apparatus. After washing and drying, radioactivity retained on the 
nitrocellulose filter was measured by phosphoimaging using a Storm Scanner (GE Healthcare). 
Equilibrium-dissociation constants were calculated from a plot of the fraction of bound RNA 
versus protein concentration using the Langmuir isotherm and the software KaleidaGraph 
(Synergy Software). For quantification, in each experiment eight serial dilutions were used in 
the following concentration range: She2p-wt binding to ASH1 zip-code elements: 0 to 4 µM; 
She2p-wt binding to HIV-1 TAR, U1snRNA, EAR1, and WSC2N RNAs: 0 to 12 µM; She2p-
wt binding to MS2 RNA: 0 to 6 µM; She2p-mutant binding to bud-localizing RNAs: 0 to 
16 µM; She2p-S120Y binding to ASH1 zipcodes, HIV-1 TAR, or U1snRNA: 0 to 12 µM; 
She2p(ΔC-term)-binding to ASH1-E2A element: 0 to 32 µM; She2p-mutant binding to HIV-1 
TAR and U1snRNA: 0 to 32 µM; She2p-wt binding to poly A RNA: 0 to 32 µM. 
4.11.5 Surface Plasmon Resonance 
Interaction studies of wild type-She2p or the variant She2p-(6-239)-ΔCys with biotinylated 
RNA oligonucleotides were performed using a Biacore 3000 system (GE Healthcare). 
Biotinylated RNAs were coupled to a streptavidin chip (GE Healthcare) to signal intensities 
below 200 response units. In order to obtain sterical flexibility, the 5’ biotin tag and the first 
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nucleobase were separated by an 18-atom spacer (hexaethylene glycol). She2p binding was 
assessed at 25 °C in running buffer containing 20 mM HEPES (pH 7.5), 150 mM NaCl, and 
2 mM DTT. For all experiments, protein concentrations ranging from 1.5 µM to 200 µM were 
used, with one concentration (25 µM) measured as duplicate. Equilibrium-dissociation 
constants were obtained from steady-state measurements using the Langmuir isotherm 
(Req=KAcRmax/(1+cKA), with Req: steady-state binding level, KA: association constant, 
c: analyte concentration, Rmax: maximum binding level). 
 
4.12 In vivo analysis of protein function 
4.12.1 Transformation and cultivation of yeast cells 
One-step transformation of plasmid DNA was performed as described (Chen et al., 1992). 
Transformed yeast cells were cultivated on selective media plates for 2 days at 30 °C. Then, 
transformants were isolated on selective media plates for 1 day at 30 °C. Liquid cultures of 
yeast strains were grown in YPD or selective medium at 30 °C with 130 rpm. The expression 
of the protein of interest was confirmed by western blot analysis of yeast whole cell extracts. 
4.12.2 Preparation of yeast analytical whole-cell extracts 
In order to analyze the protein-expression level of individual transformants, whole-cell 
extracts were generated. From freshly selected strains, one inoculation loop of cells was 
resuspended in 1 ml H2O. Cells were lysed by the addition of 150 µl alkaline solution (1.85 M 
NaCl, 7.5 % β-mercaptoethanol) and 15 minutes incubation on ice. The cell lysate was 
precipitated after the addition of 150 µl 50 % trichloroacetic acid for 10 minutes on ice. 
Following sedimentation (13000 rpm, 15 minutes, 4 °C), the pellet was resupended in 50 µl 
HU buffer (8 M urea, 5% SDS, 200 mM Tris pH 8.8, 1 mM EDTA, 1.5% DTT, 0.01 % 
bromophenol blue) and the proteins were denatured by incubation at 65 °C for 10 minutes. 
Finally, the samples were analyzed by western blotting for the expression of the desired 
protein. 
4.12.3 Co-immunoprecipitation 
Co-immunoprecipitation of myc-tagged She2p and HA-tagged She3p was performed by using 
monoclonal α-myc antibody 9E11 (Acris Antibodies). 100 µg α-myc antibody has been 
covalently coupled to 250 µl magnetic Protein-G beads (Invitrogen) according to the 
manufacturer’s instructions using dimethyl pimelimidate (DMP) as a cross linker. 25 µl of 
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coupled beads were used for co-immunoprecipitation of a 20 OD culture. Beads were pre-
incubated with RNA buffer (for all buffers, see table below) for 3 times 15 minutes to block 
unspecific RNA binding to the bead surface. 20 OD of an exponentially growing yeast culture 
were harvested (2000 g, 3 minutes, 4 °C). The pellet was transferred to a 2 ml eppendorf tube 
and resuspended in 300 µl breaking buffer. 200 µl glass beads (Roth) and 5 µl RiboLock 
RNase inhibitor (Fermentas) were added and the cells were broken by vortexing 5 times 
3 minutes at 4 °C. The lysate was cleared by centrifugation (2000x g, 2 minutes, 4 °C) and the 
supernatant (250 µl) was transferred to a fresh eppendorf tube. 1/10 of the cleared lysate was 
taken as input control. The remaining lysate was incubated with 25 µl α-myc coupled beads for 
2 h at 4 °C in breaking buffer to allow binding. After binding, the supernatant that contains 
the unbound fraction was collected and the beads were washed 3 times with wash buffer. 
Proteins were eluted from the beads by boiling at 95 °C for 10 minutes in 1x Laemmli buffer. 
1/50 (v/v) of the input (I) and unbound (FT) fraction, and 1/3 (v/v) of the elution fraction 
(IP), respectively, were subjected to western-blot analysis. For detection of She2p-3Myc and 
3HA-She3p, α-myc 9E10 and α-HA 3F10 antibodies were used, respectively. For 
quantification, western blots of two independent experiments were analyzed using the LAS-
3000 mini system (FUJIFILM). Signal intensities were quantified using the MultiGauge 
software (FUJIFILM). In all experiments, background signals were determined from she2 
lanes and subtracted from respective western-blot signals. Subsequently, signals from the 
unbound fraction (FT) were subtracted from the input fractions (I) and used to normalize co-
immunoprecipitated She3p against the bead-bound fraction of She2p-3Myc.  
 
Buffer for co-immunoprecipitation Composition
RNA buffer 50 mM HEPES/KOH (pH 7.3), 20 mM potassium acetate, 2 mM 
EDTA (pH 8.0), 0.1 % (v/v) Triton X-100, 5 % (v/v) glycerol, 
0.1 mg/ml yeast tRNA 
breaking buffer 50 mM HEPES/KOH (pH 7.3), 20 mM potassium acetate, 2 mM 
EDTA (pH 8.0), 0.1 % (v/v) Triton X-100, 5 % (v/v) glycerol, 1x 
Complete EDTA-free protease-inhibitor cocktail (Roche Applied 
Science) 
wash buffer 50 mM HEPES/KOH (pH 7.3), 50 mM potassium acetate, 2 mM 
magnesium acetate, 0.1 % (v/v) Triton X-100, 5 % (v/v) glycerol 
2x Laemmli buffer 125 mM Tris (pH 6.8), 4 % SDS, 200 mM DTT, 20 % glycerol, 
0.01 % (w/v) bromophenol blue 
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4.12.4 Fluorescence microscopy 
4.12.4.1  Preparation of yeast spheroplasts 
To 15 ml yeast cells of a logarithmically growing culture (OD600 0.8) formaldehyde was added 
to a final concentration of 3.7 %. The cells were fixed by shaking the culture at 30 °C for 
another 60 minutes. Cells were harvested (1500x g, 3 minutes) and washed 3 times with 
spheroplasting premix (1.2 M sorbitol, 0.1 M potassium phosphate (pH 7.4), 0.5 mM MgCl2). 
Subsequently, the cell pellet was resupended in 500 µl spheroplasting solution (1.2 M sorbitol, 
0.1 M potassium phosphate (pH 7.4), 0.5 mM MgCl2, 100 µg/ml Zymolyase 100T, 0.2 % β-
mercaptoethanol) and spheroplasting was performed in a 30 °C water bath for 45 minutes. 
Spheroplasts were briefly pelleted (1000x g, 2 minutes) and washed once in spheroplasting 
premix. Finally, the cells were resuspended in 150 µl spheroplasting premix and stored in 50 µl 
aliquots at -80 °C. 
4.12.4.2  Indirect immunofluorescence 
Multi-well slides (Roth) used for indirect immunofluorescence microscopy against wild-type 
She2p and She2p mutants were coated with 0.02 % poly-L-lysine for 5 minutes and washed 3 
times with water. 15 µl of a spheroplasted cell suspension was applied to each well and 
incubated for 5 minutes at RT. Then, the cells were incubated with blocking solution (1x PBS, 
0.1 % BSA) for 5 minutes. Following, 30 µl of the primary-antibody solution (α-She2p 
(323/4), 1:1000 diluted in 1x PBS, 0.1 % BSA) was added to each well and incubated for 2 h at 
RT in a wet box. After 3 washing steps with washing buffer (1x PBS, 0.1 % BSA, 0.1 % Triton 
X-100), the secondary-antibody solution was added (Alexa®488 α-rabbit-IgG, 1:250 diluted 1x 
PBS, 0.1 % BSA) and incubated for 1 h in a darkened wet box. Wells were washed again 3 
times, the nuclei were stained with Hoechst Stain Solution (SIGMA), and the cells were 
mounted in mounting solution (1x PBS, 80 % glycerol). Cells were inspected using an 
Olympus BX60 fluorescence microscope (Olympus) with a 100x NA 1.3 DIC oil objective 
and images were acquired by using Openlab 4.01 software (Improvision).  
 
4.13 Methods for structural analysis 
4.13.1 NMR data acquisition 
1H-15N HSQC (heteronuclear single quantum coherence) spectra of 15N-labeled She2p were 
acquired and analyzed by the group of Prof. Michael Sattler (EMBL Heidelberg, Helmholtz 
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Zentrum München). 15N-labeled She2p was measured at a concentration of 7.1 mg/ml in size-
exclusion buffer 5 (see chapter 4.9.4). In the two dimensional 1H-15N HSQC experiment, each 
amino acid (except for proline) of a given protein is described by one peak in the spectrum. 
For She2p, almost no peaks could be observed. Thus, the planned titration experiments with 
ASH1 RNA to map the RNA-binding sites in She2p could not be performed and NMR 
experiments with She2p were not brought forward.  
4.13.2 Crystallization of She2p:RNA complexes 
In order to co-crystallize She2p variants with different RNA oligonucleotides (ASH1-E3 and 
variants of ASH1-E2B RNA, respectively), 4 mg/ml purified protein in size-exclusion 
buffer 1 (corresponds to 70 nmol of a She2p dimer) was incubated with a 1.5-molar excess of 
RNA (dissolved in 20 mM HEPES pH 7.8) for 20 minutes on ice. For initial screening, 
commercially available screens from Hampton Research (Aliso Viejo, USA), Qiagen (Hilden, 
Germany), and Jena Bioscience (Jena, Germany) were used. The protein:RNA complex was 
crystallized at 20 °C by the sitting-drop vapor diffusion technique in 96-well plates with a total 
reservoir volume of 50 µl by mixing 0.5 µl protein:RNA solution with 0.5 µl of precipitant 
solution. Optimization of crystallization conditions was performed at 20 °C using the sitting-
drop vapor diffusion technique in 24-well plates with a total reservoir volume of 300 µl by 
mixing 1 µl protein:RNA solution with 1 µl of precipitant solution. In order to test the crystals 
for diffraction, crystals were incubated in different cryoprotectants (serial transfer from 7.5 % 
to 15 % ethylene glycol, 5 % to 20 % glycerol, or 15 % to 30 % PEG 400), subsequently 
mounted in nylon loops, and flash frozen in liquid nitrogen. Crystals were tested at several 
beamlines at DESY (Hamburg, Germany) and at the ESRF (Grenoble, France), but no data 
sets were collected. 
4.13.3 Small Angle X-ray Scattering (SAXS) experiments and data processing 
Synchrotron SAXS data were collected at the X33 beamline (EMBL/DESY, Hamburg, 
Germany) and at the ID14-3 beamline (ESRF, Grenoble, France). Wild-type She2p and 
She2p-L130Y were measured in size-exclusion buffer 4 (see chapter 4.9.4) at three 
concentrations each (1.37 mg/ml, 2.8 mg/ml, 5.92 mg/ml for She2p-wt, and 2.0 mg/ml, 
3.75 mg/ml, 6.9 mg/ml for She2p-L130Y). Scattering patterns were measured with exposure 
times of 2 min (X-33) and ten times for 30 seconds (ID14-3), respectively. Data evaluation 
and processing was performed using different programs from the ATSAS 2.1 software 
package (Konarev et al., 2006). PRIMUS was used for primary analysis of the data and to 
exclude potential sample aggregation during the measurement. Divergence of the normalized 
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scattering curves at small s-values would be a sign of concentration-dependent protein 
aggregation or of attractive forces between the molecules. The radius of gyration Rg was 
calculated using the Guinier approximation with the constraint s*Rg < 1.3 (Guinier and 
Fournet, 1955). The pair-distribution function P(r) and the maximum dimension of the 
particle Dmax were computed using the indirect transform package GNOM. The correct Dmax 
was iteratively determined by evaluating the resulting Rg value and the shape of the P(r) 
function. The theoretical scattering curves of the She2p-crystal structure (PDB ID: 1XLY) and 
of modeled tetrameric She2p structures were determined with the program CRYSOL 
(Svergun et al., 1995). SAXS data were collected for wild-type She2p and She2p-L130Y in 
various buffer conditions. Except for protein samples that were measured in size-exclusion 
buffer 4, we observed interparticle interference or protein aggregation at higher 
concentrations. Thus, only data were processed that were collected for both proteins in size-
exclusion buffer 4. As reference proteins for determination of molecular masses (Mylonas and 
Svergun, 2007), bovine serum albumine (5.7 mg/ml) and lysozyme (8.5 mg/ml) were 
measured in buffer containing 50 mM HEPES (pH 7.5) and 2 mM DTT. Ab initio models of 
wild-type She2p were calculated with the programs GASBORp and GASBORi (Svergun et al., 
2001). GASBORp uses the pair-distribution function for modeling, whereas GASBORi uses 
the non-transformed scattering intensity. For modeling, different particle symmetries were 
assumed, but only calculations without any given symmetry (P1) gave reasonable results. Since 
at the highest protein concentration, the quality of scattering data was reduced, several bead 
models were calculated for different protein concentrations. For each final bead model, 10 
identically calculated models were averaged and aligned to the She2p structure using the 
programs DAMAVER and SUPCOMB (Volkov and Svergun, 2003).  
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6  Appendix 
 
6.1  Secondary-structure predictions of zipcode elements and of  
  unrelated stem-loop containing RNAs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Secondary-structure predictions of zipcode elements and of unrelated stem-loop 
containing RNAs. Illustrated are the four ASH1 zipcodes, the minimized ASH1 E1 and ASH1 E2B 
zipcodes used for crystallization, the zipcode of EAR1, the N-terminal zipcode of WSC2, and the stem loops 
of HIV-I TAR, U1snRNA, and MS2, respectively. Secondary predictions were calculated using the MC-Fold 
algorithm (Parisien and Major, 2008). 
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6.2  RNA oligonucleotides used for co-crystallization experiments  
  with She2p-(6-246)-ΔCys 
 
RNA length 
(nts) 
Crystals in complex with 
She2p-(6-246)-ΔCys 
ASH1 E3 118 -
E1min 49 -
E2Bmin 36 -
E2Bmin-21 21 +
E2Bshort-01 23 +
E2Bshort-02 24 -
E2Bshort-03 24 -
E2Bshort-04 21 +
E2Bshort-05 19 +
E2Bshort-06 20 -
E2Bshort-07 21 -
E2Bshort-08 19 -
E2Bshort-09 19 -
 
 
6.3  2D 1H-15N-HSQC spectrum of wild-type She2p 
 
 
 
 
 
 
 
 
 
 
 
 
Table A1: RNA oligonucleotides used 
for co-crystallization experiments with 
She2p-(6-246)-ΔCys. The table 
summarizes the crystallization experiments 
that were performed with She2p-(6-246)-
ΔCys and the respective ASH1-mRNA 
fragments. The labels “+” and “-“ indicate 
if crystals of the respective RNA:protein 
complex could be obtained or not. The 
sequences of all RNAs are listed in chapter 
4.2.2. 
Figure A2: 2D 1H-15N-HSQC 
spectrum of wild-type She2p. Shown 
is a two-dimensional HSQC spectrum of 
She2p, which was recorded by the 
laboratory of Prof. Michael Sattler. Only 
a few peaks of She2p were obtained in 
the NMR experiments, rendering She2p 
inappropriate for NMR-titration 
experiments (see chapter 2.1.7). 
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6.4  She2p-sequence alignment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3: She2p-sequence alignment. Shown is a sequence aligment of She2p from different yeast 
species. Secondary structural elements that were obtained from the X-ray structure are denoted. Sequence 
similarity is encoded by a yellow-to-green color gradient, representing 40% to 100% identity. Figure was 
adapted from Niessing et al., 2004. 
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6.5  Assessment of ASH1-mRNA localization by in situ hybridization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.6  Sedimentation profile of wild-type She2p as obtained in   
  sedimentation-velocity experiments 
 
 
 
 
 
 
 
 
Figure A4: Impaired ASH1-mRNA binding by She2p results in mislocalization of 
ASH1 mRNA in vivo. In situ hybridization experiments using fluorescently labeled 
oligonucleotides against ASH1 were performed in wild-type cells and in She2p-ΔhelixE-
expressing yeast strains. a)-c) In wild-type cells ASH1 mRNA efficiently localizes to the 
bud tip (marked by an arrow). d)-f) In She2p-ΔhelixE-expressing Δshe2 cells no ASH1-
mRNA localization to the bud tip was observed (0 % localization in n ≥ 100 cells). 
(a, d) show in situ hybridization with Texas Red-labeled oligonucleotides against ASH1 
mRNA, (b, e) show Hoechst nuclear staining, and (c, f) display merged signals of the 
respective ASH1 and nuclei stainings. This experiment was performed by Maria Schmid 
from the laboratory of Prof. Ralf-Peter Jansen. 
Figure A5: Sedimentation profile of wild-
type She2p from a sedimentation-velocity 
experiment. Shown is the protein distribution 
during a sedimentation-velocity experiment, 
which was performed with wild-type She2p at 
an intermediate concentration of 16 µM. The 
absorbance measured at 280 nm is plotted 
against the radius of the measuring cell. The 
curves from left to right represent the protein 
distribution at increasing time points. From this 
profile, a sedimentation coefficient of 9.64 
Svedberg (S) was calculated.  
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